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Abstract 
 
Mastitis represents one of the major economical and animal welfare concerns 
within the dairy industry. Animals affected with this disease can experience a range of 
clinical symptoms from mild discomfort and swelling of the udder to a severe systemic 
inflammatory response that could result in the death of the animal. This range of 
responses is due to differences in pathogen, environment, and inter-animal differences in 
their innate immune response. A dermal fibroblast model was used to predict the 
magnitude of an animal’s innate immune response towards an intra-mammary S. aureus 
challenge. Animals whose fibroblasts exhibited a low response phenotype, characterized 
by lower levels of IL-8 following in vitro immune stimulation, suffered less mammary 
tissue damage and a less severe reduction in milk quality following the in vivo S. aureus 
challenge as compared to animals classified as high responders. Furthermore, the 
heightened inflammatory response of the high responders offered no advantage in 
bacterial clearance. For a S. aureus infection, the lower response phenotype is preferred.  
 To further explore inter-animal variation in the innate immune response, 
fibroblast cultures were established and challenged with LPS from two breeds of cattle, 
Holsteins, a dairy breed and Angus, a beef breed. Cultures from Holstein animals 
exhibited a higher responding phenotype than cultures from Angus animals. As these two 
breeds undergo selection for different traits and are reared differently as calves, whole 
transcriptome analysis (RNA-Seq) and DNA methylation analysis (Methylated CpG 
Island Recovery Assay; MIRA-Seq) of their fibroblasts was completed to examine the 
genetic and epigenetic basis for the contrasting responses. RNA-Seq revealed several 
immune associated genes that were expressed at higher levels in Holstein cultures 
compared to Angus cultures, including TLR4, IL-8, CCL5, and TNF-α, both basally and 
following LPS exposure. Although MIRA-Seq analysis revealed 49 regions with 
differential methylation between the Holstein and Angus cultures, overall, the 
methylation of the fibroblast genome was similar between these breeds. A combination of 
genetic and epigenetic factors seems to contribute to the breed-dependent differences 
observed between Holstein and Angus fibroblasts.  
Early life exposure to bacterial compounds or inflammatory mediators can have 
long-term effects on the magnitude of an animal’s innate immune response, and may 
contribute to inter-animal variation in this response. To determine if an early life 
exposure to LPS would modify the response to a subsequent LPS challenge in dairy 
animals, neonatal Holstein calves were treated with LPS or saline at 7 days of age and 
subsequently challenged with LPS 25 days later. Calves that received LPS at 7 days of 
age had greatly elevated levels of plasma IL-6 and TNF-α compared to calves that 
received saline, indicating a substantial inflammatory response. However, following the 
subsequent LPS challenge completed on all calves, there were no differences in plasma 
IL-6 and TNF-α between the LPS- and saline- treated calves. Alternative exposure 
strategies in calves may generate the long-term effects observed in other model systems.  
There is a wide range in the responses observed in the innate immune response of 
the bovine. Animals with a lower innate immune response effectively clear the infection, 
but avoid the collateral tissue damage from excessive inflammation. Therefore, it seems 
that a reduced innate immune response would be more beneficial to the dairy cow.  
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Chapter 1: Literature Review 
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1.1 Bovine Mastitis and its Consequences  
Mastitis, or inflammation of the mammary gland, is an economically important 
disease that affects approximately 20% of the cattle in dairy herds within the United 
States (USDA, 2007). A single case of clinical mastitis can cost the producer 
approximately $200, depending on many factors including the causative pathogen, the 
current milk price, the production level of the cow, and the cost of feed (Bar et al., 2008). 
Within the United States, mastitis has been calculated to cost the dairy industry $2 billion 
annually (G.M. Jones, 2009), and the reduction in milk yield from the affected animal is 
one of the largest contributors to this financial loss (Zhao and Lacasse, 2008). A 
comprehensive study of several New York state dairy farms revealed that many of the 
cattle that experience repeated cases of clinical mastitis during a single lactation are 
animals producing the largest volume of milk, resulting in even greater milk losses (Bar 
et al., 2007). Along with a loss in quantity, the recruitment of immune cells into the gland 
to clear the infection elevates the somatic cell count (SCC) of the milk, and if the SCC 
increases above 750,000 cells/ml, the milk is no longer marketable within the United 
States (Ma et al., 2000). Additional factors that contribute to the cost associated with 
mastitis are antimicrobial and supportive treatments administered to the animal and if 
warranted, the premature culling of the animal from the herd (Bar et al., 2008). If the 
inflammatory response is severe enough, the secretory tissue of the mammary gland may 
become damaged, thereby inhibiting the ability of the animal to return to its full 
productive potential (Akers and Nickerson, 2011). A greater profit loss can occur if the 
affected animal is culled and she was in her first lactation, as the investment into rearing 
that animal from a calf into a productive adult cow has not yet been recovered by the 
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producer. The cost of raising a single dairy calf from birth to freshening is one of the 
biggest expenditures on a farm, second to the feed costs of the milking herd. It has been 
estimated that the average producer will spend approximately $2,000 on a replacement 
animal, depending on several factors including current feed prices, management practices 
on the farm, and age at first calving (Heinrichs et al., 2013, Akins, 2015).  
Mastitis is a disease that raises animal welfare concerns for both the dairy 
producer and the consumer. Affected animals can experience pain and discomfort from 
the infected gland, and in a recent study, Norwegian dairy producers ranked the pain 
associated with severe mastitis similar to a dystocia or distal limb fracture (Leslie and 
Petersson-Wolfe, 2012). Additionally, the perception of the consumer on how adequately 
the welfare of the animal is being addressed during an illness is important, as consumers 
want to be assured that the animals producing the milk they purchase are being treated 
humanely (Leslie and Petersson-Wolfe, 2012). Because mastitis affects the animal and 
the producer, as well as the public, a better understanding of the initiation, progression, 
and resolution of the inflammatory response generated towards a mammary infection 
would benefit the dairy industry at several levels.  
1.2 Infectious Agents of Bovine Mastitis  
Mastitis can be caused by a variety of pathogens, including viruses (Wellenberg et 
al., 2002), fungi (Williamson and di Menna, 2007), and bacteria (Oliveira et al., 2013). 
Among these pathogens, bacteria are the most common and are broadly grouped into 
contagious or environmental. Bacteria that are spread from cow-to-cow or between 
quarters of the same animal during milking are considered contagious and include 
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Staphylococcus aureus, Streptococcus agalactiae, and Mycoplasma species, among 
others (Oviedo-Boyso et al., 2007). Alternatively, infection by environmental pathogens, 
such as Escherichia coli, Streptococcus uberis, and Klebsiella pneumonia typically 
occurs between milkings. These pathogens are found in the environment of the animal, 
and fecal-contaminated bedding is a common source of exposure to the bacterium. For a 
short time post-milking, the sphincter muscle at the end of the teat remains open, and if 
the animal lies down shortly after milking, this may provide an entry way into the udder 
for bacteria in the soiled bedding (Oviedo-Boyso et al., 2007).  
The inflammatory response generated following pathogen entry into the gland can 
differ between environmental bacteria such as E. coli and contagious bacteria like S. 
aureus. Infections due to E. coli are typically characterized by acute inflammation 
occurring between 12 - 24 hours post-infection with a dramatic increase in the levels of 
pro-inflammatory cytokines, milk SCC, and permeability of the blood-milk barrier of the 
mammary gland due to the recruitment of neutrophils into the infected quarter (Petzl et 
al., 2008, Suojala et al., 2008). Although a majority of E. coli infections are cleared in a 
matter of days, some strains of E. coli have been known to cause a more persistent 
mammary infection lasting up to 30 days in some animals (Fairbrother et al., 2015). In 
contrast, mammary infections due to S. aureus often develop into a chronic condition, 
and if the infected animal is not removed from the herd, it can serve as a reservoir of the 
bacteria on the farm (Bannerman et al., 2004). The inflammatory response generated 
during a S. aureus infection is typically minimal or delayed in comparison to E. coli 
infections (Petzl et al., 2008). However, there is evidence that infections with some 
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strains of S. aureus will result in a more severe inflammatory response comparable to that 
of E. coli infections (Peton and Le Loir, 2014).  
Concentrations of two cytokines that play a major role in promoting the 
inflammatory and febrile responses, interleukin (IL) -1β and tumor necrosis factor alpha 
(TNF-α), reach high levels during a case of E. coli mastitis (Bannerman et al., 2004). 
While a greater TNF-α response during E. coli mastitis has been associated with a more 
severe systemic response in dairy animals (Ohtsuka et al., 2001), levels of TNF-α in milk 
are often undetectable during S. aureus mastitis (Riollet et al., 2000, Bannerman et al., 
2004). Irrespective of the pathogen causing the infection, a desirable outcome from a case 
of mastitis is an effective inflammatory response that clears the infectious agent along 
with any cellular debris, followed by a quick return to a healthy, functioning gland. As 
the innate immune system is responsible for the initial recognition of the invading 
pathogen, this response is effectively the first line of defense against mastitis pathogens 
once they have evaded the physical barriers of the teat end and entered the mammary 
gland.   
1.3 Innate Immunity and Pathogen Recognition 
The innate immune response plays a key role in the defense against infections. 
This response is initiated within minutes following pathogen exposure and is mediated by 
macrophages, neutrophils, natural killer cells, and cytokines (Oviedo-Boyso et al., 2007). 
It has been suggested that the rapidity and magnitude of the innate immune response can 
influence the progression and resolution of a mammary infection (Bannerman, 2009). 
Pathogens are recognized by germ-line encoded receptors located either on the 
 6 
extracellular surface or within the endosomal membrane on multiple cell types within the 
host (Takeuchi and Akira, 2010). These receptors, known as pathogen recognition 
receptors (PRR), will recognize and bind to highly conserved molecules referred to as 
pathogen associated molecular patterns (PAMP) from a variety of pathogens (Takeuchi 
and Akira, 2010). One class of PRR are the Toll-like receptors (TLR), and there have 
been 10 TLRs discovered in the bovine (Menzies and Ingham, 2006).  
  The recognition of lipopolysaccharide (LPS) from gram-negative bacteria by 
TLR4 requires several adaptor proteins that facilitate the interaction between the receptor 
and LPS. Small amounts of LPS are released during bacterial replication; however, 
higher concentrations are liberated following the death and destruction of the bacteria 
(Zhang et al., 1998). This free LPS is collected by lipopolysaccharide binding protein 
(LBP), an acute phase protein that has a high affinity for LPS in the bloodstream and the 
mammary gland (Bannerman et al., 2003, Takeuchi and Akira, 2007). The formation of 
the LBP-LPS complex allows the trafficking of LPS to a coreceptor that is expressed on 
the cell surface, cluster of differentiation 14 (CD14), which will then chaperone the LPS 
to an accessory molecule, myeloid differentiation factor 2 (MD2) that is attached to the 
extracellular portion of TLR4, initiating a downstream signaling cascade (Mogensen, 
2009).   
TLR2 recognizes a diverse repertoire of molecules from gram-positive bacteria, 
including lipoproteins, peptidoglycan, and lipoteichoic acid (Takeuchi and Akira, 2007). 
This TLR has the ability to form a heterodimer with either TLR1 or TLR6, thereby 
expanding the number of ligands that can be recognized (Takeuchi and Akira, 2007). 
Cluster of differentiation (CD) 36, a transmembrane glycoprotein with several biological 
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roles including platelet function and angiogenesis, has been shown to be an important co-
receptor of TLR2 (Jimenez-Dalmaroni et al., 2009). However, the requirement for CD36 
seems to be ligand-dependent, and CD36 specifically facilitates the sequestering and 
recognition of bacterial diacylglycerides by TLR2/6 heterodimers (Hoebe et al., 2005, 
Jimenez-Dalmaroni et al., 2009). Additionally, the adaptor protein CD14, which is 
required for recognition of LPS by TLR4, has been shown to facilitate the recognition of 
several ligands derived from gram-positive bacteria by TLR2 (Wetzler, 2003, Janot et al., 
2008). 
Following binding of the respective ligand by a TLR, two different intracellular 
pathways can be activated, one utilizing the adaptor protein myeloid differentiation 
primary response gene 88 (MyD88), and the other employing the protein Toll/interleukin-
1 receptor (TIR) domain-containing adaptor inducing IFN-β (TRIF) (Mogensen, 2009). 
Within the ten TLRs in the bovine, every TLR utilizes the MyD88-dependent pathway 
except for TLR3, which instead signals through the TRIF-dependent pathway, and TLR4, 
which has a unique ability to signal through both the MyD88-dependent and the TRIF-
dependent pathways (Mogensen, 2009, Kawai and Akira, 2010). Factors that may 
influence which pathway is followed after LPS recognition include the bacterial species 
the LPS originated from, variations in the conformation and structure of the lipid A 
moiety of the LPS, and the amount of the various adaptor proteins available to assist in 
the recognition of LPS (Zughaier et al., 2005).  
Activation of the MyD88-dependent pathway will promote the phosphorylation 
and degradation of the inhibitory protein IκB, freeing the transcription factor nuclear 
factor-kappa B (NF-κB) and allowing its translocation into the nucleus to promote 
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transcription of various inflammatory genes (Takeuchi and Akira, 2010). Simultaneously, 
mitogen activated protein kinases (MAPK) will be activated, and induce the activity of a 
second transcription factor, activator protein 1 (AP-1) that also promotes the expression 
of various cytokines. The TRIF-dependent pathway results in the phosphorylation, 
activation, and nuclear translocation of the transcription factor interferon regulatory 
factor 3 (IRF3), which is required for the induction of Type I interferons (IFN) and IFN-
inducible genes. Additionally, the TRIF pathway does lead to a delayed activation of NF-
κB that contributes to the later-phase of the inflammatory response (Mogensen, 2009).  
Each of the TLR signaling pathways lead to the activation of the transcription 
factor NF- κB, which along with AP-1 and IRF3, control the expression of various pro- 
and anti-inflammatory genes (Kawai and Akira, 2007). Upon nuclear translocation of 
NF- κB, production of cytokines such as IL-1β, TNF-α, and IL-6 along with chemokines 
such as IL-8 and chemokine (C-C motif) ligand 5 (CCL5) is stimulated (Kawai and 
Akira, 2007). Cytokines are small soluble proteins that have the capacity to influence 
multiple biological processes within the body (Dinarello, 2007). IL-1β and TNF-α are 
two key pro-inflammatory cytokines whose effects are similar: promoting a fever, 
activating endothelial cells and leukocytes, and inducing a systemic acute phase response 
(Bannerman, 2009). Due to the overlapping roles these two cytokines play in the 
inflammatory response, high levels of both cytokines during a case of mastitis can result 
in deleterious effects including systemic shock, blood vessel leakage, and in severe cases, 
multiple organ failure and death (Bannerman, 2009). Similarly, IL-6 can induce fever, 
lymphocyte activation, and increase the magnitude of the inflammatory response by 
inducing the synthesis of acute phase proteins by the liver. Higher levels of IL-6 as well 
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as IL-1β in milk from dairy cattle suffering from mastitis have been correlated with a 
greater severity in clinical symptoms (Hagiwara et al., 2001, Bannerman, 2009).  
Chemokines are a large family of cytokines that derive their name from their 
chemotactic ability. These proteins are produced from a variety of cells and recruit 
various types of immune cells including antigen-presenting cells, neutrophils, and 
lymphocytes to sites of infection (Sokol and Luster, 2015). Expression of chemokines 
such as IL-8, CCL20, and CCL5 will increase dramatically in the infected mammary 
tissue, stimulating the influx of neutrophils, lymphocytes, and monocytes, respectively 
(Bannerman, 2009). During mastitis, neutrophils are recruited into the gland from the 
blood due to elevated levels of IL-8 in tissue and milk. These cells will make up 
approximately 90% of the incoming immune cell population and are the primary 
phagocytic cells entering the mammary gland during the early phase of the infection 
(Sordillo and Streicher, 2002).  
An effective, yet controlled inflammatory response is needed in order to 
maximize the clearance of the pathogen while minimizing collateral damage to the 
mammary gland during mastitis. The magnitude of the innate immune response can be 
quite variable between animals during a case of mastitis, which can influence the 
progression and resolution of the infection. 
1.4 Phenotypic Variation in the Innate Immune Response 
The infecting pathogen or differences in endogenous host physiology can 
influence the magnitude of the innate immune response following bacterial mastitis. As 
discussed above, the response generated towards E. coli and S. aureus mammary 
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infections are typically quite different. However, host factors can also influence the 
initiation and progression of the inflammatory response towards mastitis (Burvenich et 
al., 2003). This is best demonstrated in experimental mammary challenge models that 
control for pathogen factors, such as the strain and amount of bacteria infused. Schukken 
et al. (1999) observed a large degree of variation in the propensity for an animal to 
become infected following an experimental quarter-level S. aureus challenge conducted 
on 135 dairy cows, leading to the conclusion that individual cow factors led to the inter-
animal differences in the tendency to develop an infection. Additionally, a large range in 
the extent of clinical symptoms and bacteria clearance rates was present in 36 cows that 
underwent an intra-mammary challenge with E. coli (Kornalijnslijper et al., 2003).  
 The clinical symptoms during a natural exposure case of bovine mastitis can be 
variable as well, and these symptoms, regardless of the infecting pathogen, can be 
grouped into a three-grade severity scoring system. This system is broken down into mild 
cases, which have minor changes in milk consistency but no systemic signs, moderate 
cases that include localized swelling and discomfort of the mammary gland along with 
flakes or clots in the milk, and severe cases of mastitis with acute swelling of the 
mammary gland, changes in milk consistency and/or color, and a systemic inflammatory 
response (Pinzon-Sanchez and Ruegg, 2011). Animals can exhibit a range of clinical 
symptoms during natural mastitis caused by a variety of bacteria, as demonstrated by a 
survey conducted on 50 Wisconsin dairy farms (Oliveira et al., 2013). Within the mastitis 
cases that had a severity score recorded, 47.8, 36.9, and 15.3% had clinical symptoms 
that were classified as mild, moderate, and severe, respectively. Furthermore, a majority 
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of the severe cases of mastitis observed on these Wisconsin dairy farms were due to E. 
coli or other gram-negative bacteria (Oliveira et al., 2013).  
These studies highlight that the susceptibility to mastitis and the resulting 
inflammatory response are quite variable between animals. While some animals respond 
with a low degree of inflammation and suffer few, if any, clinical symptoms, other 
animals will mount a more robust response, characterized by high levels of cytokines and 
chemokines that could inadvertently inflict collateral damage to the mammary tissue 
(Zhao and Lacasse, 2008, Schukken et al., 2011). There has been much debate as to what 
type of response is better for pathogen clearance and the host: a rapid, more robust 
response or a slower, more moderate one.  
Through the use of an autologous dermal fibroblast model, the innate immune 
response of dairy cows towards an intra-mammary E. coli challenge was predicted 
(Kandasamy et al., 2011). Animals were classified as a low or high responding phenotype 
based on the production of IL-8 from their fibroblast cultures following a challenge with 
LPS, and animals from the top and bottom 15% of the range of IL-8 responses were 
selected for the intra-mammary challenge. It was observed that animals that were ranked 
as high responders exhibited greater levels of tissue damage within the mammary gland, 
determined by higher levels of bovine serum albumin (BSA) in milk, as well as a greater 
influx of neutrophils into the infected gland during the resolution phase of the infection 
(determined by SCC). Interestingly, the greater recruitment of neutrophils into the gland 
of the high responding animals did not result in faster E. coli clearance, as these animals 
cleared the infection in a similar time frame (approximately 7 d) as the low responders. 
This suggests that the heightened inflammation generated by the high responding animals 
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in response to the E. coli challenge did not offer any advantage in the resolution of the 
infection. Additionally, animals with a robust inflammatory response are at a greater risk 
for suffering collateral tissue damage during mastitis, increasing the potential for a long-
term reduction in milk yield from that animal.  
1.5 Breed Differences in the Innate Immune Response  
Cattle, as a species, have undergone dramatic selection pressures from producers 
in order to select for desirable traits, such as milk production or feed efficiency. As a 
result of this selection, several different breeds of cattle have arisen; each with certain 
distinguishable characteristics, and these cattle breeds can be grouped into two sub-
species, Bos indicus or Bos taurus. Cattle breeds of the B. indicus sub-species show better 
thermotolerance and can better utilize poorer quality forages compared to B. taurus 
breeds, however, B. taurus breeds typically produce greater volumes of milk and show 
greater lactation persistency.  
It has been shown that B. indicus breeds, such as the Brahman and Sahiwal, have 
greater resistance to tick infestations and tick-borne diseases as compared to B. taurus 
breeds like the Holstein (Glass et al., 2005, Piper et al., 2008). During an experimental 
tick infestation, Brahman animals had a lower number of attached ticks than Holsteins 
(15 vs. 151 per side of the animal, respectively) (Piper et al., 2008). Skin biopsies 
collected from both the Holsteins and Brahmans at tick attachment sites demonstrated 
that Holsteins had greater expression of many innate immune response-related genes, 
such as MyD88, CD14, TRAF-6, IL-1β, and TNF-α, compared to the Brahmans. 
Furthermore, Holsteins exhibited a more severe clinical response to a Theileria annulata 
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challenge, the causative agent for the tick-borne disease, tropical theileriosis, resulting in 
the euthanasia of all Holsteins prior to the conclusion of the trial. In contrast, the 
Sahiwals seemed to be more resistant to the deleterious inflammation and recovered from 
the challenge, clearing the parasite by day 14 post-infection (Glass et al., 2005). These 
studies seem to suggest that the Holstein breed has a more vigorous innate immune 
response compared to B. indicus breeds, and that this may not be beneficial.  
The breeds of the B. taurus sub-species can be further broken down into dairy 
cattle (selected for high volumes of milk production), beef cattle (selected for calf rearing 
ability and feed efficiency), and dual purpose cattle (selected for traits of both dairy and 
beef animals). Several studies have examined the innate immune response of various B. 
taurus breeds as the selection pressures imparted on these breeds are quite different, 
depending on the desirable traits the producer is selecting for. Intra-mammary challenges 
completed on Holstein and Jersey cattle, the two most common dairy breeds within the 
United States, revealed that the innate immune response towards mammary infections 
due to E. coli (Bannerman et al., 2008a) or S. aureus (Bannerman et al., 2008b) is 
relatively conserved between these two breeds. Additionally, following an intravenous 
LPS challenge on Angus and Romosinuano beef cattle, differences were observed 
between the breeds in levels of inflammatory mediators (Carroll et al., 2011). Although 
Angus steers experienced a higher serum cortisol response, Romosinuano steers had 
greater levels of serum TNF-α and IL-1β along with a higher febrile response following 
the LPS challenge. The author concluded that the Romosinuano breed seem to mount a 
more robust response towards LPS while the heightened cortisol response of the Angus 
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animals suggested that this breed may be better able to control the inflammatory 
response.  
There is a surprising lack of studies that have explored differences between dairy 
and beef breeds, particularly in regards to mastitis susceptibility. Several groups have 
collected milk samples from beef and dairy animals to determine rates of mastitis and the 
bacterial species causing infections. A mastitis survey was completed on ten beef herds 
consisting of Herefords, Simmentals, and Limousin breeds, in which milk samples were 
collected during the month after calving and again at weaning (Persson Waller et al., 
2014). Averaged across the herds, 40% of the cattle experienced a mammary infection at 
calving or weaning, and the majority of these infections were caused by S. aureus, 
followed by coagulase negative Staphylococcus species. Surprisingly, there were no 
coliform species isolated from any of the beef animals. This lack of coliforms or other 
gram-negative bacteria isolated from quarters of beef cows has been documented in other 
studies (Paape et al., 2000, Lents et al., 2008). This observation is surprisingly different 
from mastitis surveys completed on dairy herds, during which the rate of coliform 
isolation from milk samples ranges between 10 - 35.6% (Oliveira et al., 2013, Hertl et al., 
2014, Levison et al., 2016). The apparent lack of coliform mastitis in beef animals may 
indicate genetic or epigenetic breed differences that impart a degree of resistance to these 
pathogens by these breeds. However, differences between typical environments of 
lactating beef and dairy animals, such as lower stocking density and more frequent 
suckling in beef animals, may also affect mastitis incidence. 
Based on these findings, it may be of interest to investigate potential differences 
in the innate immune response between adult dairy and beef animals under controlled 
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environmental conditions. These animals are selected for different traits, which may lead 
to genetic differences in the immune response between beef and dairy cattle. 
Additionally, the young are reared quite differently between beef and dairy herds. Dairy 
calves are separated from the dam at birth and fed a milk-replacer based diet for the first 
6 - 7 weeks of life. In contrast, beef calves remain with the dam out on pasture, and are 
allowed to nurse for the first 3 - 6 months of its life. These differences in the early-life 
environment of dairy and beef calves may cause epigenetic modifications that could 
change the expression of innate-immune response genes, thereby influencing disease 
resistance or severity in the adult animal.  
1.6 Epigenetics 
A phenotypic trait of an animal results from the combination of that individual’s 
genetic make-up and how the environment has influenced the expression of genes. 
Although mutations within the DNA sequence can cause changes in gene expression 
between animals (Novak, 2014), some modifications induced by the environment do not 
change the primary DNA sequence. These are termed epigenetic modifications, and 
epigenetics is the study of these alterations, and how they impact gene expression and the 
animal’s phenotype. Epigenetic changes can include histone acetylation and methylation, 
long non-coding RNAs, and DNA methylation (Breiling and Lyko, 2015, Larriba and Del 
Mazo, 2016, Messier et al., 2016). While these modifications are responsible for the 
regulation of several biological processes, including cell differentiation (Alvarez-Errico 
et al., 2015), X chromosome inactivation in females (Engel, 2015), and aging (Munoz-
Najar and Sedivy, 2011); aberrant epigenetic changes have been linked to human diseases 
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such as Huntington’s (Glajch and Sadri-Vakili, 2015), Alzheimer’s (Sanchez-Mut and 
Graff, 2015), and several types of cancer (Gu et al., 2015, Vizoso et al., 2015). 
1.7 DNA Methylation  
DNA methylation is a covalent epigenetic modification that involves the addition 
of a methyl group onto the 5th carbon within the 6-carbon ring of the nucleotide cytosine. 
This “classic” epigenetic mark most often occurs at cytosine-guanine (CpG) 
dinucleotides, and is associated with transcriptional silencing of the gene (Schubeler, 
2015). A group of enzymes known as DNA methyltransferases (DNMTs) mediates the 
addition and maintenance of the methylation pattern on the cytosines. DNMT1, the 
maintenance enzyme, has a high affinity for hemimethylated strands of DNA following 
DNA replication, and will copy the methylation pattern from the parent to the daughter 
strand. DNMT3A and 3B are the de novo methyltransferases that establish the 
methylation pattern during early development (Uysal et al., 2015). 
The pattern of DNA methylation is dynamic during an animal’s lifetime, gaining 
and losing methylation at critical points in development or during cellular 
reprogramming. There has been much work in determining the mechanisms involved 
with the removal of methylation from DNA. One proposed method is the down regulation 
of the DNMTs, resulting in a gradual reduction in DNA methylation with each cell 
division. A second method that was recently discovered represents a more active 
demethylation that is catalyzed by a family of enzymes known as ten-eleven translocation 
(TET) proteins (Piccolo and Fisher, 2014). This is accomplished through a series of 
oxidation steps that result in the conversion of 5-methyl cytosine (5mC) to 5-
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formylcytosine (5fC) and 5-carboxylcytosine (5caC). These altered bases will then be 
removed by the enzyme thymine-DNA glycosylase, and base excision repair machinery 
will insert an unmodified cytosine nucleotide (He et al., 2011, Rasmussen and Helin, 
2016). 
Several high throughput-sequencing techniques have been developed to examine 
the methylome of an individual on a genome wide scale, each with distinct strengths and 
weaknesses. Within the bovine research field, whole genome bisulfite sequencing, 
reduced representation bisulfite sequencing (RRBS), and techniques that depend on the 
selective binding and precipitation of methylated DNA are available. Selection of one 
technique over another depends on the economic feasibility, the amount of sample 
available, and the desired sensitivity of the end result.  
During whole genome bisulfite sequencing, the genomic DNA is treated with 
sodium bisulfite, which will change unmethylated cytosines to uracil by a process known 
as deamination, while methylated cytosines are protected (Clark et al., 2006). After the 
conversion, the products are sequenced, allowing for the comparison of converted to 
unconverted DNA from each sample. Although this technique is considered the gold 
standard in determining the methylome of an individual at base pair resolution, it requires 
a tremendous amount of sequencing per sample, making the cost of whole genome 
bisulfite sequencing prohibitive for many researchers.   
A second technique that is largely based off of whole genome bisulfite sequencing 
is RRBS. This technique provides a cheaper alternative for researchers interested in 
mainly the methylation status of CpG sites in gene promoters and other regions of the 
genome with high CpG content. The genomic DNA is first treated with the restriction 
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enzyme Msp1, which cleaves at 5’-C^CGG-3’ sites. The resulting DNA fragments are 
then size-selected to lengths appropriate for sequencing, and treated with sodium bisulfite 
to convert the unmethylated cytosines to uracils. These fragments will have a CG at one 
end, as well as potential internal CGs. Following PCR amplification and sequencing, the 
sequences are compared to a whole genome reference sequence, such as Bos-taurus-
UMD-3.1, to determine methylated CpG sites (Gu et al., 2011). The amount of 
sequencing following the bisulfite conversion in RRBS is substantially less than that of 
whole genome, reducing the overall costs and making RRBS a more economically 
permissive technique for many researchers.  
Analysis of DNA methylation may also be completed by the creation of DNA 
libraries following enrichment of methylated regions of DNA. This can be accomplished 
with either an antibody-based method or a technique that uses a complex of proteins that 
bind methylated DNA. Methylated DNA immunoprecipitation sequencing (MeDIP-seq) 
utilizes antibodies generated against either 5mC or 5-hydroxymethylcytosine (5hmC), an 
oxidation product of the demethylation of 5mC by TET proteins, to precipitate 
methylated DNA fragments that can then be sequenced. The DNA does not need to be 
treated with sodium bisulfite; however, it must be denatured in order to allow for efficient 
binding of the antibodies to 5mC or 5hmC (Fouse et al., 2010). Methylated-CpG Island 
Recovery Assay (MIRA) works by capitalizing on the high binding affinity that the 
complex formed by methyl-binding protein MBD2b and its homologue, MBD3L1 has 
towards methylated DNA (Jung et al., 2015). This technique does not require 
denaturation or sodium bisulfite treatment of the DNA, and the MBD proteins do not 
interact with 5hmC, thus allowing for specificity towards 5mC (Jin et al., 2010). 
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Although MIRA and MeDIP-Seq are relatively inexpensive techniques to determine 
DNA methylation patterns of an animal’s genome, neither technique offers single base-
pair resolution as bisulfite-sequencing methods do.  
Lastly, a technique that is currently only available for human research is the 
Illumina 450k Methylation Bead Chip that examines over 480,000 CpG sites within the 
human genome following sodium bisulfite treatment of the DNA (Ma et al., 2013). 
Released in 2011, this array targets each of the selected CpG sites by two different probe 
sets: one that matches the methylated sequence and that matches the unmethylated 
sequence. While this technique can provide a researcher with the methylation status of 
several CpG sites, this array covers only 1.7% of the total CpG sites within the human 
genome (Ma et al., 2013).  
1.8 Aberrant DNA Methylation and the Inflammatory Response 
As discussed previously, DNA methylation is a key modification that regulates 
several biological processes within the body. However, a growing body of evidence 
demonstrates that differences in methylation pattern can result in differences in gene 
expression that may influence the magnitude of the inflammatory response generated 
towards a pathogen. Several factors have been shown to induce methylation differences, 
including bacterial and viral infections, and inflammation associated with those 
infections.   
Bacteria are capable of inducing epigenetic modifications within the host that can 
create an environment more suitable for the bacteria’s survival. Porphyromonas 
gingivalis, the predominate bacteria involved in chronic periodontitis, induces an increase 
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in methylation within the TLR2 promoter of gingival epithelial cells, reducing TLR2 
expression and thereby modulating the host’s innate immune response (Benakanakere et 
al., 2015). In some instances it is not the pathogen directly but rather the inflammation 
associated with the infection that induces the changes in DNA methylation. During 
experimental chronic infections with Helicobacter pylori in gerbils, the level of DNA 
methylation in intestinal epithelial cells increased and it was determined that the 
inflammatory response associated with the infection led to the greater methylation (Niwa 
et al., 2010). However, not every alteration in methylation is associated with a disease 
state. As compared to pathogens, commensal bacteria within the intestines induce greater 
methylation of the TLR4 gene promoter of intestinal epithelial cells, reducing its 
expression and preventing an excessive inflammatory response towards the “good” 
bacteria (Takahashi et al., 2011).  
Cytokines play a key role in the initiation and progression of inflammation 
following pathogen exposure, and in some diseases, an exacerbated inflammatory 
response can result in severe collateral damage to the host. Elevated levels of serum IL-6 
and IL-8 in human patients suffering from inflammatory rheumatoid arthritis and severe 
periodontitis have been linked to lower methylation in the promoter regions of those 
genes as compared to healthy controls (Andia et al., 2010, Ishida et al., 2012). In another 
example, the dengue virus is a prevalent arthropod-borne virus that in some patients can 
cause a severe hemorrhagic form of dengue fever characterized by over-expression of 
TNF-α. In these patients, the levels of methylation within the TNF-α gene promoter are 
lower compared to other individuals that developed the more moderate form of disease. 
This suggests that the reduced methylation levels of the TNF-α promoter could be 
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associated with the heightened TNF-α expression during this disease (Gomes et al., 
2016). Additionally, Sun et al. (2013) observed that while the expression and production 
of interferon-gamma (IFN-γ) is absent in newborn foals, it increases with age. This age-
dependent increase in IFN-γ production was determined to be due to a gradual loss of 
methylation within the IFN-γ promoter. While reduced IFN-γ production may be a 
protective strategy to prevent fetal loss in utero, following birth, the IFN-γ production 
must increase quickly in order to protect the foal against intracellular bacterial infections.  
Changes in DNA methylation have been linked to an increased risk for several 
human diseases, including those associated with a dysregulation of inflammation and 
various types of cancer. While genetic factors can lead to the development of non-
alcoholic fatty liver disease (NAFLD), some individuals develop a more severe form of 
the disease and this variation cannot be explained by genetics alone. A mouse model 
revealed that the levels of DNA methylation within the liver pre-determined an 
individual’s propensity towards developing the more severe form of NAFLD (Tryndyak 
et al., 2016). Likewise, an asthma study completed on a cohort of monozygotic twins 
uncovered that differences in the development of asthma was due to functional changes 
of T cell subsets associated with DNA methylation differences between the twins 
(Runyon et al., 2012). Additionally, aberrant methylation as well as other epigenetic 
modifications of several cytokine genes have been associated with their transcriptional 
dysregulation, leading to an increased risk for the development of several types of cancer, 
including breast, cervical, gastric, colorectal, and pancreatic (Yasmin et al., 2015).  
Within the field of bovine research, epigenetic modifications and the role they 
may play in susceptibility to disease is a recent area of study. Still, several studies have 
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revealed key aspects regarding DNA methylation and the modulation of the immune 
response in the dairy animal. Through the use of a dermal fibroblast cellular model, 
Green and Kerr (2014) demonstrated that DNA methylation was at least partially 
responsible for an age-dependent increase in the IL-8 response following LPS exposure 
of fibroblasts isolated from the same animals at 5 and 16 months of age. Additionally, 
Wang et al. (2013b) determined that the levels of methylation in the promoter region of 
the CD4 gene in whole blood were 16% higher in mastitic cows than healthy cows. The 
increased promoter methylation was associated with a reduced expression of CD4 that 
may have been due to the methyl groups prohibiting binding of transcription factors in 
the affected animals. In an experimental mastitis model, liver biopsies were collected 
from dairy animals that had undergone an intra-mammary E. coli challenge to determine 
epigenetic mechanisms that may contribute to the initiation and progression of 
inflammation. Chromatin analysis on four innate immune response genes, TLR2, TLR4, 
LBP, and haptoglobin (Hp) revealed that the increased expression of these genes in the 
challenged animals compared to healthy controls was associated with opening of the 
chromatin. Additional analysis on the TLR4 gene revealed the E. coli infection induced a 
loss of promoter methylation, leading to its greater expression (Chang et al., 2015).  
1.9 Fetal and Early Life Programming 
The innate immune response of an animal can be influenced by events occurring 
to the dam during pregnancy, and during the neonatal period. Aspects of the maternal diet 
can induce changes within the in utero environment, which can modulate features of the 
offspring’s immunity. Late pregnant cows are often supplemented with mineral mixes to 
 23 
ensure an adequate supply of minerals for fetal growth and parturition. Traditionally, 
cows have been fed an inorganic sulfate-based mineral mix, but new mineral mixes have 
been developed that contain chelates, or trace minerals complexed with amino acids and 
other molecules to increase their absorption by the cow (Swecker, 2014). There is some 
evidence that the chelate mixes also promote an enhanced immune response around 
parturition (Wang et al., 2013a), however, the effects of mineral mix supplementation on 
the calf are unknown. Therefore, groups of pregnant cows were fed either a sulfate-based 
or a chelate mineral mix for the last 30 days of their pregnancy and the expression of 
innate-immune response genes were examined in neutrophils isolated from their calves at 
birth, and 1, 7, and 21 days of age (Jacometo et al., 2015). Neutrophils from calves whose 
dams were fed the sulfate-based minerals had greater expression of several genes within 
the toll-like receptor pathway, including MyD88, IRAK1, TRAF6, and NF-κB, as well as 
increased expression of micro RNA (miR) 155 as compared to those calves from dams 
fed the chelate mix. These results reveal that mineral supplementation as well as the 
specific formulation of the mineral supplied to the dam can affect the expression of 
immune response genes within the calf. Although the increased expression of miR-155 
was suggested as a possible mechanism responsible for inducing the greater gene 
expression in calves from sulfate-based mineral supplemented dams, epigenetic 
modifications induced by the maternal mineral mix supplementation may also play a role.  
Obesity has been shown to induce a pro-inflammatory state within the intestines, 
which may be linked to the development of inflammatory bowel disease (IBD). A sheep 
model was used to determine the effects of maternal obesity on the inflammatory gene 
response within the intestines of the offspring and the likelihood to develop IBD (Yan et 
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al., 2011). Non-pregnant ewes were fed an obesogenic diet from 60 days prior to 
conception till lambing, and intestinal biopsies were collected from lambs at birth and 
22.5 months of age for mRNA analysis. Within the intestines of the offspring of obese 
dams, there was greater expression of TLR2, TLR4, IL-6, IL-8, and transforming growth 
factor beta (TGF-β), as well as greater fibrosis of the intestinal lining compared to 
offspring from dams fed a control diet. As TGF-β and IL-6 have been shown to drive the 
differentiation of Th17 cells, a population of inflammatory T-cells that play a crucial role 
in the development of IBD, it was suggested that the greater expression of these two 
genes and other pro-inflammatory mediators led to an increase in Th17 cells in the 
intestines, further promoting inflammation. As these increases in gene expression and 
fibrosis were not observed in the control lambs, it was determined that feeding an 
obesogenic diet to the dam during pregnancy was the primary factor driving the increased 
inflammation.  
Maternal inflammation due to an infection can lead to the production of 
inflammatory mediators that can affect the placenta or produce a febrile response that 
could impact the growing fetus. Several studies have utilized an injection of LPS given to 
the dam to induce maternal inflammation and determine its effects on the offspring. A 
single prenatal injection of LPS administered to rats at day 12 of pregnancy resulted in 
decreased levels of gonadotropin-releasing hormone (GnRH) and luteinizing hormone 
(LH). This created an imbalance in the levels of sex steroid hormones in both male and 
female offspring, and delayed the sexual maturation in the females (Izvolskaia et al., 
2016). Additionally, Depino (2015) reported that adult mice whose dams had received a 
single injection of LPS at day 9 of gestation experienced greater anxiety-like behaviors as 
 25 
compared to adult mice whose dams were treated with saline. In another study, LPS was 
administered to pregnant mice at the stage of zygote formation (day 0.5 of pregnancy), 
and the offspring of these dams underwent a subsequent LPS challenge in adulthood 
(Williams et al., 2011). Adult mice born to dams that had received LPS displayed a 
blunted cytokine response following the subsequent LPS challenge compared to the 
offspring of saline control dams.  
Furthermore, immediately after birth the offspring is exposed to a myriad of 
bacteria and environmental factors that could lead to modifications of that individual’s 
immune response phenotype. To mimic an early life exposure to bacterial infection, but 
avoid the bacterial replication, LPS is a common compound used to induce an 
inflammatory response in early life exposure studies. Mouihate et al. (2010) observed that 
rats exposed to LPS on day 14 of life experienced a reduction in the magnitude of the 
overall immune response within the brain towards a subsequent LPS challenge given in 
adulthood. Similarly, neonatal female mice that received an injection of LPS at days 3 
and 10 exhibited a reduced IL-6 and TNF-α response towards an inflammatory stimulus 
given both during adolescence (21 days of age) and adulthood (60 days of age) (Barth et 
al., 2016). Another compound that has been shown to induce changes in gene expression 
in the lung epithelium is ozone. A postnatal exposure to ozone in rhesus macaque 
monkeys resulted in a decrease in IL-6 mRNA and protein from lung epithelial cells 
following an in vitro LPS challenge. It was determined that the reduced IL-6 expression 
and protein was mediated by increased expression of miR-149, a micro-RNA that binds 
to the 3’ UTR of the IL-6 gene and inhibits transcription (Clay et al., 2014).  
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While the mechanisms that lead to these modifications in disease and 
inflammation susceptibility have not been fully elucidated in livestock, several human 
and mice studies have revealed a key mechanistic role for epigenetic modifications. A 
recent review by Vaiserman (2015) described several maternal factors that can alter the 
epigenome of the human fetus. For example, maternal stress and depression during the 
prenatal period led to greater methylation and a reduced expression of the fetal 
glucocorticoid receptor gene. Additionally, exposure to cigarette smoke during pregnancy 
results in the alteration of methylation patterns and the dysregulation of the expression of 
multiple miRNAs that have been implicated in growth and development. Glucocorticoid 
is often administered if a pre-term delivery is expected to aid in the development of the 
fetal lung. However, the impact of the glucocorticoid treatment on the infant’s immune 
system has not been well defined. Pregnant rats were given dexamethasone from days 14-
20 of gestation, and male pups were used to determine the effects of dexamethasone on 
the immune response. Levels of TNF-α mRNA were reduced in the spleens of 7 and 120 
day old rats which had been exposed to prenatal dexamethasone compared to that of 
saline controls. A chromatin immunoprecipitation assay (ChIP) revealed a loss of active 
chromatin marks (acetylation of histone H3 lysines) in the TNF-α gene promoter of 
spleens from rats that had been exposed to maternal dexamethasone (Yu et al., 2014).  
A concept within human research that seeks to explain the increased disease risk 
over the lifetime of an individual is the Developmental Origins of Health and Disease 
theory. Essentially, the idea is that harmful exposures in the early life of an individual can 
lead to genetic reprogramming that may have long-term consequences on the 
development of subsequent diseases (Heindel et al., 2015, Heindel and Vandenberg, 
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2015). The exact outcomes of these insults can vary, depending on the magnitude, timing, 
and duration of the insult itself, as well as genetic background of the exposed individual. 
It has been shown that some of these insults can cause epigenetic modifications that cross 
generations, especially if the insult occurs at a crucial stage of primordial germ cell 
development. However, continued research is required, especially within the field of 
livestock research to determine long-term effects on the offspring that can be induced by 
maternal disease, vaccination, diet, management, and other factors. 
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1.10 Hypotheses and Specific Objectives 
 
The innate immune response plays a critical role in the initiation, progression, and 
resolution of inflammation during a mammary gland infection. Within the dairy cattle 
population, a wide range exists in the magnitude of the innate immune response 
generated towards bacterial mastitis. While some animals mount a robust response 
characterized by heightened cytokine levels and collateral tissue damage, other animals 
seem better able to minimize the inflammation yet still mount an effective response to 
clear the pathogen. The host factors leading to this inter-animal variation have not been 
fully elucidated, but several studies have indicated that the innate immune response can 
be influenced by a combination of genetic and epigenetic mechanisms.  
  
This dissertation tests a number of hypotheses: 
 
1. The response of autologous dermal fibroblasts to a TLR2/6 agonist challenge 
can be used as a cellular model to predict the magnitude of the innate immune 
response towards an intra-mammary S. aureus challenge in dairy cattle.  
2. A combination of genetic and epigenetic factors contributes to the observed 
differences in the LPS response of dermal fibroblasts isolated from Angus and 
Holstein cattle. 
3. Exposure to bacteria, or bacterial compounds in early life can induce 
epigenetic modifications within the innate immune response genes, and 
maintenance of these modifications can affect the innate immune response in 
the adult animal.  
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Through the utilization of the dermal fibroblast model as well as animal challenge 
models, it is hoped that this work will further the understanding of the roles that genetic 
and epigenetic differences play in impacting the variable innate immune response of the 
dairy cow. Based on evidence from previous bovine and rodent studies, our specific 
objectives are:  
 
Experiment 1:  
To examine differences in the innate immune response and propensity to develop a 
chronic infection following an intra-mammary S. aureus challenge on two groups of 
cattle that were ranked as “low” and “high” innate immune responders based on their 
isolated dermal fibroblasts.  
 
Experiment 2: 
To determine the causes that led to the contrasting LPS response from dermal fibroblasts 
collected from Angus and Holstein cattle by performing whole transcriptome analysis to 
more fully explore gene expression differences and a genome-wide DNA methylation 
assessment to examine epigenetic differences in cultures from these two breeds.   
 
Experiment 3: 
To determine if a single exposure to LPS during the first week of life can induce 
sustained effects on the innate immune response to a subsequent LPS challenge, and if so, 
if the altered in vivo responses are reflected by in vitro differences in gene expression by 
autologous dermal fibroblasts and monocyte-derived macrophages.  
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Chapter 2: Cow-to-cow variation in fibroblast response to a toll-like 
receptor 2/6 agonist and its relation to mastitis caused by 
intramammary challenge with Staphylococcus aureus. 
 
Published in the Journal of Dairy Science as:  A.L. Benjamin, B.B Green, L.R. Hayden, 
J.W. Barlow, D.E. Kerr. (2015). Cow- to-cow variation in fibroblast response to a toll-
like receptor 2/6 agonist and its relation to mastitis caused by intramammary challenge 
with Staphylococcus aureus. Journal of dairy science, 98(3):1836-50. 
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2.1 Abstract 
Staphylococcus aureus is a common cause of chronic mammary gland infections 
in dairy cattle. However, the inflammatory response and duration of infection following 
pathogen exposure is variable between individual animals. To investigate interanimal 
differences in immune response, dermal fibroblast cultures were established from skin 
biopsies collected from 50 early lactation Holstein cows. The fibroblasts ability to 
produce IL-8 in response to a 24-h treatment with a synthetic toll-like receptor 2/6 
agonist (Pam2CSK4) was used to assign a response phenotype to the animals. Five high-
responding and 5 low-responding animals were then selected for an intramammary 
challenge with S. aureus to evaluate differences in the inflammatory response, chronicity 
of infection, and development of antibodies to the pathogen. All animals exhibited 
clinical symptoms of mastitis at 24 hours post challenge. Animals previously classified as 
high responders experienced a greater inflammatory response characterized by elevated 
levels of milk somatic cell count, IL-8, and BSA following the challenge compared with 
low responders. In addition, antibodies toward the challenge strain of S. aureus reached 
higher levels in whey from the challenged gland of high responders compared with low 
responders. Despite the antibody response, all 5 high responders were chronically 
infected for the 6-wk duration of the study, whereas 2 of the low responders cleared the 
infection, although 1 of these did become reinfected. The observed differences between 
animals classified as low and high responders based on their fibroblast responsiveness 
suggests that this cell type can be used to further examine the causes of interanimal 
variation in response to mammary infection.  
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2.2 Introduction 
Bovine mastitis can be caused by a variety of pathogens, resulting in variable 
degrees of inflammation of the infected mammary gland and subsequent decreases in 
milk production and quality (Ballou, 2012). Infections caused by S. aureus typically 
result in a relatively mild inflammatory response with a sustained elevation in SCC; 
however, some animals will experience a more severe response, leading to collateral 
damage of the host (Atalla et al., 2009). These infections can develop into chronic, 
subclinical cases, in which infected animals maintain a reservoir of S. aureus on a farm 
(Bannerman et al., 2008, Schukken et al., 2011). Rates of mastitis due to S. aureus have 
decreased since the implementation of the 10-point plan from the National Mastitis 
Council (NMC, 2011), which recommends teat dipping and dry cow therapy as ways to 
minimize the spread of contagious pathogens. However, S. aureus is still present on most 
commercial herds, with incident rates ranging from 0.1 – 10 % (Barlow et al., 2013, Hertl 
et al., 2014, Olde Riekerink et al., 2008). Treatment of long-term infections with 
antibiotics commonly yields an unsatisfactory cure rate (Barkema et al., 2006, Sol et al., 
2000), and these animals are typically removed from the herd to limit spread of the 
pathogen. 
Pathogens entering the mammary gland are recognized by toll-like-receptors 
(TLR), which are found on multiple cell types within the gland and play a pivotal role in 
the innate immune response. These membrane bound receptors are highly specific and 
identify conserved motifs known as pathogen-associated-molecular patterns from various 
pathogens, including bacteria, fungi, and viruses (Takeuchi and Akira, 2010). For 
instance, LPS, a component of the Escherichia coli outer membrane, activates TLR4 
 33 
(Park et al., 2009), and lipoproteins from the S. aureus cell wall activate TLR2 (Zähringer 
et al., 2008). Toll-like receptor signaling pathways lead to the activation of the 
transcription factor nuclear factor-kappa B (NF-κB), which regulates expression of 
various proinflammatory genes (Kawai and Akira, 2007). Increased expression of 
chemokines, such as IL-8, following NF-κB activation promotes recruitment of 
neutrophils to the site of infection. Neutrophils can account for up to 90% of the 
increased cell population within the infected gland and are the main cause of the rise in 
SCC following infection (Sordillo and Streicher, 2002).  
Pathogen-specific differences in infection outcomes following experimentally 
induced mastitis and the resulting inflammatory responses have been observed 
(Bannerman, 2009). However, even in well-controlled situations considerable variation in 
response exists between individual animals. At the farm level, animals in similar 
physiological states under common environmental conditions also exhibit variable 
susceptibility to development of clinical mastitis. Various cell models have been used to 
investigate potential sources for these interanimal differences, including neutrophils 
(Sohn et al., 2007; Revelo and Waldron, 2012), monocyte-derived macrophages 
(Taraktsoglou et al., 2011), and mammary epithelial cells (Lahouassa et al., 2007; Brand 
et al., 2011). As model cells, neutrophils and macrophages are difficult to cryopreserve 
for future studies and can become activated during isolation and culturing processes, 
potentially adding to experimental variation. Mammary epithelial cells show a robust 
response to immunostimulants such as LPS, and these cells can successfully be 
cryopreserved (Wellnitz and Kerr, 2004; Pareek et al., 2005). However, although these 
cells can easily be isolated from tissue collected at euthanasia, procedures to isolate 
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sufficient mammary tissue from live animals are relatively invasive and may compromise 
the ability of the gland to return to full production. We have previously examined the 
autologous dermal fibroblast as a model cell to predict an animal’s responsiveness to 
experimental E. coli mastitis (Kandasamy et al., 2011). The fibroblast is easily obtainable 
and, following isolation, the cells can be cultured quickly and cryopreserved. Cultured 
fibroblasts also demonstrate a robust response following stimulation with various TLR 
agonists (Kandasamy and Kerr, 2012), suggesting that it may be a useful cell type to 
explore the underlying causes for interanimal variation in response to mastitis. In the 
current study we extend these findings to include experimentally induced S. aureus 
mastitis. 
2.3 Materials and Methods 
2.3.1 Animal and Experimental Procedures 
The University of Vermont’s Institutional Animal Care and Use Committee 
approved all animal procedures before commencement of the study. Dermal fibroblast 
cultures were established from skin samples collected from 50 lactating Holstein cows 
housed at a collaborating dairy farm. Animals were randomly enrolled in the study, and at 
the time of biopsy were in early to mid lactation (117 ± 30 DIM). The average lactation 
number of the 50 enrolled cows was 2.8 (± 0.9).  
Skin samples were collected as described previously (Kandasamy et al., 2011) 
with slight modifications. Briefly, a 6-cm2 skin sample was taken from the shoulder area 
following standard surgical preparation of the site and transported back to the laboratory 
on ice in Dulbecco’s PBS (DPBS; Hyclone Laboratories, Logan, UT) supplemented with 
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a 1X antibiotic cocktail (100 U/mL of penicillin, 100 µg/mL of streptomycin, and 0.25 
µg/mL of amphotericin B; Hyclone Laboratories). After removing subcutaneous fat and 
connective tissue, a 3-cm2 piece of skin was minced into smaller pieces with opposing 
scalpel blades and subsequently washed 4 times with fresh DPBS. After washing, 10 mL 
of 0.5% collagenase type I enzyme (Life Technologies, Grand Island, NY) diluted in 
Dulbecco’s modified Eagle medium (DMEM; Hyclone) containing 1X antibiotic cocktail 
was added to the minced skin pieces and incubated at 37°C for 6 h with orbital shaking. 
The collagenase-digested tissue was then filtered through a 70-µm nylon mesh filter 
(Fisher Scientific, Pittsburgh, PA), and the filtrate was centrifuged at 1,1000 x g for 5 min 
at 20°C. The cell pellet was reconstituted with DMEM containing 10% fetal bovine 
serum (FBS; Hyclone Laboratories), 1X insulin-transferrin-selenium (Mediatech Inc., 
Herndon, VA), and 1X antibiotic cocktail and cultured in a 25-cm2 flask (Corning Inc., 
Corning, NY) in a humidified 37°C incubator with 5% CO2 until 70% confluency was 
reached. Cells were then detached with 0.25% trypsin (MP Biomedical, Santa Ana, CA) 
and seeded in a 75-cm2 flask (Corning Inc.) with DMEM supplemented with 5% FBS, 1X 
insulin transferrin- selenium, and 1X antibiotic cocktail. After approximately 4 d, cells 
were trypsinized and split into three 75-cm2 flasks. Once cells reached confluency, they 
were lifted with trypsin and aliquots of the third passage were diluted in DMEM 
supplemented with 20% FBS and 10% dimethyl sulfoxide (Sigma-Aldrich, St. Louis, 
MO) and cryopreserved in liquid nitrogen for future challenges. 
2.3.2 Dermal Fibroblast Challenges with IL-1β, LPS, and Pam2CSK4 
Aliquots of cells were revived from cryopreservation in duplicate and cultured 
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in a 75-cm2 flask until confluent. Cells were lifted with trypsin and fourth-passage cells 
were seeded into a 6-well plate (Corning Inc.) at 1 x 105 cells/mL in a total volume of 2 
mL. Following a 24-h incubation, media was removed and replaced with 2 mL of fresh 
media (negative control), or media containing either 1 ng/mL of recombinant bovine IL-
1β (AbD Serotec, Raleigh, NC), 100 ng/mL of ultra-pure LPS isolated from E. coli 
0111:B4 (Sigma-Aldrich), or 200 ng/mL of a synthetic TLR2/6 agonist Pam2CSK4 
(PAM2; Invivogen, San Diego, CA). After 24 h of exposure, media was collected from 
each well, spun at 10,000 x g for 1 min to remove cell debris, and stored at −20°C until 
future analysis. 
2.3.3 IL-8 and IL-6 ELISA 
The concentration of IL-8 in conditioned media samples was quantified by a 
custom sandwich ELISA as previously described (Kandasamy et al., 2011). Mouse anti-
bovine IL-8 (clone 170.13 from Samuel Maheswaren, University of Minnesota, St. Paul) 
and biotinylated goat anti-human IL-8 (R&D Systems Inc., Minneapolis, MN) were used 
as capture and detection antibodies, respectively, and recombinant bovine IL-8 (Thermo 
Scientific, Rockford, IL) as the assay standard. The concentration of IL-6 in conditioned 
media was determined with a commercially available bovine IL-6 ELISA kit (Thermo 
Scientific). The capture and detection antibodies were plated at 1:100 and the 
streptavidin-horseradish peroxidase was plated at 1:400. Recombinant bovine IL-6 was 
used as the assay standard (Thermo Scientific). 
 2.3.4 Preparation of S. aureus Inoculum 
A cryopreserved S. aureus specimen of multilocus sequence type 8, originally 
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isolated from milk of a cow with chronic subclinical mastitis (Barlow et al., 2013), was 
streaked on a trypticase soy agar plate with 5% sheep blood (Northeast Laboratory 
Services, Waterville, ME) and incubated at 37°C for 16 h. One bacterial colony was then 
used to inoculate 3 mL of trypticase soy broth and incubated at 37°C with shaking for 6 
h. Afterward, 1 mL of the inoculated broth was placed in 99 mL of trypticase soy broth 
and incubated for 16 h at 37°C with shaking. This stock culture was stored for 24 h at 
4°C while the bacterial concentration (cfu/mL) was determined by serial dilution and 
plate counting. 
 2.3.5 Intramammary Challenge 
Ten of the 50 skin-biopsied animals were selected for an intramammary 
challenge based on the production of IL-8 protein by their dermal fibroblasts in response 
to stimulation with PAM2. Five of the animals were designated as low responders (LR), 
as their fibroblast production of IL-8 ranked in the lowest 20% of the 50 animal fibroblast 
pool, and 5 animals were designated as high responders (HR), as their fibroblast 
production of IL-8 ranked in the highest 20%. The animals averaged 235 (± 30) DIM and 
were transported to the University of Vermont 1 wk before the challenge. Four LR and 4 
HR animals were confirmed pregnant at the time of challenge (122 ± 34 d pregnant), and 
controlled internal drug releasers (a progesterone insert, Eazi- Breed CIDR, Pfizer, New 
York, NY) were placed in the 2 nonpregnant animals to control hormonal fluctuations. 
Throughout the trial, animals were milked with individual milking units that were 
sanitized before each milking. Quarter milk samples collected before experimental 
infection were negative for mastitis pathogens and composite milk SCC were below 
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200,000 cells/mL. On the day of the challenge, teat ends were disinfected with 70% 
ethanol and 5 mL of the prepared bacterial suspension diluted in endotoxin-free, isotonic 
sterile saline was infused with the aid of a teat cannula into the right hind quarter of each 
animal. Plating of the bacterial infusion solution, followed by colony counting, indicated 
each animal received 200 cfu in total in the right hind quarter. Milk samples were 
collected from the infected and control quarters just before infusion and at various times 
for 6 wk postinfusion (PI). Bacteria counts in milk from individual challenged and 
control quarters were determined by plating 100 µL of neat or diluted milk samples, 
incubating at 37°C for 24 h, and counting bacterial colonies. Milk SCC was determined 
with a portable cell counter (DCC, DeLaval, Tumba, Sweden). Rectal temperatures of 
each animal were monitored for 4 d PI. 
 2.3.6 Whey Preparation 
Milk samples from the infected and control quarters were centrifuged at 16,000 
x g for 30 min at 4°C. The fat layer was discarded and the milk was centrifuged a second 
time at 16,000 x g for 30 min at 4°C. The clear supernatant was collected and stored at 
−20°C for future analysis. Levels of IL-8 protein in whey were determined by ELISA as 
described previously, and concentrations of BSA in whey were determined using 
commercial ELISA reagents (Bethyl Laboratories, Montgomery, TX) according to 
manufacturer directions. 
 2.3.7 Humoral Response Following S. aureus Challenge 
Total anti-S. aureus IgG antibody levels in plasma and whey were determined 
by ELISA as described by Leitner et al. (2000) with some modifications. A stock of the 
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S. aureus challenge strain was prepared as described previously for the intramammary 
challenge, however, the 100 mL of 16-h growth was subjected to heat-killing at 70°C for 
45 min with shaking every 10 min. Aliquots of this stock were stored at −20°C for 
subsequent assays. Wells of a 96-well ELISA plate were coated with either 100 µL of 1 x 
107 heat-killed bacteria diluted in 0.05 M bicarbonate buffer or 100 µL of 0.05 M 
bicarbonate buffer (a blank well) and incubated at 4°C overnight. Plates were washed 3 
times with DPBS-0.05% Tween-20 (DPBS-T; Fisher Bioreagents, Fair Lawn, NJ), then 
100 µL of a 2% nonfat milk (Lab Scientific, Highlands, NJ) solution diluted in DPBS 
was added to each well and incubated for 1 h at room temperature. Following plate 
washing, 100 µL of plasma or whey samples diluted 1:800 or 1:10, respectively, in 
DPBS-T were plated and incubated at room temperature for 1 h. Plates were washed 
again and 100 µL of a 0.025- µg/mL solution of a biotinylated polyclonal goat anti-cow 
IgG (Fisher Scientific), or 100 µL of a 0.2-µg/mL solution of a biotinylated polyclonal 
sheep anti-bovine IgG1 or IgG2 (Thermo Scientific) diluted in DPBS-T was plated and 
incubated at room temperature for 1 h. Lastly, after washing, tetramethylbenzidine 
substrate (Thermo Scientific) was added to each well and the reaction was stopped with 1 
M H2SO4 after approximately 2 min. The absorbance at 450 nm was determined using a 
4-parameter analysis with optical density correction for blank wells (Synergy-HT, Bio-
Tek). 
2.3.8 Fibroblast Gene Expression in Response to Pam2CSK4 
Gene expression analysis was performed on fibroblast cultures from the animals 
that were selected for intramammary challenge. Fibroblasts from the 10 challenged 
 40 
animals (n = 5 LR, n = 5 HR) were revived from cryopreservation, and cultured in a 75-
cm2 flask. Once confluent, cells were lifted with 0.25% trypsin, counted, and seeded into 
6-well plates at a concentration of 1 x 105 cells/mL. Following a 24-h incubation, 
fibroblasts were exposed to 200 ng/mL of PAM2 and RNA was collected at 3 time 
points: h 0 (control conditions) and h 2 and 8 post challenge using the RNeasy Mini Kit 
(Qiagen, Valencia, CA) according to manufacturer directions. Following extraction, RNA 
concentrations were assessed using the Qubit 2.0 Fluorometer (Life Technologies). First-
strand cDNA synthesis was completed using the Improm II Reverse Transcriptase Kit 
(Promega, Madison, WI). Expression levels of selected immune genes were determined 
by quantitative realtime PCR (qRT-PCR) with a 7500 Fastrun Machine (Applied 
Biosystems, Carlsbad, CA) using Fermentas Maxima SYBR Green/Fluorescein qPCR 
Mastermix (Thermo Scientific). Messenger RNA expression for target genes was 
normalized against β-actin, an endogenous control gene. Fold differences in target gene 
expression are presented as the difference between HR and LR cultures at the indicated 
hour post-PAM2. Sequences for the constructed oligonucleotide primers are presented in 
Table 1. 
2.3.9 Statistical Analysis 
Correlations between IL-8 and IL-6 responses from dermal fibroblasts following  
24 h of exposure to IL- 1β, LPS, and PAM2 were calculated by linear regression using 
the statistical software package Prism 6.0 (GraphPad Software Inc., La Jolla, CA). 
Differences between production of IL-6 and IL-8 from paired fibroblast biopsies were 
determined by paired t-test in Prism 6.0. Milk SCC and colony-forming unit counts were 
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log10 transformed before analysis. Effects of phenotype (LR or HR) on levels of milk IL-
8, BSA, SCC, bacteria counts, right hind quarter milk production, and plasma and whey 
levels of total IgG as well as IgG1 and IgG2 were analyzed with a linear mixed model 
assuming a first-order auto-regressive covariance structure, with time postinfusion as the 
repeated measure. Analyses were performed with the MIXED procedure in SAS version 
9.4 (SAS Institute Inc., Cary, NC). Changes in expression of selected immune genes 
between LR and HR animals were analyzed using a one-tailed t-test. Differences with a P 
< 0.05 were considered significant. 
 
2.4 Results 
2.4.1 Stimulation of Dermal Fibroblasts 
Isolated fibroblasts from all 50 cows were revived from cryopreservation, 
cultured, and subsequently challenged for 24 h with PAM2. The concentrations of 
secreted IL-8 in media following duplicate challenges are presented in Figure 1A. There 
was a wide range of responsiveness to PAM2, with the mean IL-8 of the highest 10% of 
animals being more than 8-fold greater (P < 0.05) than the mean of the lowest 10% of 
animals (1243 ± 119 vs. 142 ± 11 pg/mL, respectively). The detection limit of the assay 
was approximately 130 pg/mL.  
The relationships between IL-8 production by the 50 fibroblast cultures following 
challenges with LPS and IL-1β were also investigated and compared with the response to 
PAM2 (data not shown). The levels of secreted IL-8 were correlated between the IL-1β 
and LPS responses (P < 0.01, R2 = 0.63), the LPS and PAM2 responses (P < 0.05, R2 = 
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0.46), and the IL-1β and PAM2 responses (P < 0.01, R2 = 0.80). To investigate the 
within-animal stability of the fibroblast response, a second skin biopsy was collected 
from the 10 animals that had been selected for the in vivo S. aureus challenge. This 
second biopsy was obtained at slaughter on d 40 post challenge, which was 
approximately 5 mo after the initial biopsy. Unfortunately, 1 of the second HR biopsies 
did not yield a viable culture due to microbial contamination and was discarded. Fourth 
passage cultures from the first and second biopsy were revived simultaneously from 
cryopreservation and challenged in parallel wells with PAM2 for 24 h. The resulting 
media concentrations of IL-8 and IL-6 are presented in Figure 1B and C, respectively. 
Responses between replicate biopsies from the same animal were nearly identical for IL-
8 with the difference in response magnitude between the LR and HR animals being 
approximately 4-fold. Responses for IL-6 were also quite similar between the 2 biopsies. 
The production of IL-8 and IL-6 following PAM2 treatment was highly correlated 
between replicate biopsies (P < 0.01, R2 = 0.95 and P < 0.01, R2 = 0.75, for IL-8 and IL-
6, respectively). 
2.4.2 Rectal Temperature, and Milk Yield, SCC, and Bacterial Counts Following 
Intramammary Infusion of S. aureus 
Each of the 10 selected animals received a single intramammary infusion of the 
challenge strain of S. aureus and by 24 h PI, all animals had evidence of mammary 
swelling and clots in the milk from the challenged quarter. Rectal temperatures in all 
animals showed a moderate increase that peaked at approximately 30 h PI, with no 
difference between LR and HR groups (Figure 2).  
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Milk yield from the right hind quarter (RHQ) is shown in Figure 3A, and although 
the HR animals produced less milk from the challenged quarter throughout most of the 
study, this difference was not significant. However, a reduction in quarter milk yield was 
observed in both groups following the infusion, which reached its lowest value between 
48 to 60 h PI.  
Immediately before the infusion, milk SCC of each challenged quarter was below 
200,000 cells/mL; however, in response to the pathogen, it peaked at approximately 15 x 
106 cells/mL (Figure 3B). At 24 h PI, the HR SCC (5.2 x 106 cells/mL) was 
approximately 10-fold greater than the LR SCC (3.1 x 105 cells/mL), demonstrating a 
delayed influx of immune cells into the infected gland of the LR animals. Although milk 
SCC of both groups was elevated above preinfection levels throughout the study, HR 
animals had higher (P < 0.05) SCC in the RHQ milk when compared with LR animals.  
Bacterial load was monitored for 6 wk following the intramammary challenge. 
The challenge strain was recovered from milk samples collected from the RHQ of all 
animals 24 h after infusion (Figure 3C). One LR animal was culture negative at 84 h PI 
and maintained culture negative status for the reminder of the study. A second LR animal 
was culture negative at 108 h PI, but at 336 h PI (d 14) the challenge strain was reisolated 
from the RHQ and this animal remained infected until the end of the study. Whereas 
bacterial counts were not significantly different between the 2 groups, none of the HR 
animals were culture negative during the trial. 
2.4.3 Inflammatory Markers Present in Challenged Quarter Whey 
The concentration of IL-8 in whey from the RHQ was undetectable until 24 h PI 
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in both LR and HR groups (Figure 4A). Levels of IL-8 rose quickly after 24 h, however, 
and HR animals produced a greater (P < 0.05) amount of IL-8 following challenge when 
compared with LR animals. Concentrations of BSA in whey began to increase by 24 h PI 
and reached a maximum value of almost 3 mg/mL at 72 h PI in the HR animals (Figure 
4B). A similar profile was observed in the LR animals, although the rise in BSA was 
somewhat delayed and the overall magnitude of the response was lower (P < 0.05) than in 
the HR animals. 
2.4.4 Plasma and Whey Antibodies to S. aureus 
Levels of anti-S. aureus total IgG in plasma and total IgG, IgG1, and IgG2 in 
RHQ whey samples were measured by ELISA for 36 d after the challenge. On d 0, the 
levels of anti-S. aureus total IgG in whey and plasma were similar between LR and HR 
animals (Figure 5A and B). The antibody levels increased in the weeks following the 
challenge, primarily in the HR animals, such that overall levels of anti-S. aureus total IgG 
were higher (P < 0.05) in the HR when compared with the LR animals (Figure 5A and 
B). Furthermore, this greater response in the HR animals was mirrored by greater 
increases (P < 0.05) in whey levels of the IgG2 isotype of anti-S. aureus antibody as 
compared with LR animals, whereas IgG1 levels were similar between the groups. 
2.4.5 Fibroblast Gene Expression in Response to PAM2CSK4 
Aliquots of dermal fibroblasts from the 10 animals selected for intramammary 
challenge were revived from cryopreservation to investigate potential differences in 
expression of select immune genes in response to PAM2. Total RNA was extracted at h 0 
(control conditions), 2, and 8 post treatment. One component of the PAM2 recognition 
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pathway, TLR2, was induced (P < 0.05) by PAM2 stimulation, whereas the other 
component, TLR6, was not (Figure 6A and B, respectively). Genes associated with an 
inflammatory response, including IL-8, CCL20, IL-6, and TNF-α, were induced above 
control levels following PAM2 treatment (P < 0.05; Figure 6C, D, E, and F, 
respectively). These 6 genes were generally expressed at a numerically higher level in the 
HR cultures than in the LR cultures. Significantly greater expression (P < 0.05) in the HR 
cultures was found for TLR2 and IL-6 at 8 h, and for IL-8 at 0 h post-PAM2. Expression 
of CCL20 (P = 0.06) and TNF-α (P = 0.11) at 2 h and TLR6 (P = 0.06) at 8 h post-PAM2 
showed a trend toward higher levels in HR cultures compared with LR cultures. 
 
2.5 Discussion 
In the current study, dermal fibroblasts isolated from adult dairy cattle were used 
as a cellular model to predict the magnitude of an animal’s inflammatory response to an 
intramammary S. aureus challenge. The concept stems from the substantial variation that 
exists between cows and between cases within cows in the response to mammary gland 
infection. Differences in pathogen type and strain, differences in farm environment and 
resulting infection pressure, and differences in physiological state of the animal certainly 
contribute to variation in incidence and severity of mastitis (Burvenich et al., 2003; Wenz 
et al., 2006, 2010). However, considerable variation is also observed under controlled 
experimental challenges with either E. coli (Kornalijnslijper et al., 2004) or S. aureus 
(Schukken et al., 1999). In the study by Schukken et al. (1999), 135 lactating cows were 
challenged by intramammary infusion of S. aureus into all quarters. Infection status was 
then determined 2, 3, and 4 wk PI. The range of resulting infection status included 20.7% 
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of cows that did not establish infection in any of the quarters, 15.6% of cows with 1 
quarter infected, 25.9% with 2 quarters infected, 17.8% with 3 quarters infected, and 
20.0% with all quarters infected. Thus, it seems clear from their study that some cows are 
inherently more resistant to S. aureus mastitis than other cows. Our hypothesis was that a 
range of endogenous innate responsiveness to mammary gland infection exists within the 
cow population and that the high-responsive phenotype is the one more prone to develop 
severe mastitis associated with greater tissue damage and compromised return to full 
production (Kandasamy et al., 2011). Our goal was to develop an ex vivo technique that 
could be of use in identifying genetic polymorphisms or epigenetic effects contributing to 
an animal’s innate immune response phenotype, leading to more accurate breeding and 
selection strategies aimed at reducing mastitis severity. Thus, determination of an 
animal’s innate response phenotype at a young age (Green et al., 2011) could be of use in 
selecting those calves that would be ideal candidates for milking herd replacements as 
opposed to being more appropriate for beef production. Current costs of raising herd 
replacements are estimated at greater than $1,500, depending on farm-management 
practices (Heinrichs et al., 2013). Testing of existing animals at a young age would also 
incorporate the effects of epigenetic modification on gene expression that may have 
occurred from early life environmental conditions.  
Use of primary fibroblasts as an ex vivo model system is well documented for 
other species (Rogers et al., 2007; Wang et al., 2011; Schramm et al., 2012), 
demonstrating the ability of these cells to produce inflammatory markers, such as IL-6 
and IL-8, or exhibit altered gene expression in response to various stimuli, such as LPS or 
Pam2CSK4. Kandasamy et al. (2011) used dermal fibroblasts as a model cell to predict 
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the immune responses of dairy cattle following an intramammary E. coli challenge. In 
their study, animals classified as a high-responding phenotype experienced more 
mammary tissue damage, and an elevated SCC during the resolution phase of the 
infection compared with the low-responding animals, yet rates of bacterial clearance were 
similar between phenotypes. In the current study, we used a similar strategy to examine 
the relation between fibroblast stimulation with Pam2CSK4 and host immune responses 
following a S. aureus challenge.  
Previously, we found inconsistent and generally modest production of IL-8 by 
fibroblast cultures when stimulated with live, heat-killed, or UV-killed S. aureus (data 
not presented). Others have also reported limited responses of cultured mammary 
epithelial cells to heat-inactivated S. aureus (Günther et al., 2011; Fu et al., 2013). As a 
substitute, we choose to use stimulation with the synthetic ligand, PAM2, which has been 
shown to activate the TLR2/6 pathway in murine macrophages and B lymphocytes in a 
similar manner as gram-positive bacteria (Buwitt-Beckmann et al., 2005). Our fibroblasts 
secreted reproducible and easily detectable levels of IL-8 following PAM2 treatment, 
with a range in responsiveness among the cultures from the 50 individual cows. 
Furthermore, we found significant correlations between 2 proinflammatory markers (IL-8 
and IL-6) that are produced following activation of the TLR2/6 pathway, indicating that 
the range in IL-8 response phenotype of these animals was not solely due to 
polymorphisms in the IL-8 gene. We further went on to demonstrate the stability of the 
IL-8 response phenotype over time in cultures established from replicate biopsies 
obtained before and after the animals were challenged with S. aureus, and found that the 
response phenotype was not altered after the experimental intramammary infection. 
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Finally, the response to PAM2 was mirrored to some extent by the responses to LPS and 
IL-1β. These 2 ligands are recognized via different receptors (TLR4 and the IL-1β 
receptor, respectively); however, upon ligand recognition, portions of the intracellular 
signaling cascades from all 3 ligands converge, leading to common activation of 
downstream transcription factors such as NF-κB, activator protein 1 (AP1), and 
interferon regulatory factor 3 (IRF3) (Flannery and Bowie, 2010; Takeuchi and Akira, 
2010). This moderate similarity between responses to various ligands suggests that 
fibroblast response phenotype to PAM2 is not solely due to ligand recognition, but also 
incorporates signaling pathway differences.  
We selected 5 low- and 5 high-ranked animals to determine if their ex vivo 
phenotype was reflected in their in vivo response to an intramammary challenge with S. 
aureus. The selected challenge strain was originally recovered from the mammary glands 
of several animals at a Vermont dairy farm that were experiencing chronic, subclinical 
infections with elevated milk SCC (Barlow et al., 2013). It was determined to be of the 
sequence type 8 multilocus sequence type that has also been isolated from other naturally 
infected dairy animals in Turkey (Türkyilmaz et al., 2010), The Netherlands (van den 
Borne et al., 2010), and Switzerland (Sakwinska et al., 2011).  
Whereas milk SCC increased in both the HR and LR groups following the 
challenge, a more rapid influx of immune cells was observed in the HR. Considerable 
increases of IL-8 in milk from HR following the challenge likely played a role in the 
greater influx of neutrophils into the infected gland due to its role as a chemoattractant. 
However, this chemokine is but one representative member of a family of neutrophil 
chemoattractants, such as chemokine (C-X-C motif) ligand (CXCL)1, CXCL2, CXCL3, 
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and CXCL6, which are induced in bovine cells following stimulation of the TLR 
pathway; as such, IL-8 may not be the only chemokine contributing to differences in 
neutrophil influx (Griesbeck-Zilch et al., 2009; Kandasamy and Kerr, 2012). The more 
rapid and sustained influx of neutrophils in the HR offered little advantage in containing 
the infection. Rather, 2 of the 5 LR were able to initially clear the infection; although 1 
was reinfected 13 d later or perhaps had not completely cleared the infection. In addition, 
the LR animals suffered less severe mammary damage when using milk BSA as an 
indicator of breakdown of the mammary epithelial barrier.  
A considerable body of evidence exists suggesting that physiological states such 
as early lactation result in immunosuppression leading to a reduced functionality of 
neutrophils entering into the infected gland (Burvenich et al., 2007). It has also been 
suggested in several review articles that a rapid influx of cells into the gland is a major 
factor in controlling E. coli mastitis (Paape et al., 2002; De Schepper et al., 2008). 
However, this suggestion is not easily tested. In one study, 19 early lactation cows were 
classified as being moderate or severe responders based on lower or higher reactive 
oxygen species-generating capacity of their blood neutrophils. All animals were then 
challenged with intramammary E. coli and the severe responders had a slightly delayed 
increase in SCC compared with the moderate responders, as well as an increase in milk 
colony-forming units (Vandeputte-Van Messom et al., 1993). Further studies are needed 
to evaluate this delayed response hypothesis. Studies with immunosuppressive agents that 
cause a delay in neutrophil influx could be of use in evaluating the role of moderate 
changes in the speed of neutrophil influx in containing mastitis pathogens. Interestingly, 
in cows chronically infected with S. aureus, a 3-d treatment with cortisol had little effect 
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on milk SCC or colony-forming units, whereas the more potent dexamethasone had 
marked effects on reducing milk yield, which were reflected in large increases as opposed 
to immunosuppressive decreases in both milk SCC and colony-forming units (Burton and 
Kehrli, 1995).  
In contrast to delayed influx, several cytokine-based strategies have been 
investigated as a means to stimulate additional neutrophil recruitment. These studies 
have revealed inconsistent effects as mastitis therapeutics (Sordillo et al., 1997). 
Recently, Kauf et al. (2007) investigated the use of LPS as a possible treatment for S. 
aureus mastitis due to its immunostimulating properties with the hypothesis that a greater 
inflammatory response can enhance clearance of the bacteria. They infected mammary 
quarters with S. aureus and then 24 h later LPS or saline control was infused into 
challenged glands. The LPS treatment rapidly caused large increases in SCC and milk 
BSA and a moderate reduction in colony-forming units at the peak of the acute response. 
However, bacteria recovery rates from these quarters were actually higher for the 
remainder of the induced inflammation period. The results clearly indicated that, at least 
with a S. aureus mastitis, additional recruitment of leukocytes into the gland did not aid 
in bacterial clearance and may actually be detrimental by causing further damage to the 
epithelial layer, thus exposing additional sites for bacterial attachment. In our study, the 
heightened inflammatory response and over production of immune mediators in the HR 
animals led to higher amounts of collateral damage in the mammary gland, whereas the 
delayed and reduced influx of neutrophils observed in the LR was associated with a 
general trend of reduced bacterial burden.  
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It has been shown that anti-inflammatory treatments administered around the time 
of an intramammary challenge can reduce the severity of clinical symptoms and promote 
restoration of prechallenge milk production and quality (Lohuis et al., 1988; Yeiser et al., 
2012; Sipka et al., 2013). Similarly, the use of pharmaceutical agents aimed at reducing 
the magnitude of the immune response has demonstrated positive effects in human 
health. For instance, the pathologies of several human diseases, including rheumatoid 
arthritis (McInnes and Schett, 2007), psoriasis (Tamilselvi et al., 2013), and type 2 
diabetes (Crook, 2004), are due to an excessive immune response with large numbers of 
infiltrating immune cells and abnormally high production of proinflammatory cytokines, 
such as IL-1β and tumor necrosis factor-α. Many of the treatment options for these 
diseases focus on reducing or inhibiting immune mediators, such as tumor necrosis 
factor-α (Armuzzi et al., 2014), the JAK (Janus tyrosine kinase) pathway (Hsu and 
Armstrong, 2014), and IL-1β (Dinarello, 2011). Use of anti-inflammatories as a treatment 
option in bovine mastitis requires further investigation to determine what magnitude of 
immune response is effective for clearing a mammary infection while minimizing the 
damage to the host, as well as the effect of variable immune responses in the success or 
failure of mastitis treatments. 
 The development of a vaccine that generates an effective antibody response 
against S. aureus has been the focus of many studies (Leitner et al., 2003; Lee et al., 
2005; Middleton et al., 2006). In each of these studies, the levels of sera antibodies 
toward S. aureus increased following vaccination. To determine the level of protection 
conferred from the vaccine, experimental intramammary challenges were completed in 2 
of these studies. Leitner et al. (2003) administered a vaccine containing 3 S. aureus 
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strains causing mastitis in dairy cows and then subsequently challenged vaccinated 
animals with 1 of those strains. Animals receiving the vaccine were protected against an 
IMI significantly more than controls, with infection rates of 35 and 90% for vaccinated 
and control animals, respectively. Clinical symptoms, including SCC, were milder in the 
vaccinated animals post challenge as well. In the second study, Middleton et al. (2006) 
performed an intramammary challenge on 47 animals, 36 of which had been vaccinated 
against S. aureus. Rates of persistent S. aureus mammary infections were similar between 
the vaccinated and control animals and no differences in milk SCC, bacteria counts, or 
clinical mastitis scores were observed. The conflicting results between vaccine 
effectiveness could be due to different vaccine formulations between studies, but it also 
reinforces the fact that variation is present in the immune response between animals, even 
following vaccination.  
Within our challenged animals, activation of the adaptive immune system was 
confirmed by an increase in total IgG antibody levels to S. aureus from pre challenge 
levels in both milk and plasma in the HR animals, although the LR animals showed a 
much smaller increase. To further examine the antibody-mediated response, we chose to 
focus on the 2 predominant IgG isotypes of the mammary gland, IgG1 and IgG2, and 
how their concentrations in the milk would be influenced after an experimental mammary 
infection. The IgG1 isotype is the predominant one found in mammary secretions of both 
healthy and infected glands, primarily due to its selective transport across the epithelial 
lining by the IgG Fc receptor (Barrington et al., 1997). Concentrations of IgG2, normally 
low in healthy milk, will increase quickly after mammary infections due to the antibody 
binding to the Fc receptor on neutrophils in the blood and being co-recruited to the site of 
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infection (Atalla et al., 2010). In agreement with other experimental challenge models 
(Bourry and Poutrel, 1996; Tollersrud et al., 2006), there was an increase in anti-S. 
aureus total IgG present in whey and plasma, and both IgG1 and IgG2 observed in the 
whey from the HR animals. However, elevated concentrations of strain-specific 
antibodies did not offer an advantage in pathogen clearance for the HR animals. In the 
current study, basal levels of serum and milk antibodies were similar between the 2 
groups. It is unknown if higher levels of preexisting antibodies would have mitigated the 
propensity for an animal to develop a chronic infection following an experimental 
challenge. 
A panel of genes was selected to further investigate the basis of the low- versus 
high-response phenotype of the fibroblasts from the 10 challenged animals. Differences 
in expression levels of receptors and proteins involved in pathogen recognition can affect 
the propensity for an animal to develop an infection (Fonseca et al., 2011; Kandasamy 
and Kerr, 2012; Novak, 2014). Enhanced pathogen detection, due to genetic or epigenetic 
differences between animals, could be a major factor differentiating the high versus low 
phenotype observed in our fibroblasts. Koets et al. (2010) observed an SNP in the 
extracellular portion of the bovine TLR2 gene that was more prevalent in animals 
seemingly resistant to Mycobacterium avium paratuberculosis infection. This SNP 
resulted in greater proinflammatory cytokine production from monocytes as well as 
enhanced T-cell activation following challenge. The extracellular receptors (TLR2 and 
TLR6) are thought to play a key role in detection of S. aureus (Nakayama et al., 2012) 
and we observed greater expression of both receptors in high-responding cultures 
following PAM2 stimulation. This greater expression would correspond to the 
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significantly enhanced transcription of IL-6, and clear trend for enhanced transcription of 
CCL20 and TNF-α.  
Tumor necrosis factor-α and IL-6 are considered potent proinflammatory 
cytokines that can activate lymphocytes and the production of acute phase proteins 
(Bannerman, 2009). Elevated concentrations of serum IL-6 have been shown to be 
correlated with disease severity in naturally infected cows (Hagiwara et al., 2001), 
suggesting that IL-6 can be used as a second marker for a high-responding phenotype. 
Expression levels and protein concentrations of IL-6 were greater in our HR fibroblast 
cultures, perhaps reflecting the enhanced TLR2 and TLR6 expression in these cells 
compared with LR cultures. Quite surprisingly, we did not find a significant difference in 
IL-8 gene expression between the groups after stimulation with PAM2. The slight 
numerical difference in gene expression at 2 and 8 h post-PAM2 as measured by qRT-
PCR appears insufficient to cause the nearly 4-fold difference in protein accumulation in 
media 24 h post-PAM2. This suggests that determination of actual protein production at 
24 h post challenge is a more sensitive indicator of the response phenotype. In a similar 
previous study (Kandasamy and Kerr, 2012) we did find 3-fold higher IL-8 gene 
expression following an 8-h stimulation of selected high- versus low-responding 
fibroblast cultures with LPS. Ideally, the response phenotype would be best classified 
using a combination of the production of multiple proteins and the expression of a panel 
of inflammation associated genes.  
In the present study, we presented evidence for the use of dermal fibroblasts as a 
cell model for a dairy animal’s in vivo immune response following an intramammary 
challenge with S. aureus. Animals selected as HR based upon their cellular response 
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mounted a stronger innate immune response demonstrated by higher levels of IL-8 and 
SCC present in the milk of the challenged gland compared with LR. Tissue damage to the 
infected quarter, determined by increased levels of BSA in whey, was more extensive in 
the HR group as well. High-responding animals also elicited a stronger adaptive immune 
response, indicated by an increase in anti-S. aureus antibodies in whey from the 
challenge quarter, but no protective advantage was observed for these animals. The LR 
and HR animals were initially chosen based on extreme differences in the responsiveness 
of their fibroblasts following challenge with TLR agonists, and these differences were 
corroborated in the immune responses following an intramammary challenge. Our study 
indicates that dermal fibroblasts may be useful to explore potential genetic or epigenetic 
causes for the diversity in immune responses to mastitis causing pathogens between dairy 
animals. 
2.6 References 
Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: Critical proteins linking 
innate and acquired immunity. Nature immunology 2:675–680. 
 
Armuzzi, A., P. Lionetti, C. Blandizzi, R. Caporali, S. Chimenti, L. Cimino, P. 
Gionchetti, G. Girolomoni, G. Lapadula, A. Marchesoni, A. Marcellusi, F. S. 
Mennini, C. Salvarani, and R. Cimaz. 2014. Anti-TNF agents as therapeutic 
choice in immune-mediated inflammatory diseases: Focus on adalimumab. 
International journal of immunopathology and pharmacology 27:11–32. 
 
Atalla, H., C. Gyles, B. Wilkie, K. Leslie, and B. Mallard. 2009. Somatic cell scores and 
clinical signs following experimental intramammary infection of dairy cows with 
a Staphylococcus aureus small colony variant (S. aureus SCV) in comparison to 
other bovine strains. Veterinary microbiology 137:326–334. 
 
Atalla, H., B. Wilkie, C. Gyles, K. Leslie, L. Mutharia, and B. Mallard. 2010. Antibody 
and cell-mediated immune responses to Staphylococcus aureus small colony 
variants and their parental strains associated with bovine mastitis. Developmental 
and comparative immunology 34:1283-1290. 
 
 56 
Ballou, M. A. 2012. Growth and development symposium: Inflammation: Role in the 
etiology and pathophysiology of clinical mastitis in dairy cows. Journal of animal 
science 90:1466–1478. 
 
Bannerman, D. D. 2009. Pathogen-dependent induction of cytokines and other soluble 
inflammatory mediators during intramammary infection of dairy cows. Journal of 
animal science 87:10–25. 
 
Bannerman, D. D., H. R. Springer, M. J. Paape, A. C. W. Kauf, and J. P. Goff. 2008. 
Evaluation of breed-dependent differences in the innate immune responses of 
Holstein and Jersey cows to Staphylococcus aureus intramammary infection. 
Journal of dairy research 75:291–301. 
 
Barkema, H. W., Y. H. Schukken, and R. N. Zadoks. 2006. Invited review: The role of 
cow, pathogen, and treatment regimen in the therapeutic success of bovine 
Staphylococcus aureus mastitis. Journal of dairy science 89:1877–1895. 
 
Barlow, J. W., R. N. Zadoks, and Y. H. Schukken. 2013. Effect of lactation therapy on 
Staphylococcus aureus transmission dynamics in two commercial dairy herds. 
BMC veterinary research 9:28. 
 
Barrington, G. M., T. E. Besser, W. C. Davis, C. C. Gay, J. J. Reeves, and T. B. 
McFadden. 1997. Expression of immunoglobulin G(1) receptors by bovine 
mammary epithelial cells and mammary leukocytes. Journal of dairy science 
80:86–93. 
 
Bougarn, S., P. Cunha, F. B. Gilbert, A. Harmache, G. Foucras, and P. Rainard. 2011. 
Staphylococcal-associated molecular patterns enhance expression of immune 
defense genes induced by IL-17 in mammary epithelial cells. Cytokine 56:749–
759. 
 
Bourry, A., and B. Poutrel. 1996. Bovine mastitis caused by Listeria monocytogenes: 
Kinetics of antibody responses in serum and milk after experimental infection. 
Journal of dairy science 79:2189–2195. 
 
Brand, B., A. Hartmann, D. Repsilber, B. Griesbeck-Zilch, O. Wellnitz, C. Kuhn, S. 
Ponsuksili, H. H. Meyer, and M. Schwerin. 2011. Comparative expression 
profiling of E. coli and S. aureus inoculated primary mammary gland cells 
sampled from cows with different genetic predispositions for somatic cell score. 
Genetics selection evolution 43:24. 
 
Burton, J. L., and M. E. Kehrli Jr. 1995. Regulation of neutrophil adhesion molecules and 
shedding of Staphylococcus aureus in milk of cortisol- and dexamethasone-
treated cows. American journal of veterinary research 56:997–1006. 
 
 57 
Burvenich, C., D. D. Bannerman, J. D. Lippolis, L. Peelman, B. J. Nonnecke, M. E. 
Kehrli Jr., and M. J. Paape. 2007. Cumulative physiological events influence the 
inflammatory response of the bovine udder to Escherichia coli infections during 
the transition period. Journal of dairy science 90(E- Suppl. 1):E39–E54. 
 
Burvenich, C., V. Van Merris, J. Mehrzad, A. Diez-Fraile, and L. Duchateau. 2003. 
Severity of E. coli mastitis is mainly determined by cow factors. Veterinary 
research 34:521–564. 
 
Buwitt-Beckmann, U., H. Heine, K. H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A. 
J. Ulmer. 2005. Toll-like receptor 6-independent signaling by diacylated 
lipopeptides. European journal of immunology 35:282– 289. 
 
Crook, M. 2004. Type 2 diabetes mellitus: A disease of the innate immune system? An 
update. Diabetic medicine 21:203–207. 
 
De Schepper, S., A. De Ketelaere, D. D. Bannerman, M. J. Paape, L. Peelman, and C. 
Burvenich. 2008. The toll-like receptor-4 (TLR- 4) pathway and its possible role 
in the pathogenesis of Escherichia coli mastitis in dairy cattle. Veterinary research 
39:5. 
 
Dinarello, C. A. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory 
diseases. Blood 117:3720–3732. 
 
Flannery, S., and A. G. Bowie. 2010. The interleukin-1 receptor-associated kinases: 
Critical regulators of innate immune signaling. Biochemistry pharmacology 
80:1981–1991. 
 
Fonseca, I., G. R. Antunes, D. S. Paiva, C. C. Lange, S. E. Guimaraes, and M. F. Martins. 
2011. Differential expression of genes during mastitis in Holstein-Zebu 
crossbreed dairy cows. Genetics and molecular research 10:1295–1303. 
 
Fu, Y., E. Zhou, Z. Liu, F. Li, D. Liang, B. Liu, X. Song, F. Zhao, X. Fen, D. Li, Y. Cao, 
X. Zhang, N. Zhang, and Z. Yang. 2013.Staphylococcus aureus and Escherichia 
coli elicit different innate immune responses from bovine mammary epithelial 
cells. Veterinary immunology and immunopathology 155:245–252. 
 
Gilbert, F. B., P. Cunha, K. Jensen, E. J. Glass, G. Foucras, C. Robert- Granie, R. Rupp, 
and P. Rainard. 2013. Differential response of bovine mammary epithelial cells to 
Staphylococcus aureus or Escherichia coli agonists of the innate immune system. 
Veterinary research 44:40. 
 
Green, B. B., S. Kandasamy, T. H. Elsasser, and D. E. Kerr. 2011. The use of dermal 
fibroblasts as a predictive tool of the toll-like receptor 4 response pathway and its 
development in Holstein heifers. Journal of dairy science 94:5502–5514. 
 58 
 
Griesbeck-Zilch, B., M. Osman, C. Kuhn, M. Schwerin, R. H. Bruckmaier, M. W. Pfaffl, 
A. Hammerle-Fickinger, H. H. Meyer, and O. Wellnitz. 2009. Analysis of key 
molecules of the innate immune system in mammary epithelial cells isolated from 
marker-assisted and conventionally selected cattle. Journal of dairy science 
92:4621–4633. 
 
Günther, J., K. Esch, N. Poschadel, W. Petzl, H. Zerbe, S. Mitterhuemer, H. Blum, and 
H. M. Seyfert. 2011. Comparative kinetics of Escherichia coli- and 
Staphylococcus aureus-specific activation of key immune pathways in mammary 
epithelial cells demonstrates that S. aureus elicits a delayed response dominated 
by interleukin- 6 (IL-6) but not by IL-1A or tumor necrosis factor alpha. Infection 
and immunology 79:695–707. 
 
Hagiwara, K., H. Yamanaka, K. Hisaeda, S. Taharaguchi, R. Kirisawa, and H. Iwai. 
2001. Concentrations of IL-6 in serum and whey from healthy and mastitic cows. 
Veterinary research communications 25:99–108. 
 
Heinrichs, A. J., C. M. Jones, S. M. Gray, P. A. Heinrichs, S. A. Cornelisse, and R. C. 
Goodling. 2013. Identifying efficient dairy heifer producers using production 
costs and data envelopment analysis. Journal of dairy science 96:7355–7362. 
 
Hertl, J. A., Y. H. Schukken, F. L. Welcome, L. W. Tauer, and Y. T. Grohn. 2014. 
Pathogen-specific effects on milk yield in repeated clinical mastitis episodes in 
Holstein dairy cows. Journal of dairy science 97:1465–1480. 
 
Hsu, L., and A. W. Armstrong. 2014. JAK inhibitors: Treatment efficacy and safety 
profile in patients with psoriasis. Journal of immunology research 2014:283617. 
 
Kandasamy, S., B. B. Green, A. L. Benjamin, and D. E. Kerr. 2011. Between-cow 
variation in dermal fibroblast response to lipopolysaccharide reflected in 
resolution of inflammation during Escherichia coli mastitis. Journal of dairy 
science 94:5963–5975. 
 
Kandasamy, S., and D. E. Kerr. 2012. Genomic analysis of between cow variation in 
dermal fibroblast response to lipopolysaccharide. Journal of dairy science 
95:3852–3864. 
 
Kauf, A. C., B. T. Vinyard, and D. D. Bannerman. 2007. Effect of intramammary 
infusion of bacterial lipopolysaccharide on experimentally induced 
Staphylococcus aureus intramammary infection. Research in veterinary science 
82:39–46. 
 
Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends in 
molecular medicine 13:460–469. 
 59 
 
Koets, A., W. Santema, H. Mertens, D. Oostenrijk, M. Keestra, M. Overdijk, R. 
Labouriau, P. Franken, A. Frijters, M. Nielen, and V. Rutten. 2010. Susceptibility 
to paratuberculosis infection in cattle is associated with single nucleotide 
polymorphisms in Toll-like receptor 2 which modulate immune responses against 
Mycobacterium avium subspecies paratuberculosis. Preventive veterinary 
medicine 93:305–315. 
 
Kornalijnslijper, J. E., A. J. Daemen, T. van Werven, T. A. Niewold, V. P. Rutten, and E. 
N. Noordhuizen-Stassen. 2004. Bacterial growth during the early phase of 
infection determines the severity of experimental Escherichia coli mastitis in dairy 
cows. Veterinary microbiology101:177–186.  
 
Lahouassa, H., E. Moussay, P. Rainard, and C. Riollet. 2007. Differential cytokine and 
chemokine responses of bovine mammary epithelial cells to Staphylococcus 
aureus and Escherichia coli. Cytokine 38:12–21. 
 
Lee, J. W., C. N. O’Brien, A. J. Guidry, M. J. Paape, K. A. Shafer- Weaver, and X. Zhao. 
2005. Effect of a trivalent vaccine against Staphylococcus aureus mastitis 
lymphocyte subpopulations, antibody production, and neutrophil phagocytosis. 
Canadian journal of veterinary research 69:11–18. 
 
Leitner, G., E. Lubashevsky, A. Glickman, M. Winkler, A. Saran, and Z. Trainin. 2003. 
Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. 
I. Challenge trials. Veterinary immunology and immunopathology 93:31–38. 
 
Leitner, G., B. Yadlin, A. Glickman, M. Chaffer, and A. Saran. 2000. Systemic and local 
immune response of cows to intramammary infection with Staphylococcus 
aureus. Research of veterinary science 69:181–184. 
 
Lohuis, J. A., W. Van Leeuwen, J. H. Verheijden, A. S. Van Miert, and A. Brand. 1988. 
Effect of dexamethasone on experimental Escherichia coli mastitis in the cow. 
Journal of dairy science 71:2782–2789. 
 
McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid 
arthritis. Nature reviews immunology 7:429–442. 
 
Middleton, J. R., J. Ma, C. L. Rinehart, V. N. Taylor, C. D. Luby, and B. J. Steevens. 
2006. Efficacy of different Lysigin formulations in the prevention of 
Staphylococcus aureus intramammary infection in dairy heifers. Journal of dairy 
research 73:10–19. 
 
Nakayama, H., K. Kurokawa, and B. L. Lee. 2012. Lipoproteins in bacteria: Structures 
and biosynthetic pathways. FEBS Journal 279:4247– 4268. 
 
 60 
NMC. 2011. Recommended mastitis control program. Accessed Aug. 1, 2014. 
http://www.nmconline.org/docs/NMCchecklistInt.pdf. 
 
Nov.k, K. 2014. Functional polymorphisms in Toll-like receptor genes for innate 
immunity in farm animals. Veterinary immunology and immunopathology 157:1–
11. 
 
Olde Riekerink, R. G., H. W. Barkema, D. F. Kelton, and D. T. Scholl. 2008. Incidence 
rate of clinical mastitis on Canadian dairy farms. Journal of dairy science 
91:1366–1377. 
 
Paape, M., J. Mehrzad, X. Zhao, J. Detilleux, and C. Burvenich. 2002. Defense of the 
bovine mammary gland by polymorphonuclear neutrophil leukocytes. Journal of 
mammary gland biology and neoplasia 7:109–121. 
 
Pareek, R., O. Wellnitz, R. Van Dorp, J. Burton, and D. Kerr. 2005. Immunorelevant 
gene expression in LPS-challenged bovine mammary epithelial cells. Journal of 
applied genetics 46:171–177. 
 
Park, B. S., D. H. Song, H. M. Kim, B. S. Choi, H. Lee, and J. O. Lee. 2009. The 
structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. 
Nature 458:1191–1195. 
 
Revelo, X. S., and M. R. Waldron. 2012. In vitro effects of Escherichia coli 
lipopolysaccharide on the function and gene expression of neutrophils isolated 
from the blood of dairy cows. Journal of dairy science 95:2422–2441. 
 
Rogers, K. M., D. H. Black, and R. Eberle. 2007. Primary mouse dermal fibroblast cell 
cultures as an in vitro model system for the differential pathogenicity of cross-
species herpesvirus papio 2 infections. Archives of virology152:543–552. 
 
Sakwinska, O., M. Giddey, M. Moreillon, D. Morisset, A. Waldvogel, and P. Moreillon. 
2011. Staphylococcus aureus host range and human- bovine host shift. Applied 
and environmental microbiology 77:5908–5915. 
 
Schramm, F., A. Kern, C. Barthel, S. Nadaud, N. Meyer, B. Jaulhac, and N. Boulanger. 
2012. Microarray analyses of inflammation response of human dermal fibroblasts 
to different strains of Borrelia burgdorferi sensu stricto. PLoS ONE 7:e40046. 
 
Schukken, Y. H., J. Gunther, J. Fitzpatrick, M. C. Fontaine, L. Goetze, O. Holst, J. Leigh, 
W. Petzl, H. J. Schuberth, A. Sipka, D. G. Smith, R. Quesnell, J. Watts, R. 
Yancey, H. Zerbe, A. Gurjar, R. N. Zadoks, and H. M. Seyfert. 2011. Host-
response patterns of intramammary infections in dairy cows. Veterinary 
immunology and immunopathology144:270–289. 
 
 61 
Schukken, Y. H., K. E. Leslie, D. A. Barnum, B. A. Mallard, J. H. Lumsden, P. C. Dick, 
G. H. Vessie, and M. E. Kehrli. 1999. Experimental Staphylococcus aureus 
intramammary challenge in late lactation dairy cows: Quarter and cow effects 
determining the probability of infection. Journal of dairy science 82:2393–2401. 
 
Sipka, A., A. Gurjar, S. Klaessig, G. E. Duhamel, A. Skidmore, J. Swinkels, P. Cox, and 
Y. Schukken. 2013. Prednisolone and cefapirin act synergistically in resolving 
experimental Escherichia coli mastitis. Journal of dairy science 96:4406–4418. 
 
Sohn, E. J., M. J. Paape, E. E. Connor, D. D. Bannerman, R. H. Fetterer, and R. R. Peters. 
2007. Bacterial lipopolysaccharide stimulates bovine neutrophil production of 
TNF-alpha, IL-1beta IL-12 and IFN-gamma. Veterinary research 38:809–818. 
 
Sol, J., O. C. Sampimon, H. W. Barkema, and Y. H. Schukken. 2000. Factors associated 
with cure after therapy of clinical mastitis caused by Staphylococcus aureus. 
Journal of dairy science 83:278–284. 
 
Sordillo, L. M., K. Shafer-Weaver, and D. DeRosa. 1997. Immunobiology of the 
mammary gland. Journal of dairy science 80:1851–1865. 
 
Sordillo, L. M., and K. L. Streicher. 2002. Mammary gland immunity and mastitis 
susceptibility. Journal of mammary gland biology and neoplasia 7:135–146. 
 
Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 
140:805–820. 
 
Tamilselvi, E., D. Haripriya, M. Hemamalini, G. Pushpa, and S. Swapna. 2013. 
Association of disease severity with IL-1 levels in methotrexate-treated psoriasis 
patients. Scandinavian journal of immunology 78:545–553. 
 
Taraktsoglou, M., U. Szalabska, D. A. Magee, J. A. Browne, T. Sweeney, E. Gormley, 
and D. E. MacHugh. 2011. Transcriptional profiling of immune genes in bovine 
monocyte-derived macrophages exposed to bacterial antigens. Veterinary 
immunology and immunopathology140:130–139. 
 
Tollersrud, T., A. H. Kampen, and K. Kenny. 2006. Staphylococcus aureus enterotoxin D 
is secreted in milk and stimulates specific antibody responses in cows in the 
course of experimental intramammary infection. Infection and immunity 
74:3507–3512. 
 
Türkyilmaz, S., S. Tekbiyik, E. Oryasin, and B. Bozdogan. 2010. Molecular 
epidemiology and antimicrobial resistance mechanisms of methicillin-resistant 
Staphylococcus aureus isolated from bovine milk. Zoonoses Public Health 
57:197–203. 
 
 62 
van den Borne, B. H., M. Nielen, G. van Schaik, M. B. Melchior, T. J Lam, and R. N. 
Zadoks. 2010. Host adaptation of bovine Staphylococcus aureus seems associated 
with bacteriological cure after lactational antimicrobial treatment. Journal of dairy 
science 93:2550–2558. 
 
Vandeputte-Van Messom, G., C. Burvenich, E. Roets, A. M. Massart-Leen, R. 
Heyneman, W. D. Kremer, and A. Brand. 1993. Classification of newly calved 
cows into moderate and severe responders to experimentally induced Escherichia 
coli mastitis. Journal of dairy research 60:19–29. 
 
Wang, J., K. Hori, J. Ding, Y. Huang, P. Kwan, A. Ladak, and E. E. Tredget. 2011. Toll-
like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. 
Journal of cellular physiology 226:1265–1273. 
 
Wellnitz, O., and D. E. Kerr. 2004. Cryopreserved bovine mammary cells to model 
epithelial response to infection. Veterinary immunology and immunopathology 
101:191–202. 
 
Wenz, J. R., L. K. Fox, F. J. Muller, M. Rinaldi, R. Zeng, and D. D. Bannerman. 2010. 
Factors associated with concentrations of select cytokine and acute phase proteins 
in dairy cows with naturally occurring clinical mastitis. Journal of dairy science 
93:2458–2470. 
 
Wenz, J. R., F. B. Garry, and G. M. Barrington. 2006. Comparison of disease severity 
scoring systems for dairy cattle with acute coliform mastitis. Journal of the 
american veterinary medical association 229:259–262. 
 
Yeiser, E. E., K. E. Leslie, M. L. McGilliard, and C. S. Petersson-Wolfe. 2012. The 
effects of experimentally induced Escherichia coli mastitis and flunixin 
meglumine administration on activity measures, feed intake, and milk parameters. 
Journal of dairy science 95:4939–4949. 
 
Zahringer, U., B. Lindner, S. Inamura, H. Heine, and C. Alexander. 2008. TLR2—
Promiscuous or specific? A critical re-evaluation of a receptor expressing 
apparent broad specificity. Immunobiology 213:205–224. 
  
 63 
Table 1 Oligonucleotide primers used for real-time PCR quantification. 
(The top and bottom sequences are the forward and reverse, respectively.)  
 
 
Gene Name Sequence (5’ to 3’) Reference 
TLR2 GGTTTTAAGGCAGAATCGTTTG 
AAGGCACTGGGTTAAACTGTGT 
Akira, Takeda, and 
Kaisho (2001) 
TLR6 CCTTGTTTTTCACCCAAATAGC 
TAAGGTTGGTCCTCCAGTGAGT 
Akira, Takeda, and 
Kaisho (2001) 
IL-8 GCTGGCTGTTGCTCTCTTG 
AGGTGTGGAATGTGTTTTTATGC 
Pareek et al.  
(2005) 
CCL20 TTCGACTGCTGTCTCCGATA 
GCACAACTTGTTTCACCCACT 
Gilbert et al.  
(2013) 
IL-6 TGAGGGAAATCAGGAAAATGT 
CAGTGTTTGTGGCTGGAGTG 
Pareek et al.  
(2005) 
TNF-α TCTTCTCAAGCCTCAAGTAA 
CCATGAGGGCATTGGCATAC 
Bougarn et al.  
(2011) 
Β- actin GCAAATGCTTCTAGGCGGACT 
CAATCTCATCTCGTTTTCTGCG 
Pareek et al.  
(2005) 
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Figure 1 Production of IL-8 and IL-6 by cultured dermal fibroblasts.  
(A) Concentrations of IL-8 in fibroblast culture media following a 24 h challenge with 
200 ng/ml of Pam2SCK4 (Pam2). An * and a + indicate the low responding (LR) and 
high responding (HR) animals, respectively, that were selected for an in vivo S. aureus 
challenge. Cells cultured in media alone (negative control) produced no detectable IL-8. 
Values are mean ± SEM of two replicates. (B) IL-8 and (C) IL-6 protein concentrations 
in media following a 24 h challenge with Pam2 of fibroblasts isolated from the selected 
animals approximately five months before, and six weeks after an experimental challenge 
with S. aureus. For the first biopsy, n=5 LR and n=5 HR, for the second biopsy n=5 LR 
and n=4 HR (one 2nd HR biopsy did not yield a viable culture due to microbial 
contamination and was discarded). Concentrations of IL-8 and IL-6 were similar between 
replicated biopsies from animals within the LR and HR groups (P > 0.05; paired t-test). 
Media wells had no detectable IL-8 or IL-6.  
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Figure 2 Rectal temperatures post challenge.  
Rectal temperatures were monitored after a single intra-mammary infusion of S. aureus 
in the right hind quarter of ten challenged animals. Values are expressed as mean ± SEM. 
There were no significant differences in rectal temperatures following the challenge 
between low responder (LR) and high responder (HR) animals.  
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Figure 3 Challenged quarter milk yield, milk SCC, and S. aureus cfu following 
intra-mammary challenge.  
 
The LR animals (n=5) and HR animals (n=5) received an infusion of S. aureus in the 
right hind quarter, after which, milk yield from the infected quarter (A), milk SCC (B), 
and bacteria counts (C) were monitored. Milk SCC and bacteria counts were log10 
transformed. Values are expressed as mean ± SEM. There was no significant difference 
in milk yield between LR and HR animals during the challenge. Milk SCC was different 
between the groups throughout the challenge, with low responding animals experiencing 
reduced SCC (P < 0.05) SCC in milk from the right hind quarter when compared to the 
high responders. S. aureus was recovered from the right hind quarter of all animals by 24 
h post-challenge. There was no significant difference in average milk bacteria count 
between the low and high responding animals throughout the trial, although two of the 
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low responders cleared the infection (days 3 and 4), with one of these becoming 
measurably reinfected by day 14. The other three quarters of each cow served as control 
quarters and were culture negative throughout the challenge.  
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Figure 4 Levels of inflammatory markers in challenge quarter whey.  
Concentrations of IL-8 (A) and bovine serum albumin (B) were determined in whey from 
the right hind quarter of the LR animals (n=5) and HR animals (n=5) following an intra-
mammary infusion of S. aureus. Values represent the mean ± SEM for the two groups. 
The high responders had increased (P < 0.05) IL-8 and BSA concentrations when 
compared to the low responders. 
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Figure 5 Anti- S. aureus antibodies present in blood plasma and whey from the right 
hind quarter.  
 
Total levels of anti-S. aureus IgG were determined via an ELISA (represented as OD 
values) in whey and plasma of the five LR and five HR animals following challenge. 
Infection by S. aureus increased levels of total IgG in challenge quarter whey (A) and 
plasma (B) in both groups, and they were significantly greater (P < 0.05) in the HR 
compared to the LR animals. The levels of two IgG isotypes, IgG1 and IgG2, in whey 
from the challenged quarter were determined as well, and are presented in (C) and (D), 
respectively. Values represent the mean ± SEM of the LR and HR animals. The HR 
animals had an increase (P < 0.05) in total levels of IgG2 in whey compared to the LR 
animals, while IgG1 levels were similar between LR and HR animals.  
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Figure 6 Real-time PCR quantification of messenger RNA.  
Aliquots of dermal fibroblasts from the ten challenged animals (n=5 LR, n=5 HR) were 
revived, treated with Pam2 (200 ng/ml), and total RNA was extracted at hour zero 
(control conditions), two and eight for quantification of gene expression. Results are 
expressed as delta Ct in comparison to β-actin. Expression fold differences between LR 
and HR cultures are indicated by the values in parenthesis above 0, 2, or 8 h time points, 
with values indicating the greater expression in HR cultures. † indicates P < 0.1, * 
indicates P < 0.05. Values are mean ± SEM.  
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Chapter 3: Differential responsiveness of Holstein and Angus dermal 
fibroblasts to LPS challenge occurs without major differences in the 
methylome 
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3.1 Abstract 
 
Background: We have previously found substantial animal-to-animal and age-dependent 
variation in the response of Holstein fibroblast cultures challenged with LPS. To expand 
on this finding, fibroblast cultures were established from dairy (Holstein) and beef 
(Angus) cattle and challenged with LPS to examine breed-dependent differences in the 
innate immune response. Global gene expression was measured by RNA-Seq, while an 
epigenetic basis for expression differences was examined by methylated CpG island 
recovery assay sequencing (MIRA-Seq) analysis.  
Results: The Holstein breed displayed a more robust response to LPS than the Angus 
breed based on RNA-Seq analysis of cultures challenged with LPS for 0, 2, and 8 hours. 
Several immune-associated genes were expressed at greater levels (FDR < 0.05) in 
Holstein cultures including TLR4 at all time points and a number of pro-inflammatory 
genes such as IL8, CCL20, CCL5, and TNF following LPS exposure. Despite extensive 
breed differences in the transcriptome, MIRA-Seq unveiled relatively similar patterns of 
genome-wide DNA methylation between breeds, with an overall hypomethylation of 
gene promoters. However, by examining the genome in 3Kb windows, 49 regions of 
differential methylation were discovered between Holstein and Angus fibroblasts, and 
two of these regions fell within the promoter region (-2500 to +500 bp of the 
transcription start site) of the genes NTRK2 and ADAMTS5.  
Conclusions: Fibroblasts isolated from Holstein cattle display a more robust response to 
LPS in comparison to cultures from Angus cattle. Different selection strategies and 
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management practices exist between these two breeds that likely give rise to genetic and 
epigenetic factors contributing to the different immune response phenotypes.   
Keywords: Innate immunity, DNA methylation, RNA-Seq, MIRA-Seq 
 
3.2 Background 
The innate immune response plays a critical role in pathogen detection and the 
resulting inflammatory response that arises to contain and eliminate foreign invasions 
into host tissues. Infection of the mammary gland resulting in mastitis is an important and 
well characterized disease of dairy cattle, such as the Holstein breed (Bannerman, 2009). 
However, the incidence and severity of this disease in beef cattle has received little 
attention although two recent studies that examined mastitis prevalence in beef cows 
reported a moderate incidence with a surprising lack of Escherichia coli induced mastitis 
(Paape et al., 2000, Persson Waller et al., 2014). This pathogen is a major cause of 
mastitis in dairy animals and thus differences in susceptibility to E. coli infection may 
exist between dairy and beef breeds. Bovine mammary infections due to E. coli typically 
cause an acute response with inflammation ranging from mild and quickly resolving, to 
severe forms that can lead to sepsis, shock, and even death (Schukken et al., 2011). The 
response is initiated following recognition of E. coli lipopolysaccharide (LPS) by the 
extracellular Toll-like receptor 4 (TLR4), which is expressed on multiple cell types 
within the mammary gland (Gilbert et al., 2013). 
While there are multiple factors that can influence the inflammatory response to 
mammary gland infection, it has been suggested that host factors play the largest role in 
determining the severity of E. coli mastitis (Burvenich et al., 2003). These host factors 
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include age, stage of lactation, vaccination history, as well as genetic, and possibly 
epigenetic mechanisms all contributing to the magnitude and resolution of the host 
response. Identification of genetic or epigenetic factors controlling the inflammatory 
response may lead to enhanced selection or management strategies to produce dairy 
animals that have reduced collateral damage from mastitis. For example, genetic 
polymorphisms within pathogen recognition receptors or signaling pathway intermediates 
have been shown to lead to differences in disease susceptibility (von Bernuth et al., 2008, 
Kataria et al., 2011). Epigenetic mechanisms, such as DNA methylation or histone 
modifications can also influence gene expression resulting in phenotypic variation in 
immune response (Bayarsaihan, 2011). For example, human intestinal epithelial cells 
have increased DNA methylation in the TLR4 gene promoter that reduces its expression 
and leads to a reduced responsiveness to LPS (Takahashi et al., 2009). 
Selective breeding of cattle has been employed for many generations to produce 
breeds differing in economically important traits such as enhanced milk production in 
dairy breeds, and greater feed efficiency and meat quality in beef breeds (Miglior et al., 
2005, Kause et al., 2015). Cattle breeding has even resulted in sub-species (Bos taurus 
and Bos indicus) that differ markedly in resistance to disease such as that caused by tick 
infestation (Piper et al., 2008, Piper et al., 2010) or challenge with Theileria annulata 
(Glass et al., 2005a). Results from these studies suggest that B. taurus animals develop a 
greater inflammatory response to pathogens than do breeds of the B. indicus subspecies. 
Within the B. taurus sub-breed, studies directly comparing the inflammatory response to 
mammary infection between dairy and beef breeds have not been conducted. To further 
investigate potential differences in immune responses between dairy and beef animals, 
 75 
we challenged dermal fibroblasts obtained from Holstein (dairy) and Angus (beef) cows 
with LPS and then used RNA-Seq to examine global gene expression differences. We 
also employed MIRA-Seq to examine if global differences in the methylome could 
explain differences in the transcriptome. 
 
 
3.3 Results 
3.3.1 Fibroblast IL-8 Response 
Dermal fibroblasts (DF) isolated from Holstein and Angus heifers were used to 
investigate differences in the innate immune response between dairy and beef breeds. 
Fibroblasts isolated from Holsteins produced considerably higher levels of IL8 (P < 0.01) 
in response to a 24 h LPS (100ng/ml) challenge (Fig. 1a) when compared to Angus 
cultures (703 ± 86 pg/ml vs. 322 ± 46 pg/ml, respectively). A similar pattern was 
observed following IL1B (1ng/ml) treatment (Fig. 1a), with Holstein DF having a greater 
magnitude of IL8 response than Angus DF (1355 ± 160 pg/ml vs. 639 ± 80 pg/ml, 
respectively). There was no detectable IL8 in media collected from un-stimulated 
Holstein or Angus fibroblasts.  
RNA-Seq and MIRA- Seq analysis was performed on eight cultures (n = 4/breed) 
randomly selected from the pool of animals. These cultures were revived simultaneously 
from cryopreservation and prepared for a second challenge with LPS and IL1B. The 
Holstein cultures produced approximately twice (P < 0.01) as much IL8 protein in 
response to LPS compared to the Angus cultures (Fig. 1b). Similarly, differential IL8 
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responses were observed following IL1B exposure, with Holstein cultures exhibiting a 
hyper-responsive phenotype in IL8 protein production (Fig. 1b). 
3.3.2 RNA-Seq analysis of Holstein and Angus LPS response 
Total RNA samples for RNA-Seq analysis were obtained from the four Holstein 
and four Angus cultures following LPS exposure for 0, 2, and 8 h. These 24 samples 
generated approximately 54 million reads per sample following quality control. 
Alignment to the UMD v3.1 bovine genome resulted in 95% of the reads falling within 
alignment parameters (see Methods), thus an average of 51 million reads per sample. 
Under our definition of expression (CPM > 1 in at least 50% of the samples), there were 
20,356 targets detected at hour 0, which defined the core bovine fibroblast transcriptome 
under basal conditions. At hours 2 and 8 following LPS treatment, there were 21,411 and 
21,590 targets detected, respectively. By combining breeds, and comparing basal gene 
expression to time points following LPS-induced innate immune response, 624 
transcripts were revealed to have differential gene expression (FDR < 0.05; CPM > 1; FC 
≥ 2) with 470 up- and 154 down-regulated at hour 2 post-LPS (Additional file 1). At hour 
8 post-LPS, 331 transcripts were discovered having differential gene expression 
compared to hour 0, of which, 250 were up- and 81 were down- regulated (Additional file 
2). LPS treatment of the fibroblast cultures induced various innate immune-associated 
genes in the LPS signaling pathway and those coding for response proteins (Table 1). 
There were temporal differences in the induction of these genes following LPS exposure 
for 2 or 8 hours. Early induced genes included several pro-inflammatory chemokines and 
cytokines such IL8, IL1A, TNF, chemokine (C-X-C) motif ligand (CXCL) 2, and 
 77 
Interferon regulatory factors (IRF) 1 and 5. Following 8 h of LPS exposure, several Type 
I IFN-related genes showed greater expression compared to hour 0, while TNF 
expression had returned to basal levels. 
A comparison between Holstein and Angus cultures revealed 844, 968, and 730 
differentially expressed (DE) genes (FDR < 0.05; CPM > 1; FC ≥ 2) at hours 0, 2, and 8-
post LPS, respectively (Fig. 2; Additional file 3). Of these genes, 369, 517, and 477, 
respectively, had higher expression levels in Holstein cultures compared to Angus 
cultures. Pathway enrichment analysis was completed with DAVID and genes with 
differential expression between the breeds at 2 h post-LPS were involved with the MAPK 
(P = 0.029) and TGF-beta (P = 0.031) signaling pathways. By 8 h post-LPS, the NOD-
like (P = 0.003), Toll-like (P = 0.02), and RIG-I-like (P = 0.02) receptor signaling 
pathways were represented in our set of DE genes between the two breeds. Table 2 lists 
several of the DE genes that are involved in the innate immune response. TLR4, NOD1, 
and TRAF1, genes involved with the recognition of pathogen associated molecular 
patterns and activation of NF-κB pathway, were expressed higher in Holstein cultures. 
Chemokines such as chemokine (C-C motif) ligand (CCL) 2, 5, and 20, and IL8 that 
recruit monocytes, T cells, lymphocytes, and neutrophils to sites of infection also had 
higher expression levels in Holstein fibroblasts. In addition to genes related to the innate 
immune response, differences were observed in genes that have been implicated in DNA 
methylation, such as the family of DNA methyltransferase (DNMT) genes and ubiquitin-
like with PHD and RING finger domains 1 (UHRF1) (Bostick et al., 2007, Moore et al., 
2013). Expression of DNMT3A and 3B, which are involved with de novo DNA 
methylation, were similar between the breeds. However, expression of DNMT1, which is 
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responsible for maintenance of DNA methylation patterns following DNA replication, 
was 1.6-fold higher at hour 0 and 1.5-fold higher at hours 2 and 8 in Angus cultures 
compared to Holstein cultures. Angus cultures also had 2.3-, 2.0-, and 2.0-fold higher 
expression of UHRF1 at 0, 2, and 8 hours post-LPS treatment (Table 3). Interestingly, 
greater activation of a potentially anti-inflammatory signaling pathway in Angus cultures 
was noted by the 3.1-fold higher expression of the gene encoding chemokine (C-X-C 
motif) receptor 4 (CXCR4) at hour 0 compared to Holsteins. While CXCR4 expression 
was not different at hours 2 and 8 post-LPS, the sole ligand of this receptor, CXCL12, 
was expressed 5.7-, 7.4-, and 6.5-fold higher in Angus cultures at hour 0 and at 2 and 8 
hours post LPS stimulation. 
 3.3.3 RT-qPCR Confirmation of RNA-Seq 
Several immune-response associated genes were selected for RT-qPCR 
confirmation of expression differences observed between Holstein and Angus cultures 
following LPS treatment as determined by RNA-Seq. TLR4, IL8, CCL20, CCL5, and 
TNF showed similar expression levels in RT-qPCR analysis in comparison to the RNA-
Seq data set. Basal expression of IL8, CCL20, CCL5, and TNF was similar between the 
breeds. However, by 2 h after LPS stimulation, marked differences were observed 
between Holstein and Angus expression of IL8, TNF, CCL20, and CCL5, with a 3.0-, 
24.3-, 4.9-, and 3.9- fold higher expression in Holstein fibroblasts compared to Angus 
fibroblasts (Fig. 3 b, c, d, and e). A similar pattern was observed at 8 hours, with Holstein 
cultures having higher expression in the following genes: IL8 (13.1-fold), TNF (13.0-
fold), CCL20 (35.3-fold), and CCL5 (17.8-fold). LPS exposure did not induce TLR4 
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expression in either breed; however, Holstein cultures consistently expressed higher 
levels of TLR4 compared to Angus cultures (Fig. 3a; 4.5-, 5.7-, and 3.1- fold higher at 
hours 0, 2, and 8, respectively). In general, gene expression values determined by RT-
qPCR are in agreement with the transcriptomic results from RNA-Seq data.  
3.3.4 MIRA-Seq 
The 8 DNA samples (4 per breed) processed for MIRA-Seq analysis resulted in 
approximately 44 million reads per sample following quality control. Alignment to the 
bovine UMD v3.1 reference genome yielded 97% of reads falling within alignment 
parameters (see Methods) and an average of 43 million mapped reads per sample. To 
determine differential methylation rates between Holstein and Angus fibroblasts, the 
genome was divided into 3Kb windows, and then the read count in each window was 
compared. Analysis of the 3Kb windows revealed 49 regions that had different levels of 
methylation between Holstein and Angus cultures based on the following thresholds: 
FDR < 0.1; CPM > 1; FC ≥ 2 (Table 3). Of these differentially methylated regions 
(DMR), 24 had higher rates of methylation in cultures from Holstein animals, while 25 
displayed higher methylation levels in Angus fibroblasts. Of the 24 regions with higher 
methylation in Holstein, 14 were found partially within an annotated gene while 10 were 
not. Within the 25 DMR with higher methylation levels in Angus cultures 13 fell within 
annotated genes while the remaining 12 regions did not. Only two of the DMR (greater 
methylation in Angus cultures) were located within the defined promoter regions of 
genes: a disintegrin and metalloprotease with thrombospondin motifs 5 (ADAMTS5) and 
neurotrophic tyrosine kinase, receptor type 2 (NTRK2). These DMRs were not reflected 
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by differences in expression of either gene between the Holstein and Angus cultures at 
hours 0, 2, and 8 post-LPS (Table 3). A DMR spanning intron 3 and exon 4 of the agouti 
signaling protein (ASIP) gene had greater methylation in the Angus cells and was 
associated with a marked increase in its expression in these cells at all time points.  
3.3.5 Influence of DNA methylation on gene expression  
The genome-wide association between gene expression and methylation levels 
within a gene body or gene promoter region was investigated by plotting MIRA-Seq 
values for a gene body or gene promoter against RNA-Seq values for 8 h post-LPS. As 
data from the two breeds appeared similar, the combined data points from both the 
Holstein and Angus cultures were binned as either low or high, with a gating value of 
reads per kilobase per million matched reads (RPKM) =5 for RNA-Seq or RPKM = 0.5 
for MIRA-Seq. When the relationship between methylation levels in either the gene 
promoter region or the gene body and that gene’s subsequent expression level was 
analyzed, it revealed the two values were significantly dependent upon one another (P < 
0.001; O.R. = 0.83; 95% C.I. = 0.76 – 0.89 and P < 0.001; O.R. = 1.26; 95% C.I. = 1.14 – 
1.40), for gene promoter (Fig. 4a) and gene body (Fig. 4b), respectively. This indicates a 
strong inverse relationship between methylation in either the gene promoter or gene body 
and the level of gene expression. Analysis of the 0- and 2-hour time points following LPS 
treatment gave similar results (data not shown).  
 Levels of DNA methylation were also measured, as RPKM, in gene promoters, 
gene bodies, or intergenic regions (Fig. 4c). Data from un-treated cultures of the 4 
Holstein and 4 Angus were combined for this analysis, as there were no significant breed 
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differences. Levels of methylation in all three regions were significantly different (P < 
0.05), with gene promoters having the lowest and intergenic regions having the highest 
levels of methylation. 
 
3.4 Discussion 
Variation exists between cows in their innate immune response to mastitis. A 
greater understanding of the basis for this variation could facilitate new breeding, 
selection, or management practices to develop animals with superior ability to contain 
and eliminate pathogens from the normally sterile mammary gland. We have previously 
used dermal fibroblasts to model this animal variation within groups of Holstein cows 
(Kandasamy et al., 2011, Benjamin et al., 2015). In these studies we found substantial 
differences between dairy cows in the magnitude of their fibroblasts’ response following 
treatment with LPS or PAM2CSK4 that are ligands for TLR4 and TLR2/6, respectively. 
Intra-mammary bacterial challenges were also conducted on groups of lactating animals 
from these studies that had been classified as having low or high responding phenotypes. 
Low responding animals developed a reduced inflammatory response characterized by 
less leakage of bovine serum albumin (BSA) into milk, as well as a less severe reduction 
in milk quality, as determined by a lower milk somatic cell count. This reduced response 
was accompanied by similar bacterial clearance rates between the phenotypes, suggesting 
the heightened response of the high responding animals did not offer any advantage in 
resolution of the infection. There is limited data to suggest that a high response 
phenotype is characteristic of dairy in comparison to beef breeds of cattle (Glass et al., 
2005b, Piper et al., 2009) and thus, in the current study, we have expanded our use of the 
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fibroblast model to explore differences between a dairy breed (Holstein) and a beef breed 
(Angus) in their innate responses to LPS exposure.  
Previous studies have looked at differences in the innate immune response 
between dairy breeds (Holstein and Jersey) following an intra-mammary challenge with 
S. aureus (Bannerman et al., 2008b) or E. coli (Bannerman et al., 2008a). While there 
was high inter-animal variation in milk levels of IL8 and TNF during the challenge, the 
overall responses were similar between Holstein and Jersey animals. This suggested that 
the innate immune response is conserved between these two dairy breeds. Likewise, an 
intravenous LPS challenge comparing beef breeds (Angus and Romosinano) revealed 
small differences in the serum response profiles of TNF and IL1B (Carroll et al., 2011). 
Each of these studies examined differences within dairy or within beef breeds, while few 
studies have explored differences in innate immune responses between a dairy and a beef 
breed. In one such study, skin biopsies were collected from Holstein (B. taurus) and 
Brahman (B. indicus) animals following an experimental tick challenge to compare 
localized innate immune responses at tick-attachment sites (Piper et al., 2010). 
Microarray analysis of the biopsies revealed that Holstein animals had greater expression 
of many innate immune response-associated genes in comparison to the Brahmans. It was 
suggested that the greater expression of chemokine and cytokines at tick-attachment sites 
might facilitate feeding by the tick, thereby leading to the lower resistance to tick 
infestations observed in the Holstein breed. Similarly, Holstein and Sahiwal (B. indicus) 
calves were used to explore breed differences in the inflammatory response (Glass et al., 
2005b). In that study, calves from both breeds underwent an experimental challenge with 
Theileria annulata, the protozoan parasite that causes bovine theileriosis. Holstein calves 
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experienced severe clinical symptoms following the challenge while Sahiwal calves 
seemed better able to control the inflammatory response. Furthermore, we have 
previously presented data from a related experiment, now being prepared for full 
publication, indicating that Holstein heifers have greater serum IL6 and TNF levels after 
an intravenous LPS challenge compared to age-matched Angus heifers (Benjamin et al., 
2014). In our current study, a comparison of Holstein and Angus fibroblasts revealed 
significant breed differences in response to an LPS challenge, with Holstein cultures 
exhibiting a hyper-responsive phenotype compared to the hypo-responsiveness of Angus 
cultures.  
3.4.1 Holstein vs. Angus differences in LPS response 
RNA-Seq analysis of LPS-challenged fibroblasts revealed a large number of 
immune-associated differentially expressed genes between Holstein and Angus cultures. 
Many of these genes are known to play critical roles in the response to — and the 
recovery from  — bacterial infections such as E. coli mastitis (Burvenich et al., 2003, 
Kandasamy and Kerr, 2012). In particular, TLR4, which is the extracellular receptor 
responsible for recognition of LPS, was expressed at higher levels in Holstein cultures 
before (4.5 fold) and following LPS stimulation (5.7 and 3.1 fold). This may suggest the 
Holstein animals will detect and respond to Gram-negative bacteria more vigorously than 
Angus animals. Additionally, several subunits of the NF-κB transcription factor complex 
were differentially expressed between breeds. Specifically, Holstein cultures had greater 
expression of RELB (1.8-fold) at hours 0 and 2, and NFKB1 (1.6-fold) and NFKB2 (1.8-
fold) at hour 8 post LPS treatment. This transcription factor is central to innate immune 
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signaling pathways leading from a diverse array of pattern recognition receptors 
including the TLR and NOD receptor families (Sun et al., 2013). Once activated, NF-κB 
promotes the transcription of chemokine and cytokine genes associated with the innate 
immune system. While the activity of NFKB is carefully regulated under normal 
conditions, excessive production of pro-inflammatory cytokines can lead to its further 
activation, which may create a chronic inflammatory condition (Hayden and Ghosh, 
2012). The higher expression of both TLR4 and the various subunits of NFKB complex in 
the Holstein fibroblasts would enable the greater responsiveness to LPS observed in this 
breed.   
An appropriate innate immune response is also dependent on timely production of 
anti-inflammatory factors once the stimulatory agent has been eliminated. The chemokine 
receptor 4 (CXCR4) and its sole ligand, CXCL12 are important in this regard and their 
interaction has been shown to suppress TLR4 signaling and NFKB activation in response 
to LPS in human embryonic kidney cells (Kishore et al., 2005) and to suppress LPS-
induced IL6 production by murine bone marrow-derived macrophages (Fan et al., 2012). 
The CXCL12 chemokine has the ability to activate anti-inflammatory pathways in T-cells 
and macrophages and to suppress inflammation (Meiron et al., 2008, Karin, 2010). A 
single injection of a CXCL12 analog administered to mice in parallel with LPS was able 
to decrease the levels of LPS-induced plasma TNF (Fan et al., 2012). Within our 
fibroblasts, Angus cultures expressed greater levels of CXCR4 and CXCL12 prior to LPS 
treatment. At hours 2 and 8 post-LPS, CXCL12 expression continued to be higher in 
Angus while the differences in CXCR4 expression disappeared. Due to the inhibitory 
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function of CXCR4 and CXCL12, the higher basal expression of these two genes in 
Angus cultures may have reduced their LPS responsiveness.   
Breed differences in the expression of genes associated with the maintenance of 
DNA methylation were also uncovered in RNA-Seq analysis. DNMT1 and UHRF1 were 
more highly expressed in Angus cultures both basally and following LPS exposure. 
DNMT1 is responsible for maintaining DNA methylation patterns following replication 
(Moore et al., 2013), and UHRF1 interacts with hemimethylated DNA and recruits 
DNMT1 to facilitate methylation of the daughter strand (Bostick et al., 2007). Greater 
expression of these two genes in Angus cultures may indicate this breed is better able to 
maintain methylation levels. Increased methylation of gene promoter regions is generally 
associated with reduced gene transcription and thus could account for the reduced 
expression of pro-inflammatory genes in fibroblasts from this breed. 
3.4.2 Methylation differences between breeds 
The breed comparison also included an examination into the potential role that 
differences in early life environment might play in determining breed differences in an 
animal’s epigenome. Holstein calves are removed from their dams within 24 h of birth, 
moved to individual housing, and fed a milk replacer diet; while Angus calves are 
allowed to nurse from the dam for months and are typically housed with the herd out on 
pasture. These environmental differences could affect DNA-methylation patterns and 
lead to differences in gene transcription in response to immune stimulation. The MIRA-
Seq analysis of Holstein and Angus fibroblasts revealed 49 3Kb regions of the genome 
that were differentially methylated between breeds (Table 3). In a global sense, the breed 
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difference was minimal despite the higher expression of DNMT1 and UHRF1 in Angus 
cultures. Unexpectedly, genes involved in the LPS-response pathway were under-
represented in these 49 regions. While it would appear that DNA methylation does not 
play a major role in the differential breed response to LPS observed in our fibroblast 
model, MIRA-Seq is only a moderate-resolution technique and a potential limitation of 
the current study. The MIRA technique is based on the high affinity of a two-protein 
complex formed by methyl-CpG-binding proteins (MBD) 2b and 3L1, which bind to 
methylated DNA in a methylated CpG density-dependent manner (Jung et al., 2015). 
Regions of fragmented DNA with greater methylated CpG content, such as CpG islands, 
will have enhanced affinity for the MBD complex, allowing for enrichment of these 
regions in the final analysis, whereas regions with low CpG content will be under-
represented. While this allows for a comparison of the overall methylome between 
individuals, MIRA-Seq is not sensitive enough to detect more subtle, but influential, 
differences in methylation at specific CpG sites. For example, differential methylation at 
a single CpG site in the IL6 gene promoter was attributed to differential serum levels of 
IL6 in patients suffering from rheumatoid arthritis (Ishida et al., 2012). Patients that were 
experiencing elevated serum levels of IL6 had lower methylation rates at a single CpG 
site in the gene promoter, suggesting that methylation at this site represses IL6 
transcription. Subtle differences in CpG methylation between Holstein and Angus 
cultures may have been lost in our analysis. Future studies of methylation differences 
between cattle breeds would benefit from a technology with greater resolving power such 
as those based on sequencing of bisulfite converted DNA (Mensaert et al., 2014).  
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3.4.3 Identification of biomarkers linked to phenotypic responses  
Previously, we have demonstrated age-dependent increases in LPS-
responsiveness of fibroblasts collected from the same animals at 5 and 16 months of age 
(Green et al., 2011). Cultures isolated from young (5-month-old) Holsteins produced 
considerably lower levels of IL8 following LPS exposure compared to cultures collected 
from the older (16-month-old) Holsteins. RNA-Seq analysis was completed on the young 
vs. old cultures following LPS treatment, and revealed several pro-inflammatory response 
genes, including IL8, IL6, CCL20, TNF, and CXCL2 that had greater expression in older 
cultures following LPS stimulation (Green et al., 2015). Comparing the RNA-Seq data 
sets from the previous young vs. older Holstein study, and the current Holstein vs. Angus 
study revealed several genes that had similar expression patterns defining a high vs. low 
response phenotype. The higher response phenotype of older animals in the previous 
study, and Holstein animals in the current study, is characterized by greater expression of 
TLR4, IL8, CCL2, CCL5, CCL20, and TNF. These genes are critical in the recognition of, 
and resulting inflammation following infection by Gram-negative bacteria. The 
identification of this set of biomarkers from the global transcriptome may allow for 
greater precision in classifying an animal’s innate immune response phenotype even at a 
young age. This has potential utility in selecting low response replacement heifers as 
young calves to avoid raising high response animals that are more likely to develop 
severe rather than milder forms of coliform mastitis. Alternatively, selective modification 
of the Holstein genome with appropriate Angus genes may be used to generate Holstein 
animals with a reduced, potentially beneficial, innate response to infection.  
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3.5 Conclusions 
Our previous work on characterizing within-breed variation in the innate 
immune response has now been extended to reveal substantial differences between a 
dairy and a beef breed. Our fibroblast model system indicates that divergent selection for 
dairy or beef character has resulted in substantial differences in immune phenotypes 
between these breeds, with dairy animals being more responsive to LPS than beef 
animals. Genetic differences between the dairy and beef breeds are likely of key 
importance, but management differences resulting in differing in utero and neonatal 
environments may lead to epigenetic differences as well. Events such as health of the 
dam during pregnancy or the level of maternal care a calf receives in early life may lead 
to epigenetic modifications that alter that animal’s innate immune response phenotype as 
an adult. Our current studies also provide a set of gene expression biomarkers, 
measurable in dermal fibroblasts, which are indicative of an animal’s innate immune 
response magnitude. 
 
3.6 Materials and Methods 
3.6.1 Animals and experimental set-up 
Female animals of two cattle breeds were used in this study: Angus (n = 12) and 
Holstein (n = 5). All animals were 19.4 (± 0.1) months of age at the time of skin sampling 
(see below) and were housed and cared for at the University of Minnesota. The 
Institutional Animal Care and Use Committee at both the University of Vermont and the 
University of Minnesota approved all animal procedures prior to beginning the study.  
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3.6.2 Dermal Fibroblast Isolation 
Skin biopsies were collected from the shoulder area of animals housed at the 
University of Minnesota as previously described (Kandasamy et al., 2011) and shipped 
overnight on ice packs to the University of Vermont in a transport media consisting of 1X 
Dulbecco’s PBS (DPBS; Hyclone Laboratories, Logan, UT) with 1X antibiotic cocktail 
(100 U/mL penicillin, 100µg/mL streptomycin, and 0.25µg/mL amphotericin B; Hyclone 
Laboratories). Once received, biopsy samples were processed as described (Benjamin et 
al., 2015). Briefly, fibroblasts were isolated with a 0.5% collagenase type I enzyme 
solution (Life Technologies, Grand Island, NY) and seeded in a 25cm2 flask (Corning 
Inc., Corning, NY) in Dulbecco’s Modified Eagle Medium (DMEM; Hyclone 
Laboratories) with 10% FBS (Hyclone Laboratories), 1X antibiotic cocktail, and 1X 
Insulin-Transferrin-Selenium (ITS; Mediatech Inc., Herndon, VA). Upon confluency, 
cells were detached with 0.25% trypsin (MP Biomedical, Santa Ana, CA) and seeded into 
a 75cm2 flask (Corning Inc.) in DMEM with 5% FBS, 1X antibiotic cocktail, and 1X 
ITS. After approximately four days, cells were expanded into three 75cm2 flasks, and 
once confluent, cells were detached from the flasks with trypsin, diluted in DMEM 
supplemented with 20% FBS and 10% dimethyl sulfoxide (Sigma- Aldrich, St. Louis, 
MO), and nine aliquots of third passage cells were cryopreserved in liquid nitrogen for 
subsequent challenges.  
3.6.3 In vitro challenges 
A challenge was conducted to compare breed differences in the fibroblast 
response to LPS exposure on fibroblasts isolated from Holstein and Angus animals. 
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Aliquots of fibroblasts isolated from both breeds were revived in parallel from 
cryopreservation and cultured in a 75cm2 flask in DMEM supplemented with 5% FBS, 
1X antibiotic cocktail, and 1X ITS. Once confluency was reached, cells were detached 
with 0.25% trypsin, washed, counted with a cell counter (Bio Rad, Hercules, CA) and 
seeded into 6-well plates (Corning Inc.) at 1.25 x 105 cells/ml in a total volume of 2ml. 
Media was replaced 24 h later with 2ml of either fresh media (negative control), media 
containing 100ng/ml of ultra-pure LPS isolated from Escherichia coli O111:B4 (Sigma-
Aldrich), or media containing 1ng/ml of recombinant bovine IL1B (AbD Serotech, 
Raleigh, NC). After the challenge period, media was collected from each well, spun at 
10,000x g for one minute to remove cell debris, and stored at -20°C until further analysis.  
3.6.4 IL8 ELISA  
The concentration of IL8 in conditioned media samples was determined by a 
custom sandwich ELISA as described previously (Kandasamy and Kerr, 2012). Mouse 
anti-bovine (clone 170.13, gifted by Samuel Maheswaren, University of Minnesota, St. 
Paul, MN) and a biotinylated goat anti-human IL8 (R&D Systems Inc., Minneapolis, 
MN) were used as capture and detection antibodies, respectively. Recombinant bovine 
IL8 (Thermo Scientific, Rockford, IL) was used as the assay standard. The detection limit 
for this assay was 130pg/ml. Differences in IL8 protein production between Holstein and 
Angus fibroblast cultures were determined using a Student’s t-test (Graph Pad Prism 6.0).  
3.6.5 RNA-Seq 
Fibroblast cultures collected from four animals of each breed (Holstein and 
Angus) were randomly chosen for investigation of whole transcriptome (RNA-Seq) 
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differences between the breeds. Aliquots from each culture were revived from 
cryopreservation and grown to confluency in a 75cm2 flask with DMEM supplemented 
with 5% FBS, 1X antibiotic cocktail, and 1X ITS. Cells were lifted with 0.25% trypsin, 
counted, and seeded into 6-well plates at 1.00 x 105 cells/ml. Following a 48 h 
incubation, fibroblasts were challenged with 100ng/ml of LPS and RNA was collected 
from replicate wells at three time points: hour zero (control conditions), hour two, and 
hour eight post-LPS using the PurefectPure RNA Cultured Cell extraction kit (5 Prime, 
Hamburg, Germany), which includes a DNase treatment step to eliminate DNA 
contamination. RNA concentration and quality were assessed using a Qubit 
Spectrofluorometer (Life Technologies, Carlsbad, CA) and an Agilent Bioanalyzer 2100 
(Agilent Technologies, Santa Clara, CA), ensuring that all samples had an RNA integrity 
number (RIN) of 9.5 or greater. Libraries for RNA-Seq analysis were constructed as 
previously described (Green et al., 2015). Briefly, 500ng of total RNA was PolyA 
enriched using magnetic beads, reversed transcribed, and the resulting cDNA was 
fragmented, end repaired, and adenylated. Oligonucleotide adaptors (Illumina, San 
Diego, CA), each with a unique adaptor sequence or barcode, were then ligated onto each 
sample. PCR amplification was completed using Illumina reagents, followed by quality 
assessment (as described above), and high accuracy qPCR quantification (KAPA 
Biosciences kit # 4824, Barre, VT). AMPure XP Magnetic Beads (Beckman Coulter, 
Pasadena, CA) were used in cDNA clean-up steps. Sequencing was performed using a 
12pM/flow cell lane on an Illumina CBOT for flow cell cluster generation and the 
Illumina HiSeq1000 for sequencing by synthesis equipped with the HiSeq Control and 
sequence analysis software.  
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3.6.6 DNA isolation and methylated CpG Island recovery assay (MIRA-Seq) 
MIRA-Seq libraries were generated to investigate genome wide methylation 
levels in fibroblasts isolated from Holstein and Angus cattle. Genomic DNA was isolated 
from the same Holstein (n = 4) and Angus (n = 4) cultures used in the RNA-Seq 
experiment (with no exposure to LPS) using the 5 Prime Pure Perfect Archive DNA 
Extraction kit (Hamburg, Germany). Following extraction, genomic DNA was sonicated 
and processed into MIRA-Seq libraries of approximately 300-700 bp in size, essentially 
as described previously [35] starting with 1.5µg of DNA. MIRA pull-down was 
performed using the Methyl Collector Ultra Kit (Active Motif, Carlsbad CA) per 
manufacturer’s instructions. Sequencing of the libraries was performed using a 
12pM/lane bridge amplification on an Illumina CBOT for flow cell cluster generation and 
the HiSeq1000 for sequencing by synthesis equipped with the HiSeq Control and 
sequence analysis software.  
3.6.7 Analysis of RNA-Seq data 
Raw sequence reads that had a median quality (Q) score of less than 20, more 
than 3 uncalled bases, or were less than 25bp following trimming were removed from 
further analysis, and filtered reads were aligned to the reference UMD v3.1 (Zimin et al., 
2009) bovine genome using the software package NextGENe v. 2.3.4 (Softgenetics, State 
College, PA). In order for a read to be considered a mapped read, alignment parameters 
required > 85% of the read’s length to align to the reference sequence. After reads were 
mapped using NextGENe, total raw read counts were generated for each annotated gene, 
as defined by the UCSC genome browser UMD v 3.1/bosTau 6.  
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RNA-Seq data was analyzed by statistical methods used by edgeR in the R software 
package (version 3.0.1). Initially, genes with a low read count, defined as at least one 
mapped read per million mapped reads (counts per million; CPM) in less than 50% of the 
samples being compared, were eliminated. For example, comparison of cultures from 
Holstein and Angus animals at a given time point required analysis of n=4 samples/breed, 
so at least 4 samples needed a CPM equal to or greater than 1 to be considered for 
analysis.  
A generalized linear model likelihood-ratio test using the limma package was 
used to conduct comparisons of cultures from animals of the two breeds at the different 
time points post-LPS for RNA-Seq. Similar analysis was also employed to determine the 
LPS response (0 h vs. 2 h and 0 h vs. 8 h post-LPS). Raw p-values were adjusted to 
account for multiple comparisons using the Benjamini-Hochberg method (Benjamini and 
Hochberg, 1995).  
When analyzing the effect of breed on the LPS response, genes were considered 
differentially expressed if they passed the false discovery rate (FDR) < 0.05 and fold 
change (FC) ≥ 2 thresholds. The effect of LPS on gene expression was determined by 
comparing cultures at the 2- and 8-h time points to the 0 h cultures. The Database for 
Annotation, Visualization and Integrated Discovery (DAVID; 
http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009b, a) was used for functional 
annotation and analysis by uploading the official gene symbol of statistically significant 
genes (FC ≥ 2; CPM > 1; FDR < 0.05 for RNA-Seq).  
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3.6.8 Analysis of MIRA-Seq 
Raw sequence reads were filtered and aligned as described above. After reads 
were mapped using NextGENe, total raw read counts for each gene, as defined by the 
UCSC genome browser, UMD v 3.1/bosTau6, were generated. Data analysis was 
completed using the edgeR module in the R software package (v3.0.1). Genes with a low 
read count, defined as a CPM of at least 1 in less than 50% of the samples were removed. 
A generalized linear model likelihood-ratio test using the limma package was employed 
to compare methylation levels between cultures from Holstein and Angus animals. 
Identification of differentially methylated regions (DMR) was completed on 3Kb 
windows of the genome to allow for an overall assessment of the bovine fibroblast 
methylome. Raw p-values were adjusted to account for multiple comparisons using the 
Benjamini-Hochberg method (Benjamini and Hochberg, 1995). For analysis of MIRA-
Seq data, levels of methylation were considered different between breeds if the region 
passed the FDR < 0.1 and FC ≥ 2 thresholds.  
3.6.9 Quantitative real-time PCR  
Five immune-associated genes from those identified in RNA-Seq were selected 
for quantitative real-time PCR (RT-qPCR). Oligonucleotide primers specific for the 
following genes were used: Toll-like receptor 4 (TLR4), interleukin 8 (IL8), tumor 
necrosis factor alpha (TNF), chemokine (C-C-motif) ligand 5 (CCL5), and chemokine (C-
C-motif) ligand 20 (CCL20). Primer sequences are in Table 4. The RNA that was used 
for the whole transcriptome analysis was also used in RT-qPCR. The Improm II Reverse 
Transcriptase kit (Promega, Madison, WI) was used to complete first strand cDNA 
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synthesis. Gene expression was quantified by RT-qPCR on a CFX96 Real-Time 
Instrument (Bio-Rad) using PereCTa SYBR Green Super-Mix, Low ROX kit (Quanta 
Biosciences). Cycling conditions were: initial denaturation at 95°C for 2 minutes; then 40 
cycles of denaturation at 95°C for 15 seconds, annealing at 60°C for 30 seconds, and 
extension at 72°C for 1 minute. Samples were run in duplicate and melt curves were 
performed to check amplification of desired gene product. The beta-actin (ACTB) gene 
was used as a reference gene for normalization (Robinson et al., 2007, Bougarn et al., 
2011b). Cycles to threshold (Ct) were calculated for each sample and analyzed with the 
ΔCt method with fold change being 2-ΔΔCt. Analysis of RT-qPCR data was completed 
using a two-way ANOVA model with repeated measures (Graph Pad Prism 6.0). 
Comparisons with P < 0.05 were considered statistically significant within experiments.  
3.6.10 Relationship between MIRA-Seq and RNA-Seq 
To determine a relationship between DNA methylation and gene expression, the 
average reads per kilobase per million matched reads (RPKM) from the RNA-Seq and 
MIRA-Seq of the 8 cultures from the two cattle breeds were investigated. Gene body and 
intergenic regions were determined based on annotations of the UMD v3.1 bovine 
genome, while gene promoters were defined as -2500 to +500 bp from the gene 
transcription start site. A two-tailed Fisher’s exact test in the R software package was 
used to determine the relationship between mRNA transcription levels and DNA 
methylation, in which, an association was investigated between low or high levels of 
methylation and either low or high gene expression. Values for gene expression RPKM 
were calculated as the cumulative size of the gene exons, while for gene methylation, 
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gene body length was the total size of both intronic and exonic segments. All values were 
normalized to library and transcript size by conversion of read counts into RPKM values. 
RNA-Seq RPKM values were binned into either low or high levels at a cutoff of RPKM 
= 5, while MIRA-Seq RPKM values were divided into low and high levels at PRKM = 
0.5. 
To determine if the type of genomic region had an effect on DNA methylation 
levels, average RPKM was calculated for gene promoters, gene bodies, and intergenic 
regions. Gene body and intergenic regions were determined by UMD v3.1 bovine 
genome, and gene promoters were defined as -2500 to +500 bp of a gene transcription 
start site. A one-way ANOVA with a Bonferroni post-test for multiple comparisons was 
run to determine differential methylation levels based on genomic location. 
 
3.7 Availability of supporting data 
The datasets supporting the conclusions of this article are available in NCBI’s Gene 
Expression Omnibus and are accessible through GEO SuperSeries accession number 
GSE72075 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72075. 
 
3.8 Additional files 
Additional file 1: Genes displaying differential gene expression (FDR < 0.05; CPM > 
1; 2 ≤ FC ≤ -2) due to LPS at hour 2 as compared to hour 0. A positive fold change 
indicates higher expression at hour 2 compared to hour 0. CPM = counts per million. 
FDR = false discovery rate. Data shown for comparisons with an FDR < 0.05; CPM > 1; 
FC ≥ 2.  
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Additional file 2: Genes displaying differential gene expression (FDR < 0.05; CPM > 
1; 2 ≤ FC ≤ -2) due to LPS at hour 8 as compared to hour 0. A positive fold change 
indicates higher expression at hour 8 compared to hour 0. CPM = counts per million. 
FDR = false discovery rate. Data shown for comparisons with an FDR < 0.05; CPM > 1; 
FC ≥ 2. 
Additional file 3: Differentially expressed genes (FDR < 0.05; CPM > 1; 2 ≤ FC ≤ -2) 
between Holstein and Angus fibroblast cultures exposed to 100ng/ml LPS for 0, 2, 
and 8 hours. A positive fold change indicates higher expression in Holstein cultures. 
CPM = counts per million. FDR = false discovery rate 
 
*Please obtain additional files from Dr. David Kerr (David.Kerr@uvm.edu) * 
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Table 1 Average LPS response from combined Holstein and Angus cultures 
measured by increases in expression of immune-associated genes compared to hour 
0 post-LPS. 
 
Gene 
symbol 
Gene Name Fold Change* 
Transcription and activation pathways  Hour 2 Hour 8 
BIRC3 Baculoviral IAP repeat-containing protein 3 7.3 4.2 
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, alpha 
24.3 9.3 
NFKBIZ Nuclear factor of kappa-B inhibitor zeta 11.7 3.2 
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 2 
- -  2.8 
NFKBID Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, delta 
2.3 - -  
Cytokines, chemokines, and growth factors    
CCL2 Chemokine (C-C motif) ligand 2 14.9 14.6 
CCL5 RANTES 49.6 132.8 
CCL20 Chemokine (C-C motif) ligand 20 1102.1 3147.3 
CXCL2 Chemokine (C-X-C motif) ligand 2 67.9 31.6 
CXCL6 Chemokine (C-X-C motif) ligand 6 12.3 45.0 
IL1A Interleukin 1, alpha  9.2 5.7 
IL6 Interleukin 6 88.2 124.1 
IL8 Interleukin 8 325.7 387.8 
SAA3 Serum Amyloid A 3 65.1 1145.6 
TNF Tumor Necrosis Factor, alpha 87.4 - -  
Type I IFN-related genes    
IRF1 Interferon regulatory factor 1 12.3 4.2 
IRF5 Interferon regulatory factor 5 3.0 - -  
ISG15 Ubiquitin-like modifier  - -  308.3 
MX2 Myxovirus (influenza virus) resistance 2 - -  156.6 
OAS1 2'-5'- oligoadenylate synthetase 1 - -  128.7 
OAS2 2'-5'- oligoadenylate synthetase 2 - -  65.6 
 
 
*Data obtained by RNA-Seq and presented as fold induction of the indicated gene at 
either 2 or 8 hours post-LPS in comparison to expression levels at 0 hours post-LPS. All 
fold changes shown are FDR<0.05; FC>2; and CPM >1.  - - indicates FDR>0.05, FC<2, 
or CPM<1. 
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Table 2 Differential gene expression (fold change) of immune-associated genes at 
hours 0, 2, and 8 post-LPS treatment of fibroblasts collected from Holstein animals 
as compared to fibroblasts collected from Angus animals. 
 
Gene Hour 0 Hour 2 Hour 8 
Innate Immune Related Genes 
   CCL2 - - - - 2.9 
CCL5 - - - - 5.7 
CCL20 - - - - 8.6 
CCL26 - - 2.8 3.6 
CX3CL1 - - - - 14.8 
CXCL12 -5.7 -7.4 -6.5 
CXCL16 - - - - 2.3 
CXCR4 -3.1 - - - - 
HMGB1 -1.9 -1.9 -1.8 
IFIH1 - - - - 3.6 
IL1R1 - - 1.5 - - 
IL8 - - - - 4.5 
IRF5 2.4 2.4 2.6 
MX2 - - - - 14.0 
NOD1 - - 2.4 - - 
TLR2 -3.5 -2.8 - - 
TLR4 3.0 4.0 2.5 
TLR6 1.8 - - 2.5 
TNF - - 6.9 - - 
TNFSF18 6.5 6.0 5.1 
TNFSF4 4.4 - - 2.6 
TRAF1 2.4 2.4 - - 
TRAIP - - -2.7 - - 
DNA Methylation Associated 
Genes 
   
DNMT1 -1.6 -1.5 -1.5 
DNMT3A - -  - -  - -  
DNMT3B - -  - -  - -  
UHRF1 -2.3 -2.0 -2.0 
 
Data obtained by RNA-Seq and presented as fold change between Holstein and Angus 
cultures. Positive values indicate higher expression in Holstein cultures as compared to 
Angus cultures. All presented values indicate FDR<0.05 with an average CPM> 1, while 
- - notes a values with either FDR>0.05 or an average CPM< 1. 
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Table 3 Differentially methylated 3Kb regions between Holstein and Angus cultures 
as determined by MIRA-Seq and gene expression data for annotated gene. 
 
  
 
 RNA-Seq fold change*** 
FC* Chr Genomic coordinates Gene** Hour 0 Hour 2 Hour 8 
-2.9 1 8811701 - 8814700 ADAMTS5    - - - - - - 
4.2 1 4686501 - 4689500 LOC100848874 - - - - - - 
2.0 1 8325701 - 8328700 LOC526789 - - - - - - 
-3.4 2 88463334 - 88466333 - - - - - - - - 
-3.4 2 88469334 - 88472333 - - - - - - - - 
2.6 2 18491734 - 18494733 OSBPL6 - - 1.4 1.5 
2.0 5 116626706 - 116629705 FBLN1 - - - - - - 
2.3 6 5529182 - 5532181 - - - - - - - - - 
-8.3 7 18532846 - 18535845 LOC100337044 - - - - - - 
2.9 8 23178787 - 23181786 LOC100300143 - - - - - - 
-2.6 8 34929387 - 34932386 - - - - - - - - 
-2.7 8 78669587 - 78672586 - - - - - - - - 
-2.8 8 12568687 - 12571686 - - - - - - - - 
-4.0 8 79335787 - 79338786 NTRK2    - - - - - - 
-2.6 8 98801087 - 98804086 - - - - - - - - 
-2.6 9 20444051 - 20447050 - - - - - - - - 
-2.7 9 93571151 - 93574150 - - - - - - - - 
-4.0 9 88292251 - 88295250 ULBP1 - - - - - - 
-2.7 10 32127701 - 32130700 - - - - - - - - 
2.1 12 51081922 - 51084921 - - - - - - - - 
-2.5 13 64236797 - 64239796 ASIP -14.0 -15.2 -13.4 
2.8 13 48576797 - 48579796 LRRN4 - - - - - - 
2.6 14 36500947 - 36503946 - - - - - - - - - 
2.1 15 53581057 - 53584156 LOC100336675 - - - - - - 
-2.3 15 9012857 - 9015856 - - - - - - - - 
-7.5 15 27535857 - 27538856 - - - - - - - - 
-2.8 15 55516557 - 55519556 SERPINH1 - - - - - - 
-2.4 17 7224294 - 7227293 MAB21L2 - - - - - - 
2.2 17 17977294 - 17980293 MAML3 - - - - - - 
-2.8 18 60220698 - 60223697 LOC100848332 - - - - - - 
-3.6 18 63217498 - 63220497 LOC783134 - - - - - - 
2.4 18 33452798 - 33455797 - - - - - - - - 
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(Table 3 continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Data obtained by MIRA-Seq and presented as fold difference in read count of 
methylated regions. Positive fold change indicates higher methylation levels in Holstein 
cultures while negative values are higher methylation in Angus cultures. ** DMRs with 
an associated gene indicate that some portion of the 3Kb region falls within an annotated 
gene, while - - indicates DMRs that are intergenic. Bolded gene names indicate that the 
discovered DMR fell within the promoter region of that gene (-2500 to +500bp from 
gene transcription start site). *** Positive values indicate greater expression in Holstein 
cultures as compared to Angus. 
 
 
 
 
 
    RNA-Seq fold change*** 
FC* Chr Genomic coordinates Gene** Hour 0 Hour 2 Hour 8 
2.4 19 42556475 - 42559474 - - - - - - - - 
2.3 19 62858675 - 62861674 AXIN2 - - - - - - 
-2.4 19 43381475 - 43384474 CNTNAP1 - - 1.8 2.0 
-3.6 19 23655275 - 23658274 HIC1 - - 1.7 - - 
2.2 19 42109475 - 42112474 KRTAP9-2 - - - - - - 
2.4 19 62705675 - 62708674 RGS9 2.0 2.1 2.5 
4.8 23 49777993 - 49780992 - - - - - - - - - - - - 
2.8 24 59112931 - 59115930 CCBE1 -2.3 -2.2 -1.8 
2.4 24 62388931 - 62391930 - - - - - - - - - - - - 
2.5 25 27266601 - 27269600 - - - - - - - - - - - - 
2.4 26 23658031 - 23661030 C26H10orf26 - - - - - - 1.4 
-2.4 26 16776031 - 16779030 LOC100848660 - - - - - - - - - 
3.2 27 23720367 - 23723366 - - - - - - - - - - - - 
-2.4 X 63726195 - 63729194 LOC100848206 2.4 2.6 2.3 
2.1 X 111529495 - 111532494 LOC516666 - - - - - - - - - 
2.1 X 128195395 - 128198394 - - - - - - - - - - - - 
-2.6 X 55935095 - 55938094 - - - - - - - - - - - - 
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Table 4 RT-qPCR primer pairs used for amplification of target genes. 
(The top and bottom sequences are the forward and reverse, respectively) 
 
 
Gene Primer Sequences Reference  
TLR4 ACTGCAGCTTCAACCGTATC TAAAGGCTCTGCACACATCA 
Ibeagha-Awemu 
 et al., 2008 
IL8 GCTGGCTGTTGCTCTCTTG AGGTGTGGAATGTGTTTTTATGC 
Pareek et al., 
2005 
TNF TCTTCTCAAGCCTCAAGTAA CCATGAGGGCATTGGCATAC 
Bougarn et al., 
2015 
CCL20 TTCGACTGCTGTCTCCGATA GCACAACTTGTTTCACCCACT 
Gilbert et al., 
2013 
CCL5 CTGCCTTCGCTGTCCTCCTGATG TTCTCTGGGTTGGCGCACACCTG 
Gilbert et al., 
2013 
ACTB GCAAATGCTTCTAGGCGGACT CAATCTCATCTCGTTTTCTGCG 
Pareek et al., 
2005 
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Figure 1 IL-8 protein production from Holstein and Angus fibroblasts.  
IL8 production by dermal fibroblasts isolated from 19-month old Holstein (n=5) and 
Angus (n=12) heifers and challenged for 24 h with LPS (100ng/ml) or IL1B (1ng/ml) 
(A). Eight cultures (n=4/breed) were randomly chosen for RNA-Seq and MIRA-Seq 
analysis and levels of IL8 protein following second 24 h challenge with either LPS 
(100ng/ml) or IL1B (1ng/ml) on these 8 cultures are shown in (B). There was no 
detectable IL8 production from un-treated cultures of both breeds. Values are mean ± 
SEM. * indicates P < 0.05, ** indicates P < 0.01. 
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Figure 2 Scatter plots of RNA-Seq analysis. 
 Eight fibroblast cultures (four of each breed) were used in RNA-Seq to explore gene 
expression differences. Scatter plots of indices analyzed from RNA-Seq data were 
generated for expression level (log2CPM) and differential expression (log2 Fold Change) 
at 0 hours (A), 2 hours (B), and 8 hours (C) following LPS exposure. Positive fold 
change values indicate higher expression in Holstein cultures while negative fold change 
values show higher expression in Angus cultures. Red dots denote FDR < 0.05. 
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Figure 3 Expression of selected genes by Holstein and Angus fibroblasts. 
 Differences in expression of TLR4 (A), IL8 (B), TNF (C), CCL20 (D), and CCL5 (E) 
between Holstein and Angus fibroblast cultures at hours 0, 2, and 8 post-LPS exposure 
were determined by RT-qPCR. Values are expressed as delta Ct, or the difference in 
cycles to threshold (Ct) between the gene of interest and the endogenous gene control 
beta-actin (ACTB). Fold differences (2-ΔΔCt) in expression between Holstein and Angus 
cultures are indicated in parentheses. All values are mean ± SEM. (n=4/group). *P < 0.05 
and **P < 0.01 (t-test).  
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Figure 4 Role of DNA methylation on gene expression and differential methylation 
levels due to genomic location.  
 
As there were no significant effects of breed on the correlations between genomic 
location of DNA methylation and subsequent gene expression, data was combined for the 
4 Holstein and 4 Angus cultures in this analysis. Scatter plots show the relation between 
gene expression at 8 hours post-LPS treatment and levels of DNA methylation at the 
gene’s promoter (A) or gene body (B). Gene expression levels (RNA-Seq) and DNA 
methylation (MIRA-Seq) were normalized to gene size and presented as RPKM. The 
average methylation levels of combined Holstein and Angus MIRA-Seq libraries based 
upon genomic region (C). Lettering denotes differential methylation levels as measured 
by a one-way ANOVA with Bonferonni post-test (p < 0.05). All values are mean ± SEM. 
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Chapter 4: Neonatal LPS exposure does not diminish the innate 
immune response to a subsequent LPS challenge in Holstein bull calves. 
 
 
Published in the Journal of Dairy Science as: Benjamin, A.L., Korkmaz, F.T., Elsasser, 
T.H., & Kerr, D.E. (2016). Neonatal lipopolysaccharide exposure does not diminish the 
innate immune response to a subsequent lipopolysaccharide challenge in Holstein bull 
calves. Journal of dairy science, 99:1-14.  
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4.1 Abstract 
The innate immune response following experimental mastitis is quite variable 
between individual dairy cattle. An inflammatory response that minimizes collateral 
damage to the mammary gland while still effectively resolving the infection following 
pathogen exposure is beneficial to dairy producers. The ability of an LPS exposure in 
early life to generate a low-responding phenotype and thus reduce the inflammatory 
response to a later life LPS challenge was investigated in neonatal bull calves. Ten 
Holstein bull calves were randomly assigned to either an early life LPS (ELL) group 
(n=5) or an early life saline (ELS) group (n=5). At 7 days of age, calves received either 
LPS or saline, and at 32 days of age, all calves were challenged with an intravenous dose 
of LPS to determine the effect of the early life treatment (LPS or saline) on the immune 
response generated towards a subsequent LPS challenge. Dermal fibroblast (DF) and 
monocyte-derived macrophage (MDM) cultures from each calf were established at age 
20 and 27 d, respectively, to model sustained impacts from the early life LPS exposure on 
gene expression and protein production of components within the LPS response pathway. 
The ELL calves had greater levels of plasma IL-6 and TNF-α than the ELS calves 
following the early life LPS or saline treatments. However, levels of these two immune 
markers were similar between ELL and ELS calves when both groups were subsequently 
challenged with LPS. A comparison of the in vitro LPS-responses of the ELL and ELS 
calves revealed similar patterns of protein production and gene expression following an 
LPS challenge of both DF and MDM cultures established from the treatment groups. 
While an early life exposure to LPS did not result in a dampened inflammatory response 
towards a later LPS challenge in these neonatal bull calves, the potential that exposure to 
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inflammation or stress in early life or in utero can create an offspring with a low-
responding phenotype as an adult is intriguing and has been documented in rodents. 
Further work is needed to determine if an inflammatory exposure in utero in a dairy 
animal would result in a low-responding innate immune phenotype.  
 
Keywords: early life LPS, inter-animal variation, inflammatory response 
 
 
4.2 Introduction 
 The innate immune system plays a key role in the clearance of pathogens 
following an infection such as bovine mastitis. This acute, non-specific response is 
initiated when conserved pathogen associated molecular patterns (PAMP) from a diverse 
number of pathogens are recognized by germ-line encoded receptors known as pattern 
recognition receptors (PRR) that are expressed on a variety of cell types. 
Lipopolysaccharide (LPS) from the cell wall of gram-negative bacteria, a major causative 
agent of bovine mastitis, is recognized by the PRR toll-like receptor (TLR) 4. Once LPS 
is bound by TLR4, an intracellular signaling cascade activates transcription factors such 
as nuclear factor-kappa B (NF-κB) which promote the transcription of cytokines 
including interleukin (IL) -1β, -6, and tumor necrosis factor alpha (TNF-α) (Kawai and 
Akira, 2007). These three cytokines play major roles in driving the pro-inflammatory 
response by promoting febrility, inflammation, and activation of leukocytes to aid in the 
clearance of the pathogen (Bannerman 2009). However, an excessive inflammatory 
response can be detrimental to the host, causing collateral damage to tissues, such as the 
mammary gland (Schukken et al., 2011), thereby reducing future milk production and 
profit (Grohn et al., 2004). The factors that lead to a more robust inflammatory response 
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in some animals and not in others have not been fully elucidated. Even in controlled 
intra-mammary challenge models of mastitis, inter-animal variation has been observed in 
cytokine concentrations in milk or blood, milk bacterial counts, and severity of clinical 
symptoms (Schukken et al., 1999, Lee et al., 2006, Simojoki et al., 2009), supporting the 
belief that host factors play a major role in determining the severity and outcome of 
mammary infections (Burvenich et al., 2003). 
Genetic polymorphisms in components of the host’s pathogen recognition 
pathways could lead to the variable immune responses between animals. Within cattle, a 
number of single nucleotide polymorphisms (SNP) have been identified in genes 
encoding the toll-like receptors (Novak, 2014) and SNPs in these and other genes 
involved in the inflammatory response have been associated with individual differences 
in their resistance to mastitis (Thompson-Crispi et al., 2014). Epigenetic modifications of 
an animal’s DNA can also contribute to the observed phenotypic differences in the 
immune response of individuals. DNA methylation in particular, has been shown to 
influence transcription of genes (Moore et al., 2013). In human diseases such as 
periodontitis and rheumatoid arthritis, aberrant methylation within immune response 
genes has been linked to an increased risk of disease or severity of symptoms 
(Benakanakere et al., 2015, Kojima et al., 2015). The role that epigenetics may play in 
modulating the bovine innate immune response is now being investigated (Paibomesai et 
al., 2013, Green and Kerr, 2014, Chang et al., 2015) and may provide a more complete 
picture of how genetic and epigenetic factors combine to produce inflammatory 
responses following bovine mastitis that range from mild to severe.  
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While pathogen detection by innate immune cells prompts a robust inflammatory 
response that is essential to resolving the infection, this response must be under tight 
regulation to prevent excessive inflammation and extensive tissue damage. There are 
some mechanisms that can generate a low responding phenotype in an animal, either 
transiently or long-term, following pathogen exposure. An animal exposed to a low level 
of LPS can develop a short-term reduction or even an abolished inflammatory response 
towards a subsequent LPS exposure, thereby exhibiting endotoxin tolerance (Biswas and 
Lopez-Collazo, 2009). It has been suggested that this toleraized state, generated primarily 
through macrophages and their reduced production of TNF-α, could be due to a variety of 
events, including methylation of histone tails, which modify the chromatin structure of 
anti- and pro-inflammatory genes (El Gazzar et al., 2007), up-regulation of anti-
inflammatory or inhibitory genes (Fan and Cook, 2004), and micro-RNA regulation of 
immune response genes (Baltimore et al., 2008). Additionally, there is abundant evidence 
that exposure to inflammation or disease in early life can have long-term consequences 
on the innate immune response of an animal. Several studies completed on rodents have 
shown that a neonatal LPS exposure can cause a reduction in the cytokine or febrile 
response following a LPS challenge in the adult rat (Ellis et al., 2005, Spencer et al., 
2011). Thus, it would appear that an early life exposure to LPS has the potential to 
modify the inflammatory response in the adult animal, creating a low-responding 
phenotype.   
In this current study, we investigated if a single exposure to LPS during the 
neonatal period would modify the in vivo inflammatory response to a subsequent LPS 
challenge in dairy calves. Additionally, two cellular models, dermal fibroblasts and 
 117 
monocyte-derived macrophages, were utilized to explore if early life exposure to LPS 
would result in sustained epigenetic modifications of the LPS response of these cells, 
thereby influencing the innate immune response. 
 
 
4.3 Materials And Methods 
4.3.1 Experimental design and animal use 
Holstein bull calves that were free of clinical disease and had received 4 L of 
pooled colostrum within 1 h of birth and a second feeding of pooled colostrum 12 h later 
were purchased from a collaborating dairy farm. The calves (n=10) were brought to the 
University of Vermont Miller Research Farm at 3.3 ± 0.5 days of age and given a four-
day acclimation period. Calves were housed in individual plastic calf hutches and had 
access to a fenced-in outside area of approximately 3 m x 3 m. Free choice water and a 
commercially available calf starter were offered to each calf throughout the trial. Calves 
were bucket-fed an ad libitum amount of a 23% protein, 22% fat milk replacer (OptiMilk 
Nature’s Formula, Arctic Blend; Poulin Grain, Newport, VT) divided between two 
feedings per day throughout the study period. The University of Vermont Institutional 
Animal Use and Care Committee approved of all experimental procedures prior to the 
commencement of this study.  
4.3.2 Early life treatment  
Calves were randomly divided into two groups: Early Life LPS (ELL) and Early 
Life Saline (ELS), each consisting of five calves. At approximately 7 days of age, 
roughly 2 h after the morning feeding, the early life treatment was administered to each 
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calf. Calves in the ELL group received a jugular injection of 0.5 ug of LPS/kg of body 
weight isolated from Escherichia coli 0111:B4 (Sigma, St. Louis, MO) diluted in saline, 
while the calves in the ELS group received an equal volume of saline. The dose of LPS 
was based on our previous experiments with 14 month-old heifers (Green et al., 2011). 
Prior to a single injection of either the LPS solution or saline, the fur along the jugular 
vein area was clipped and the area was thoroughly cleansed with 70% ethanol. Rectal 
temperatures were collected immediately prior to the injection (hour 0) and hourly for 
seven hours. Blood samples were collected at hours 0, 2, and 6 post-LPS infusion with an 
18-gauge Vacutainer needle (BD, Franklin Lakes, NJ) and a 10 ml Vacutainer tube 
containing 158 USP Units of Sodium Heparin (BD). Tubes were inverted several times to 
ensure adequate mixing of the anti-coagulant and stored on ice for approximately 2 h 
before centrifugation at 800 x g for 20 min at 4°C. Plasma was then collected and stored 
at -20°C for future analysis.   
4.3.3 LPS challenge 
Each calf was fitted with a jugular catheter for the LPS challenge to allow for 
easier administration of the LPS solution and blood sampling. Twenty-four hours prior to 
the catheterization, a 50 cm section of polyethylene tubing (I.D. 1.19mm, O.D. 1.70mm; 
Intramedic, BD) was cut per calf and sanitized in a Nolvasan S solution (Pfizer, NY, 
NY). The day of catheterization each calf was secured in a headlock and the fur was 
clipped on top of the jugular vein and the area was cleansed with 70% ethanol. A 12-
gauge, 1.5-inch metal hub needle (Hamilton, Reno, NV) was then inserted into the 
jugular vein, and 20-25 cm of the polyethylene tubing was inserted through the needle. 
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The needle was then removed, an 18-guage luer stub adapter (Intramedic) attached, and 
the catheter filled with heparinized saline. The following day, after morning feeding, a 
single dose of 0.25 ug of LPS/kg of body weight isolated from E. coli 0111:B4 (Sigma) 
was infused into each calf at hour 0. Heparinized blood samples were collected at -30 
min, and then at hours 1, 2, 3, 5, and 7 post-infusion and stored on ice. Plasma was 
isolated within 2 h and stored at -20°C for future analysis.  
4.3.4 Plasma IL-6 and TNF-α quantification  
Concentrations of IL-6 in plasma samples were determined with a commercially 
available bovine IL-6 ELISA kit (Thermo Scientific, Rockford, IL). The capture and 
detection antibodies were both plated at 1:100 and the streptavidin-horseradish 
peroxidase was plated at 1:400. Recombinant bovine IL-6 (Thermo Scientific) was used 
at the assay standard. Concentrations of tumor necrosis factor alpha (TNF-α) were 
determined via RIA as previously described (Elsasser et al., 2005). 
4.3.5 Dermal fibroblast isolation 
Skin biopsies were collected from the ELL (n=5) and ELS (n=5) calves as 
previously described (Kandasamy et al., 2011). Briefly, dermal fibroblasts (DF) were 
isolated following a 6 h digest with 0.5% collagenase type I enzyme (Life Technologies, 
Grand Island, NY). The collagenase-digested tissue was filtered, centrifuged, and the cell 
pellet was reconstituted with Dulbecco’s modified Eagle medium (DMEM; Hyclone 
Laboratories, Logan, UT) containing 10% fetal bovine serum (FBS; Hyclone 
Laboratories), a 1X antibiotic cocktail (100 U/ml of penicillin, 100 µg/ml of 
streptomycin, and 0.25 µg/ml of amphotericin B; Hyclone Laboratories), and 1X insulin-
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transferrin-selenium (ITS; Mediatech, Herndon, VA) and seeded into a 25-cm2 flask 
(Corning Inc., Corning, NY). Media was replaced after an initial 16 h incubation with 
fresh DMEM (10% FBS, 1X antibiotic cocktail, and 1X ITS). Once confluency was 
reached, cells were detached with 0.25% trypsin (MP Biomedical, Santa Ana, CA) and 
seeded into a 75-cm2 flask. After approximately 4 days, cells were expanded into three 
75-cm2 flasks. Finally, confluent cultures were lifted with trypsin and aliquots of the third 
passage were diluted in DMEM supplemented with 20% FBS and 10% dimethyl 
sulfoxide (Sigma) and cryopreserved in liquid nitrogen for subsequent challenges.  
4.3.6 Monocyte isolation and macrophage culturing 
A 180 ml blood sample was obtained from each of the ELL (n=5) and ELS 
(n=5) calves via jugular venipuncture with a 60 cc syringe pretreated with heparin 
(10,000 USP units/ml; Sagent Pharmaceuticals, Schaumburg, IL) and immediately 
transferred to heparinized vacutainer tubes (BD). Samples were stored on ice for 
approximately one hour prior to processing. Vacutainer tubes were centrifuged at 800 x g 
for 20 min at 4°C. Peripheral blood mononuclear cells (PBMC) were removed and 
treated with red blood cell lysis buffer (Biolegend, San Diego, CA). No more than five 
buffy coats were treated with 7.5 ml of 1X red blood cell lysis buffer and inverted for 30 
s. Two washes were then performed using sterile Dulbecco’s phosphate-buffered-saline 
(DPBS, Hyclone Laboratories) by centrifuging samples at 500x g for 5 min at room 
temperature. After the second wash, cells were resuspended in 30 ml of DPBS and 10 ml 
of a Percoll (GE Healthcare, Sweden) solution with a specific density of 1.077 g/cm3 
(mixture with 1.5 M NaCl and 30% endotoxin-free water) was carefully underlain below 
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the sample. The Percoll gradient was centrifuged at 400 x g for 40 min, at room 
temperature, with no brake. The PBMC layer was removed from the interface of the 
DPBS and Percoll and placed into a clean polypropylene tube. One more DPBS wash 
was performed as stated above to remove residual Percoll. After washing, PBMC were 
resuspended in 30 ml DPBS and centrifuged at 250 x g for 12 min at room temperature to 
remove platelets. After the platelet spin, the cells were resuspended in DMEM, 15% FBS, 
1X ITS and 1X penicillin-streptomycin (100 U/ml of penicillin and 100 µg/ml of 
streptomycin). The PBMC were then transferred to a 25-cm2 flask and incubated in a 
humidified chamber at 37°C and 5% CO2 for 3 h. Non-adherent cells were removed and 
placed in a clean polypropylene tube and adherent cells were washed with DPBS and 
fresh DMEM media was added. Non-adherent cells were transferred to a second 25-cm2 
flask and those that had adhered overnight were washed the next morning and fresh 
media was added. Monocytes were incubated for 5 d and media was replaced as needed. 
After 5 d, cells were lifted with 0.25% trypsin, and the 3 h cultures and overnight cultures 
were combined and transferred to a 12-well plate at a concentration of 1.0 x 105 cells/ml 
in a total volume of 1 ml. The cells were cultured for 3 more days to allow for complete 
macrophage differentiation. 
4.3.7 In vitro challenges  
Aliquots of fibroblast cultures isolated from the ten bull calves were revived in 
parallel and grown to confluency in a 75-cm2 flask. Cells were then detached with 
trypsin, counted, and seeded into 6-well plates at a concentration of 1.25 x 105 cells/ml in 
2 ml total/well. Following a 24 h incubation, cells were exposed to 500 ng/ml of ultra-
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pure LPS isolated from E. coli 0111:B4 (Sigma) or fresh culture media for 24 h. Media 
was then collected and centrifuged at 10,000x g for 1 minute to remove cell debris and 
the supernatant was stored at -20°C for future analysis. Cells were lysed at hours 0 and 24 
post-LPS, and RNA was extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until 
future analysis.  
After 8 days in culture, macrophages were treated with either media or media 
containing 100 ng/ml of LPS isolated from E. coli O111:B4 for 24 h, after which, media 
was removed and centrifuged at 10,000x g for 1 min and supernatant was stored at -20°C 
until further analysis. Cells were lysed at hours 0 and 24 post-LPS, and RNA was 
extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until future analysis.  
4.3.8 Quantification of in vitro immune response proteins  
Levels of IL-8 protein produced from fibroblast and MDM cultures following an 
LPS challenge were determined in duplicate with a commercially available bovine IL-8 
ELISA kit (Mabtech, Cincinnati, OH) as per manufacturer’s instructions with some 
modifications. A solution of 1 µg/ml of the monoclonal coating antibody (MT8H6) was 
plated in 0.05 M bi-carbonate buffer on a high affinity 96-well ELISA plate (Corning 
Life Sciences, Tewksbury, MA) and incubated overnight at 4°C. Media samples or 
recombinant bovine IL-8 standard (Thermo Scientific) were plated following a series of 
three washes with a solution of DPBS and 0.05% Tween-20 (DPBS-T; Fisher 
Bioreagents, Fair Lawn, NJ) and incubated for 2 h at 20°C. Plates were washed with 
DPBS-T and a monoclonal detection antibody (26ES-Biotin) was plated at 0.025 µg/ml 
and incubated for 1 h at 20°C. After a series of washes, streptavidin-horseradish 
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peroxidase (Sigma) was plated at 0.1 µg/ml and incubated for 1 h. Lastly, 3,3′,5,5′-
tetramethylbenzidine (TMB) substrate (Fisher Scientific, Pittsburgh, PA) was added for 
approximately 7 min, and the reaction was stopped with 1M H2SO4.  
Concentrations of TNF-α protein in macrophage-conditioned media were 
determined in duplicate using a custom sandwich ELISA as described above except: 
coating antibody (polyclonal rabbit anti-bovine TNFα, 1 mg/ml, Thermo Scientific) was 
diluted 1:200 in 0.05 M bi-carbonate buffer, recombinant bovine TNF-α (Kingfisher 
Biotech, Inc., St. Paul, MN) was used as standard, and biotinylated secondary antibody 
(rabbit anti-bovine TNF-α, Thermo Scientific) was diluted 1:1,000 to a concentration of 
0.25 µg/ml in DPBS-T. Detection limit of the assay was 156 pg/ml. The concentrations of 
IL-1β were similarly quantified using a commercially available sandwich ELISA 
(Thermo Scientific). The detection limit of the assay was 62 pg/ml. All ELISA reactions 
were quantitated by measuring absorbance at 450nm and analyzed by a 4-parameter 
analysis with optical density corrected against blank wells (Synergy-HT, Bio-Tek, 
Winnoski, VT).   
4.3.9 Quantitative real time-PCR  
Dermal fibroblasts (DF) and monocyte-derived macrophages (MDM) were 
isolated and cultured for an LPS challenge as described above for each of the ten calves 
and cell lysate was collected at hours 0 and 24 post-LPS for each culture. The 
PurefectPure RNA Cultured Cell extraction kit (5 Prime), which includes a DNase 
treatment step to eliminate DNA contamination, was used to extract total RNA from the 
cell lysate. RNA concentration was determined using a Qubit Spectrofluorometer (Life 
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Technologies, Carlsbad, CA). The Improm II Reverse Transcriptase Kit (Promega, 
Madison, WI) was utilized to complete first strand cDNA synthesis. The following genes 
were selected for real-time PCR analysis: TLR4, IL-6, IL-8 (in both DF and MDM 
cultures) and CD14, IL-1β receptor, and IL-1β (in MDM cultures only). Expression 
levels of these genes were determined by quantitative real-time PCR (qRT-PCR) with a 
7500 Fastrun Machine (Applied Biosystems, Carlsbad, CA) using Fermentas Maxima 
SYBR Green/Fluorescein qPCR Mastermix (Thermo Scientific): An endogenous control 
gene, β-actin was used for normalization of the target genes. Sequences for the 
constructed primers are listed in Table 1.  
4.3.10 Statistical analysis  
Differences in rectal temperatures, as well as concentrations of plasma TNF-α 
and IL-6 were determined between the ELL and the ELS calves following the early life 
treatment and the LPS challenge by a repeated measures ANOVA using Prism 6.0 
(GraphPad Software Inc., La Jolla, CA). Differences in immune response proteins and 
gene expression following an LPS challenge between the fibroblast and monocyte-
derived macrophage cultures collected from the ELL and ELS calves were determined by 
an unpaired t-test in Prism 6.0. 
 
 
4.4 Results 
Blood samples were collected from each calf at hours 0, 2, and 6 following the 
early life treatment (LPS or saline) to determine concentrations of two key inflammatory 
cytokines, IL-6 and TNF-α. Prior to the treatment, levels of IL-6 (Figure 2A) and TNF-α 
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(Figure 2B) were similar between the ELL and ELS calves. However, by hour 2 post-
treatment levels of IL-6 and TNF-α in the ELL calves had reached peak values (P < 0.05; 
14.4 ± 3.1 and 3.2 ± 1.0 ng/ml, respectively) while no increase in either cytokine was 
observed in the ELS calves. At 6 h post-treatment, IL-6 levels remained elevated (P < 
0.05) in the ELL calves and plasma TNF-α had decreased to pre-treatment levels, with no 
detectable changes in plasma IL-6 or TNF-α from the ELS calves. Moderate respiratory 
distress, and lethargy was typically observed in the ELL animals. Rectal temperatures did 
not increase due to the early life treatment in either group and were similar between the 
ELL and the ELS calves (Figure 2C).  
 Twenty-five days after the early life treatment, an LPS challenge was performed 
on all ten calves to compare the LPS response between calves that had received LPS 
(n=5) and calves that had received saline (n=5) in early life. Following an LPS bolus of 
0.25 µg/kg of body weight, plasma levels of IL-6 increased in both the ELL and ELS 
calves, reaching similar peak values (6.7 ± 0.6 and 6.1 ± 0.7 ng/ml) at hour 3, and 
decreasing slightly by hour 7 post-infusion (Figure 3A). Plasma TNF-α reached 
maximum concentrations in ELL calves 1 h following LPS (4.8 ± 1.3 ng/ml) while TNF-
α concentrations peaked in ELS calves 2 h post-LPS (3.9 ± 1.1 ng/ml). Despite the early 
temporal differences, TNF-α levels were similar between ELL and ELS calves for the 
remainder of the challenge (Figure 3B). Rectal temperatures following the LPS challenge 
decreased slightly in both groups, as shown in Figure 3C, however, there were no 
differences observed between the ELL and ELS calves.  
 Skin biopsies were collected from each calf 13 days after the early life treatment 
and 12 days before the LPS challenge to isolate dermal fibroblasts (DF). This time point 
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was selected in anticipation that any epigenetic modifications resulting from the early life 
LPS treatment that could influence the fibroblast LPS response would be present in our 
cellular model. Aliquots of fibroblasts from each animal were revived and challenged in 
parallel with LPS (500 ng/ml) for 24 h, and levels of IL-6 and IL-8 protein secreted in 
media were used as indicators of that fibroblast culture’s LPS response. Fibroblasts 
isolated from the ELL and ELS calves at approximately 20 d of age produced similar 
levels of IL-6 (Figure 4A) and IL-8 (Figure 4C) protein following LPS exposure.  
Monocyte-derived macrophages (MDM) were isolated from each of the calves 
(n=10) 21 days after the early life treatment and 4 days before the LPS challenge to 
determine if the in vitro LPS response from the MDM would be dampened due to the 
early life LPS treatment. MDM cultures were seeded into 6-well plates, incubated for 24 
h, and then challenged with LPS (100 ng/ml) for 24 h. Concentrations of IL-6 and IL-8 
protein produced by the MDM cultures following LPS exposure were similar between the 
treatment groups (Figure 4B and 4D). Additionally, levels of IL-1β and TNF-α were 
determined in MDM supernatant following LPS treatment (Figure 4E and 4F, 
respectively). Each of the immune response proteins measured in MDM cultures 
established from the calves were similar between the two early life treatment groups 
(ELL vs. ELS).  
Expression levels of genes involved with the LPS recognition and response 
pathway were investigated in both the DF and MDM cultures established from all calves. 
Total RNA was collected from DF and MDM at hours 0 and 24 post-LPS and gene 
message was determined by qRT-PCR. Expression of TLR4, the receptor responsible for 
LPS recognition, was consistent following LPS stimulation and was not different between 
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the ELL and ELS groups in either DF or MDM cultures, but was much greater in the 
MDM cultures (Figure 5A and D). The cytokine IL-6 and chemokine IL-8 are critical 
immune response genes following LPS exposure, and the expression of these genes 
increased from hour 0 to hour 24 in both cellular models (Figure 5B and E). However, no 
differences were observed between the ELL and ELS calves in either cellular model, 
although the expression of both IL-6 and IL-8 was much greater in the MDM cultures. 
Levels of expression of three other genes (CD14, IL-1β receptor, and IL-1β) were 
determined in control and LPS-treated MDM cultures from the ELL and ELS calves 
(Figure 5G, H, and I). The expression of IL-1β was markedly induced by LPS treatment 
of the MDM cultures, while the expression of CD14 and the IL-1β receptor were not 
affected. However, there were no differences in gene expression between the cultures 
established from the ELL and ELS calves.  
 
4.5 Discussion 
Previous work from our laboratory and others has shown that dairy cattle manifest 
a wide range of immune responses following experimentally induced E. coli 
(Kornalijnslijper et al., 2003, Bannerman et al., 2004, Kanasamy et al., 2011) or 
Staphylococcus aureus (Schukken et al., 1999, Bannerman et al., 2004, Benjamin et al., 
2015) mastitis. Some animals exhibit a much more robust inflammatory response during 
mastitis, characterized by high levels of IL-8, IL-6, and TNF-α, which can lead to severe 
clinical symptoms and damage to the mammary tissue. Inter-animal variation in the 
expression of genes within the LPS response pathway, including TLR4, the receptor for 
LPS, may lead to individual differences in the ability to recognize and respond to gram-
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negative pathogens (Kandasamy and Kerr, 2012). A genetic component to individual 
differences is highly likely, but new research suggests that epigenetics may also play a 
role. For example, we have found that the LPS responsiveness of an animal’s fibroblasts 
changes with age. In side-by-side cultures of cells, recovered from cryopreservation but 
originally collected from the same animals at different ages, we find a marked increase in 
response to LPS stimulation. Furthermore, the age-dependent difference in LPS response 
of these cells can be abolished by treatment with epigenetic modifiers (Green and Kerr, 
2014). Expanding on the inter-animal variation observed in the fibroblast model, cultures 
established from dairy and beef animals displayed contrasting responses following an in 
vitro LPS exposure. Whole transcriptome analysis of LPS-treated cultures revealed large 
breed-dependent differences in the expression of many LPS-responsive genes, including 
TLR4, IL-8, TNF-α, CCL5, and CCL20 (Benjamin et al., 2016). These genes, which are 
associated with the inflammatory response to LPS, were expressed between 2.5- and 7.0-
fold higher in Holstein fibroblast cultures as compared to Angus cultures. While genetics 
may contribute to the contrasting in vitro LPS responses between these breeds, offspring 
from each breed experience very different early life environments, which could lead to 
varying degrees of epigenetic modifications between the dairy and beef breeds, 
potentially moderating inflammatory gene expression.  
4.5.1 Impact of neonatal inflammation  
Several studies have shown that inflammation in the neonatal period (shortly after 
birth) can lead to sustained suppression of the innate immune response to a subsequent 
inflammatory challenge. Ellis et al. (2005) observed reduced plasma levels of TNF-α and 
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IL-1β as well as a suppressed febrile response following an LPS challenge of adult rats 
that had been exposed to LPS at 14 days of age compared to saline-exposed controls. 
Similarly, adult rats that had previously received a neonatal dose of LPS (100 ug/kg) at 
14 or 21 days of age produced a lower febrile response, compared to neonatal saline 
controls, during a subsequent LPS (50 ug/kg) challenge (Spencer et al., 2006). However, 
the timing of the neonatal exposure was found to be critical in that LPS treatments given 
at 7 or 28 days of age were not effective. Additionally, the suppressive effect is not 
observed if the adult challenge dose of LPS is increased to a septic dose of 1 mg/kg 
(Spencer et al., 2010). In the current study, we hypothesized that an early life LPS 
exposure would generate a low-responding phenotype in Holstein calves towards a 
subsequent LPS challenge. Surprisingly, ELL calves mounted a similar inflammatory 
response as the ELS calves during the later LPS challenge that was completed on all 
calves 25 days after the first LPS or saline exposure. Plasma levels of TNF-α and IL-6 
during the later LPS challenge were comparable between treatment groups, showing the 
early life treatment with LPS (0.5 ug/kg) at 7 days of age did not dampen the subsequent 
inflammatory response to LPS (0.25 ug/kg). The doses used did produce substantial 
inflammation and may have been too high to generate the expected result. 
Although other studies have shown that administering LPS in the neonatal period 
does reduce the LPS response in the adult, most of these studies have been completed in 
rats (Spencer et al., 2011, Wang et al., 2011). Different rates of development and maturity 
within the immune system between calves and rodents may be one explanation for the 
lack of differences between our LPS- and saline- treated calves. Offspring from species 
with a comparatively short gestation period, such as rats (length of 21 days), are born 
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with a less mature immune system than offspring from species with a longer gestation, 
cattle for example (length of 9 months) (Holsapple et al., 2003). A less mature immune 
system during the neonatal period in a rat pup may provide an opportunity for 
inflammation to epigenetically modify the genes of the immune response in the adult, 
whereas the immune system of a neonatal calf may be less vulnerable to those types of 
modifications during that same stage of life. Following parturition, the humoral and cell-
mediated immune response of the calf is much lower than an adult cow, but within the 
first month of life, B-cell numbers increase and the cell-mediated response is similar to 
that of an adult animal (Barrington and Parish, 2001). The immune system in newborn 
rats is immature, and continues to develop during the postnatal period and although an 
immune response can be mounted at 21 days of age, it is not of the same magnitude as an 
adult animal (Holsapple et al., 2003). A comparison of the degree of immune system 
development of the rat pups in studies mentioned previously and the calves in this current 
study suggests the timing of the LPS exposure in the neonatal calves may have been too 
late to obtain a reduction in the inflammatory response towards an LPS challenge.  
4.5.2 Fetal programming: maternal inflammation and nutrition  
Exposure to bacterial molecules or inflammation while in utero can also alter 
aspects of an offspring’s behavior, health, and development. Increases in anxiety and 
depression-like behaviors as well as an increased propensity towards developing 
schizophrenia have been observed in rodents whose dams suffered stress or inflammation 
during gestation (Ashdown et al., 2006, Depino, 2015). Additionally, several studies have 
shown that the inflammatory response of the offspring can be suppressed following in 
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utero LPS exposure. For example, Lasala and Zhou (2007) found that an intraperitoneal 
injection of LPS given to pregnant rats on day 18 of pregnancy greatly reduced the 
inflammatory response (serum levels of TNF-α, IL-1β, and IL-6) of the resulting pups 
when they were challenged with LPS at 21 days of age. In a similar study, adult rats that 
were exposed to LPS in utero at days 16, 18, and 20 of gestation have a blunted 
inflammatory response towards an LPS challenge as compared to saline-exposed rats 
(Hodyl et al., 2007). Similarly, offspring of mouse dams that were administered LPS 
approximately 12 h after fertilization had a diminished cytokine response following an 
LPS challenge at 40 weeks of age (Williams et al., 2011). Perhaps an in utero exposure of 
LPS, or maternally derived inflammatory cytokines, would cause a reduction in the 
inflammatory response towards a later LPS challenge in dairy calves. However, careful 
consideration of the timing and dosing of the immune stimulant for such a study must be 
taken, as previous studies conducted in dairy cattle have shown that experimental uterine 
bacterial infections and LPS infusions can cause abortions prior to gestational term 
(Miller et al., 1983, Giri et al., 1990).  
4.5.3 LPS tolerance  
Endotoxin tolerance is a protective mechanism that allows for innate immune 
cells to experience a transient unresponsive period of time following exposure to low 
levels of LPS (Biswas and Lopez-Collazo, 2009). Depending on the species, this 
refractory period can vary in duration, from roughly a week in rats (West and Heagy, 
2002),10 days in dairy cattle (Petzl et al., 2012), to at least two weeks in human patients 
suffering from endotoxemia (Kox et al., 2011). Several studies have shown that a primary 
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result of endotoxin tolerance is a reduction or complete abolishment of TNF-α transcript 
and protein following a second exposure to LPS (West and Heagy, 2002). Within our 
study, the calves that were treated with LPS in early life were likely outside the range of a 
tolerant state during the subsequent LPS challenge that was given 25 days later. The 
levels of plasma TNF-α in these calves were actually higher during the later LPS 
challenge compared to levels reached during the LPS treatment in early life (4 ng/ml vs. 3 
ng/ml, respectively). This demonstrates that the cells primarily responsible for executing 
LPS tolerance, monocytes and macrophages (Kox et al., 2011), were able to mount an 
unabated inflammatory response towards the later LPS challenge. 
4.5.4 Cellular models of innate immunity  
Extensive use of in vitro models to study the bovine innate immune response is 
evident, with several different cell types, including mammary epithelial cells (Pareek et 
al., 2005, Gilbert et al., 2013), neutrophils (Sohn et al., 2007, Revelo and Waldron, 
2012), and whole blood (Ballou et al., 2015, Jahan et al., 2015) being utilized. However, 
each of these models has drawbacks, including invasive collection procedures, inability 
to cryopreserve for subsequent challenges, and a heterogeneous cell population. 
Conversely, monocyte-derived macrophages do provide a classical innate immune cell 
model that is relatively easy to collect and culture. Bovine monocyte-derived 
macrophages have been shown to be responsive to challenges with Mycobacterium bovis 
(Magee et al., 2012) and LPS (Taraktsoglou et al., 2011), resulting in the induction of 
many immune -response genes such as IL-8, CCL5, and TLR4.  
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In the current study, the establishment of fibroblast and monocyte cultures from 
each animal provided two cellular models to determine if the early life LPS induced 
epigenetic modifications within innate immune response genes that would be reflected in 
the in vitro LPS-response. Additionally, collection of these two cell types from each 
animal allowed for a comparison of the LPS response of two cellular models from the 
same animal. Fibroblasts are long-lived cells that are capable of modulating the 
inflammatory response as they express innate immune receptors such as TLRs and 
secrete various cytokines and chemokines following pathogen recognition (Buckley et al., 
2001, Kandasamy et al., 2011, Benjamin et al., 2015). Alternatively, circulating 
monocytes are released from bone marrow, and depending on the environmental 
conditions, undergo apoptosis within a few days or migrate into tissues (Parihar et al., 
2010). Once inside the tissue, monocytes will differentiate into macrophages that aid in 
the clearance of a pathogen or damaged cells (Parihar et al., 2010). These tissue-resident 
macrophages can survive for days to months depending on the needs of the host. Within 
this study, the main objective in collecting both monocytes and fibroblasts from the 
saline- and LPS-treated calves was to observe if the early life LPS created a change, 
either permanent or temporary, in the in vitro LPS response between the early life 
treatment groups. Monocytes are continually produced in the bone marrow by myeloid 
progenitor cells and a systemic cytokine response following LPS exposure may reach 
these stem cells and induce permanent epigenetic DNA modifications that could be 
detected in monocytes collected three weeks later. Dermal fibroblasts however are a more 
stable cell type than monocytes, but may still be susceptible to epigenetic modifications 
following exposure to a systemic inflammatory response. While epigenetic modifications 
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could be induced within fibroblast progenitor cells, it is more likely that the fibroblast 
cells we collected three weeks post-challenge were the same cells present at the time of 
the early life LPS treatment. This may create more transient epigenetic modifications, 
such as histone modifications, that are still capable of influencing the inflammatory 
response, but are potentially too short-lived to detect the effect after several rounds of cell 
division while in cell culture. While progenitor fibroblast cells could be affected, they 
proliferate at a slower rate and this effect may not be evident only three weeks post early 
life treatment. Surprisingly, the in vitro response following an LPS challenge on each of 
these cell types revealed similar profiles in both cytokine secretion and gene expression 
between the LPS- and saline-treated calves, which confirmed the lack of differences 
observed in vivo during the second LPS challenge. Interestingly, the monocyte-derived 
macrophages exhibited a much more robust IL-6 response following LPS stimulation as 
compared to the fibroblasts (Figure 4). Other groups have observed a similar induction of 
IL-6 in macrophages following LPS stimulation (Jian et al., 1995, Taraktsoglou et al., 
2011) but, there have been few studies examining differences in the IL-6 response 
following LPS stimulation between bovine MDM and DF cultures. A comparison 
between mouse gingival fibroblasts and macrophages revealed that the mouse alveolar 
macrophage cell line produced less IL-6 following stimulation with LPS compared to the 
fibroblast cultures (Jones et al., 2010). While this is inconsistent with our findings, Jones 
et al. (2010) utilized a commercially available cell line from mice and challenged with a 
LPS dose of 1 µg/ml for 24 h. Our MDM model is derived from primary bovine 
monocytes that are allowed to differentiate into macrophages in culture, and we exposed 
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the cells to a lower LPS dose (100 ng/ml) for 24 h. Additional challenges that compare 
the LPS response of primary bovine MDM and DF may be of interest.  
 
4.6 Conclusions 
Variation in the innate immune response towards mammary infections exists in 
dairy cattle, with some animals exhibiting a mild inflammatory response and others 
suffering a severe inflammatory reaction that results in collateral damage or death. It has 
been shown that exposure to inflammation or stress either during early life or in utero can 
cause epigenetic modifications to the animal’s innate immune response. The potential for 
this type of exposure to create a low responding phenotype in the offspring, one that 
mounts an effective inflammatory response without inflicting damage on host’s tissue, is 
exciting. However, based on the results from this study, an early life exposure to LPS 
does not cause a dairy calf to mount a milder inflammatory response to a subsequent LPS 
challenge 25 days later compared to saline-treated control calves. Through the use of 
monocyte-derived macrophages and dermal fibroblasts, the lack of difference in vivo 
between LPS-treated and saline-treated calves was confirmed in vitro.  
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Table 1 Oligonucleotide primers for expression quantification with real-time PCR. 
 
(The top and bottom sequences are the forward and reverse, respectively) 
 
 
 
 
 
Gene 
Symbol 
Primer (5’ to 3’) Reference 
TLR4 ACTGCAGCTTCAACCGTATC Ibeagha -Awemu et al. (2008) 
 TAAAGGCTCTGCACACATCA  
IL-6 TGAGGGAAATCAGGAAAATGT Pareek et al. (2005) 
 CAGTGTTTGTGGCTGGAGTG  
IL-8 GCTGGCTGTTGCTCTCTTG Pareek et al. (2005) 
 AGGTGTGGAATGTGTTTTTATG  
CD14 CTCCAGCACCAAAATGAC Sohn et al. (2007) 
 TCCTCTTCCCTCTCTTCC  
IL-1βR GCTCGTGTCCTCTCATCACA 
ACCTTTGTGCTGGTGAATCC 
Mills et al. (2009) 
IL-1β CTCTCACAGGAAATGAACCGAG Bougarn et al. (2011)  
 GCTGCAGGGTGGGCGTATCACC  
Β-actin GCAAATGCTTCTAGGCGGACT Pareek et al. (2005) 
 CAATCTCATCTCGTTTTCTGCG  
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Figure 1 Timeline of the Study.  
The effects of an early life LPS exposure on response to a subsequent LPS challenge 
were determined in ten neonatal Holstein calves. Trial days are shown in the gray bar, 
with the calf arrival date on day 0 and completion of the trial on day 30, at which point 
calves were sold. The average age of the calves and key events within the trial are 
denoted below and above the gray bar, respectively. Early life treatment at day 4 
consisted of either an LPS or saline intravenous injection (n=5/treatment). Skin biopsies 
and blood samples were collected from each calf to isolate dermal fibroblasts (DF) and 
monocyte-derived macrophages (MDM), respectively. An LPS challenge was completed 
on all calves at day 29 of the trial to determine the affect of the early life treatment on 
response to the subsequent LPS challenge. 
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Figure 2 Plasma cytokine responses and rectal temperatures following the early life 
treatment.  
 
Calves were split into two groups, one of which received LPS and the other received 
saline at 7 days of age. Blood samples were collected from each calf at hours 0, 2, and 6 
following administration of the early life treatment. Plasma levels of IL-6 (A) and TNF- α 
(B) were determined after the early life treatment, and rectal temperatures were taken on 
animals from both groups (C). ELL= early life LPS and ELS= early life saline. Values 
are mean ± SEM.  
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Figure 3 Plasma cytokine response and rectal temperature profiles following an LPS 
challenge. 
 
 Holstein bull calves were divided into two groups (n=5/group) based on an early life 
treatment consisting of either LPS (ELL) or saline (ELS) that was given at 7 days of age. 
A subsequent LPS challenge was completed on all calves at 32 days of age to determine 
if the early life treatment had an affect on the systemic response to the later LPS. Plasma 
concentrations of IL-6 (A) and TNF- α (B) were measured in the calves from the ELL 
and ELS groups following the LPS challenge. Rectal temperatures (C) of calves 
following the LPS intravenous infusion at 32 days of age were not different between the 
treatment groups. Values are mean ± SEM. 
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Figure 4 Effect of early life LPS on cellular response to LPS in vitro.  
Dermal fibroblasts (DF) and monocyte-derived macrophages (MDM) were isolated from 
each calf (n=10) to determine if an in vivo LPS exposure during early life would 
influence the response of these cell types to an in vitro LPS challenge. A 24 h LPS 
challenge was completed on each cell type, however DF were treated with 500 ng/ml of 
LPS and MDM were treated with 100 ng/ml of LPS. The amount of secreted IL-6 from 
DF (A) and MDM (B), IL-8 from DF (C) and MDM (D) following LPS exposure was 
determined via an ELISA. Panel (E) and (F) represent the levels of IL-1β and TNF-α 
secreted by MDM post-LPS (concentrations of IL-1β and TNF-α were undetectable in 
LPS-treated fibroblast cultures). ELL= early life LPS, ELS= early life saline. There were 
no significant differences between treatment groups. Values are mean ± SEM. 
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Figure 5 Expression levels of LPS recognition and response genes.  
Dermal fibroblasts (DF) from each calf were revived and challenged with 500 ng/ml of 
LPS for 24 h and total RNA was collected at hours 0 and 24. A similar challenge was 
completed on monocyte-derived macrophages (MDM) isolated from each calf; however, 
an LPS dose of 100 ng/ml was used. Gene expression levels of TLR4, IL-6, and IL-8 
post-LPS were investigated on both DF and MDM cultures using qRT-PCR. Expression 
levels from DF cultures are presented in panels (A) TLR4, (B) IL-6, and (C) IL-8, while 
expression levels of MDM cultures are in panels (D) TLR4, (E) IL-6, and (F) IL-8. 
Panels (G), (H), and (I) represent the expression levels of CD14, IL-1 β receptor, and IL-
1 β from MDM, respectively. Expression values for these three genes were not 
determined in DF cultures. ELL= early life LPS, ELS= early life saline. There were no 
significant differences between treatment groups. Values are mean ± SEM. 
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Chapter 5: General Conclusions 
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A common goal within the dairy industry is to selectively breed animals for 
increased resistance to mastitis. Although advancements in the control of mastitis have 
occurred through improved management strategies that can reduce an animal’s exposure 
to pathogens, dairy cattle are still affected by mastitis. This can be partially attributed to 
the lack of an effective selection trait, leading to a low heritability of mastitis resistance 
in dairy animals. Currently, milk somatic cell count (SCC) is the trait used as an 
indication of an animal’s ability to resist mastitis. The SCC value represents the number 
of cells present in the milk, and can be used as an indicator of the infection status of an 
animal. Although monthly SCC tests can provide a monitoring system for fluctuations in 
an animal’s SCC over a lactation, some infections can occur and resolve quickly and may 
be missed by the SCC test. In these cases, the animal may incorrectly be classified as 
resistant to mastitis.  
In addition, the wide range in the clinical responses associated with mastitis 
between animals can make it difficult to effectively select for a desirable phenotypic 
response. As the innate immune system is responsible for pathogen recognition, and both 
the initiation and the resolution of the inflammatory response following a mammary 
infection, the magnitude of an animal’s innate immune response can influence the degree 
of inflammation and clinical symptoms associated with mastitis. Researchers have not 
been able to agree on what the ideal phenotype is following mastitis, as some have 
suggested that a rapid, robust response is more effective for E. coli clearance (Burvenich 
et al., 2003, Rinaldi et al., 2010, Quesnell et al., 2012), while others have shown that a 
more mild response is sufficient to clear E. coli mammary infections (Kandasamy et al., 
2011, Petzl et al., 2012). A better understanding of what host factors could lead to the 
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variation in the innate immune response and how those variations effect an animal’s 
ability to recover from mastitis may provide insight into which phenotype is a more 
desirable one for producers.  
The current studies aimed to determine if a particular innate immune response 
phenotype had a greater propensity towards developing a chronic S. aureus mammary 
infection, as well as advancing the knowledge on what factors could be causing the inter-
animal variation in the innate immune response. First, it was determined that the 
magnitude of the IL-8 response from dermal fibroblasts challenged in vitro with 
PAM2CSK4, a TLR2/6 agonist, was predictive of an animal’s in vivo innate immune 
response towards a S. aureus intra-mammary challenge. Further in vitro expression 
analysis on these fibroblasts challenged with PAM2SCK4 revealed that high responding 
cultures had greater expression of TLR2 and 6, which recognize bacterial lipopeptides 
and synthetic TLR2 agonists. The higher expression of these two genes may allow for the 
increased binding of bacterial ligands, thus leading to greater activation of transcription 
factors and the expression of inflammatory mediators such as IL-8 and IL-6. During the 
intra-mammary challenge, animals predicted to have a robust innate immune response by 
the in vitro cell model secreted much higher levels of IL-8 into their milk, leading to a 
greater recruitment of neutrophils into the infected quarter. In addition, greater levels of 
bovine serum albumin (BSA) were present in the milk from the infected quarter of the 
high responders, indicating a greater breakdown of the blood-milk barrier and more tissue 
damage to the mammary gland. Infection rates throughout the challenge were similar 
between the phenotypes; however, one low responder did clear the infection early in the 
experiment and remained free of infection till the conclusion of the trial, while a second 
 152 
low responder was culture negative between day 4 and 14 post-infection, upon which, the 
challenge strain was re-isolated from the challenged quarter. These observations suggest 
that the heightened inflammatory response generated by the high responders offered no 
advantage in bacterial clearance or in the ability of the animal to resist developing a 
chronic S. aureus infection, and instead, led to greater damage to mammary tissue and a 
more drastic decrease in milk quality.  
In an effort to further elucidate the causes for the variation observed in our 
cohort of dairy cattle, we elected to compare the in vitro responses of fibroblasts isolated 
from Holstein and Angus animals. These two breeds of cattle have undergone extensive 
selection for different production traits, which may introduce genetic variants within key 
innate immune response genes. Furthermore, the early life environment of calves from 
these two breeds differ, thereby providing an opportunity for differences in epigenetic 
modifications between Holstein and Angus animals. A comparison of the fibroblast LPS 
response between these two breeds revealed that Holstein cultures produced more IL-8 
following LPS stimulation. The observation that Holsteins responded more robustly than 
Angus is in agreement with several other groups that have shown the Holstein breed 
suffers more severe clinical symptoms following parasite challenges, and has greater 
expression of several pro-inflammatory genes at tick attachment sites compared to breeds 
of B. indicus cattle. 
As these observed in vitro differences could be due to both genetic and 
epigenetic differences between the Holstein and Angus breed, the transcriptome of 
unstimulated and LPS-treated fibroblast cultures from both breeds were examined using 
RNA-Seq, and the DNA methylation patterns were compared on genomic DNA isolated 
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from unstimulated cultures with MIRA-Seq (Methylated CpG Island Recovery Assay). 
RNA-Seq analysis revealed a number of innate immune response genes, including TLR4, 
IL-8, CCL20, and TNF-α, were differentially expressed between Angus and Holstein 
cultures. As TLR4 expression was greater in Holstein cultures, this may lead to an 
increased ability to recognize and respond to LPS by this breed, and a greater capacity to 
bind LPS would allow for increased activation of the transcription factors that promote 
the expression of inflammatory mediators. Surprisingly, there were few differences in the 
DNA methylation levels. MIRA-Seq analysis did uncover 49 regions within the genome 
that had different rates of methylation between Holstein and Angus cultures, however, 
innate immune response genes were under-represented in these regions.  
The breed difference in the innate immune response is exciting, and provides an 
opportunity to explore the effects that the early life environment can have on the 
magnitude of the inflammatory response in an animal. While beef calves suckle from the 
dam and have access to pasture and the rest of the beef herd, dairy calves are separated 
from the dam, fed a milk-replacer based diet, and often housed individually. Differences 
in the early life environment such as the rates of exposure to commensal and pathogenic 
bacteria between suckled calves and bottle-fed calves may induce epigenetic 
modifications in genes involved with the innate immune response. Our analysis of 
epigenetic differences between Holstein and Angus fibroblasts was done exclusively with 
MIRA-Seq, and while this technology provides a description of the genome-wide 
methylome, its sequencing resolution is approximately 100bp. Smaller changes in the 
DNA methylation pattern would have been missed in this analysis. Future studies 
comparing the DNA methylation levels between dairy and beef cattle using a more 
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sensitive technique, such as RRBS or whole genome bisulfite sequencing, are warranted. 
If an increase in methylation is identified as a key factor leading to a reduced innate 
immune response, perhaps feeding methyl donors to the dairy dam during pregnancy can 
induce greater methylation of inflammatory genes in the fetus, thereby creating a more 
desirable, low responding offspring. 
Several studies completed in rodents have shown that events occurring in early 
life can have long-lasting effects on the innate immune response of the adult animal. 
Exposure to bacterial compounds such as LPS has been shown to induce a reduction in 
pro-inflammatory mediators following a subsequent LPS challenge in adulthood, 
essentially creating a low responding individual. As the research presented here has 
shown that a low responding phenotype is desirable in dairy animals, we attempted to 
replicate these results from the rodent studies in dairy calves. However, our efforts 
proved ineffective, as calves exposed to the early life LPS had similar levels of 
inflammatory mediators in serum following a subsequent LPS challenge as the calves that 
had received saline in early life.  
This work on dairy calves was novel, therefore, the dosage and timing of the 
early life LPS was based off previous studies, which had been completed in rodents. 
Bovines are known to be more sensitive to LPS as compared to mice and rats, so a much 
lower dose of LPS was chosen in hopes of avoiding severe systemic responses, but still 
inducing a moderate degree of inflammation that might lead to epigenetic changes in 
innate immune response genes. However, this dose of LPS still produced a very vigorous 
response from the calves, with substantial inflammation and clinical symptoms. Perhaps 
an even lower dose would be better as this response may have been too high for the 
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desired result. Additionally, the timing of the LPS exposure in the calves may not have 
been at a critical time to induce epigenetic modifications of innate immune response 
genes, as the timing of the LPS in rodent studies was shown to be crucial for the 
induction of a lower innate immune response. Future studies examining the effects of 
different LPS doses or the timing of the early life exposure on the innate immune 
response of the calf are warranted.  
As the world’s population increases, the demand for food, and greater efficiency 
in the production of that food increases as well. Within the dairy industry, the increased 
production of milk to fill the demand for dairy products needs to be cost-effective for the 
producer while maintaining the welfare of the dairy cow. Animals that respond more 
vigorously to mastitis can make both of those tasks difficult, as these animals often 
require more extensive treatment, have greater losses in milk production, and generally 
suffer greater pain and discomfort than animals with a milder inflammatory response. 
These studies presented here have advanced the knowledge of the innate immune 
response of the bovine. We have shown that a reduced innate immune response is more 
beneficial for the dairy animal, as there are less pro-inflammatory mediators secreted into 
the milk and less tissue damage to the mammary gland. In addition, this milder response 
does not increase an animal’s propensity towards the development of a chronic S. aureus 
mammary infection.  
Furthermore, the examination of breed-dependent differences in the innate 
immune response resulted in the development of a panel of genes that show differential 
expression between low and high responding phenotypes. These biomarkers can be used 
in future in vitro studies to more accurately define an individual’s phenotype. As we have 
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shown that a low innate immune response is more desirable in the dairy animal, 
identifying animals with this phenotype at a young age, or inducing that phenotype 
through environmental factors would be financially beneficial for the producer since 
heifer rearing costs are second to feed costs on a dairy farm. Our attempt to induce a 
lower innate immune response in dairy calves was not successful, however, this work 
provides a foundation on which future studies can build on in determining what 
environmental cues may result in the creation of a low responding dairy animal. 
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Appendix A: LPS response of dermal fibroblasts isolated from 
genomically tested dairy cattle 
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A.1 Experimental Design and Rationale 
The innate immune response can be quite variable between animals during a case 
of mastitis with some animals experiencing mild inflammation and others exhibiting a 
more severe inflammatory response. Selecting for an effective innate immune response 
that results in pathogen clearance while minimizing collateral damage to the mammary 
tissue is desirable by dairy producers. Genomic testing has been used within the dairy 
industry for animal selection since 2007 (Marcos V.B. Silva, 2014); and since it’s 
implementation, it has allowed dairy producers to determine the genetic potential of 
offspring at a young age, thereby reducing the generation interval and increasing the 
accuracy of selection (Weigel et al., 2012). The most cost-effective way for a producer to 
estimate the genetic merit of an animal is with SNP chips; which contain probes for 
thousands of known SNPs in the bovine genome that have been linked (directly or in-
directly) to different production, health, and conformation traits of the dairy cow (Zare et 
al., Kadri et al., 2015).  
Productive life (PL) is a trait in which the assigned numerical value indicates the 
number of additional months an individual is expected to stay within the herd compared 
to the average Holstein animal that was genomically tested (Holstein Association USA); 
with the average Holstein bull stud having a PL of 0.95. An animal with a PL of 3.5 
would be expected to have an additional 3.5 productive months in the herd compared to 
the average Holstein, and an animal with a PL value of -1.0 would be expected to have 
one less productive month than the average Holstein. In this sense, PL is considered a 
fitness trait, as it takes into consideration many phenotypes that contribute to the overall 
health and longevity of the animal, including feet and leg conformation, udder 
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attachment, milk production, and conception rates. Therefore, PL may be a useful 
indicator of an animal’s ability to mount an effective innate immune response to mastitis 
without suffering severe clinical symptoms that can be accompanied by mammary tissue 
damage and potential removal from the herd. Using our fibroblast cellular model, we 
sought to determine if PL could be a predictor of an animal’s in vitro innate immune 
response phenotype.  
A.2 Materials and Methods 
A.2.1 Experimental Design and Animal Selection  
The owner of Welcome Stock Farm (Saratoga Springs, NY) was performing 50K 
SNP chip analysis (Illumina, Inc., San Diego, CA) on all of his animals, and agreed to 
give our laboratory access to the SNP chip data files. We selected two groups of adult 
female Holsteins: one with a high PL value (n=6; avg. PL of 5.4 ± 0.46) and one with a 
low PL value (n=5; avg. PL 0.36 ± 0.89) for inclusion on this study (Table 1). We did not 
have access to health records or monthly SCC of the animals selected for this study. The 
University of Vermont’s Institutional Animal Care and Use Committee approved all 
animal procedures before commencement of the study. 
A.2.2 Dermal Fibroblast Isolation 
Dermal fibroblasts were isolated as described previously (Kandasamy et al., 
2011). Briefly, skin biopsies were collected from each animal, and dermal fibroblasts 
were isolated following a 6 h digestion with collagenase type I (Life Technologies, Grand 
Island, NY). Cells were seeded into a 25-cm2 flask (Corning Inc., Corning, NY) and 
cultured in Dulbecco’s modified eagle medium (DMEM; Hyclone Laboratories, Logan, 
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UT) supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories), 1X 
insulin-transferrin-selenium (ITS; Mediatech Inc., Herndon, VA), and 1X antibiotic 
cocktail (100 U/mL of penicillin, 100 µg/mL of streptomycin, and 0.25 µg/mL of 
amphotericin B; Hyclone Laboratories). Once confluent, cells were detached with 0.25% 
trypsin (MP Biomedical, Santa Ana, CA) and seeded into a 75-cm2 flask (Corning Inc.) 
for approximately 2 days, after which, cells were detached and expanded into three 75-
cm2 flasks. Following 3 days in culture, fibroblasts were detached and frozen in DMEM 
supplemented with 20% FBS and 10% dimethyl sulfoxide (Sigma- Aldrich, St. Louis, 
MO) and aliquots were cryopreserved in liquid nitrogen for subsequent challenges.  
A.2.3 Dermal Fibroblast Challenges 
Aliquots of dermal fibroblasts were revived from cryopreservation and seeded 
into a 75-cm2 flask for approximately 3 days to allow for adequate cell expansion. Once 
confluent, cells were lifted with trypsin and seeded into a 6-well plate (Corning Inc.) at a 
cell concentration of 1.25 x 105 cells/ml in 2 ml of media total and incubated for 24 h. 
After removal of old media, cells were treated with either fresh media, media containing 
100ng/ml of ultra-pure LPS isolated from Escherichia coli O111:B4 (Sigma-Aldrich), or 
media containing 1ng/ml of recombinant bovine IL-1β (AbD Serotech, Raleigh, NC) for 
24 h. Following the challenge, media was collected from each well, centrifuged at 10,000 
x g for 1 min to remove cellular debris and stored at −20°C until future analysis for IL-8 
and IL-6 protein.  
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A.2.4 IL-8 and IL-6 ELISA 
The concentration of IL-8 in conditioned media samples was quantified by a 
custom sandwich ELISA as previously described (Kandasamy et al., 2011). Mouse anti-
bovine IL-8 (clone 170.13 from Samuel Maheswaren, University of Minnesota, St. Paul, 
MN) and biotinylated goat anti-human IL-8 (R&D Systems Inc., Minneapolis, MN) were 
used as capture and detection antibodies, respectively, and recombinant bovine IL-8 
(Thermo Scientific, Rockford, IL) as the assay standard. The concentration of IL-6 in 
conditioned media was determined with a commercially available bovine IL-6 ELISA kit 
(Thermo Scientific). The capture and detection antibodies were plated at 1:100 and the 
streptavidin-horseradish peroxidase was plated at 1:400. Recombinant bovine IL-6 was 
used as the assay standard.  
A.2.5 Statistical Analysis  
 Differences in the levels of IL-8 and IL-6 between low and high PL cultures 
were determined using an unpaired t-test in Prism 6.0 (Graph Pad Prism 6.0). 
 
A.3 Results 
Fibroblasts isolated from animals with a high PL (n=6) and a low PL (n=5) were 
challenged for 24 h with either LPS (100ng/ml) or IL-1β (1ng/ml) and media was 
collected to determine the amount of secreted IL-8 and IL-6 protein. The amount of IL-8 
protein produced from the low and high PL cultures following LPS exposure (863 ± 184 
vs. 969 ± 241 pg/ml, respectively; Figure 1A) and IL-1β treatment (5664 ± 685 vs. 6161 
± 1036 pg/ml, respectively; Figure 1B) was not significantly different. Similarly, levels 
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of secreted IL-6 protein following LPS or IL-1β challenges were not different between 
low and high PL cultures (Figure 2A and 2B).  
 
A.4 Discussion 
In this study, dermal fibroblasts were isolated from animals with different 
productive life (PL) values and challenged with LPS to determine if we could predict an 
animal’s innate immune response phenotype based on the PL values assigned to her. This 
trait is an indicator of how many additional months an animal may remain in the herd 
compared to her herd-mates. Since longevity in a dairy herd requires a combination of 
health and conformation traits that minimize disease risk while maximizing milk 
production, an animal with a greater PL may have a lower propensity to succumb to a 
severe mammary infection that could result in removal from the herd. Surprisingly, 
fibroblast cultures established from the two groups of animals (low and high PL) had 
similar IL-8 and IL-6 protein responses following the LPS challenge, suggesting that PL 
may not be the best trait to predict the innate immune response phenotype of an animal.  
The most common trait that producers utilize to select animals for greater mastitis 
resistance is somatic cell count (SCC). This involves collecting a composite milk sample 
once a month to determine the level of immune cells present in the mammary gland. 
Within a healthy gland there are some resident immune cells readily available to sense 
and respond to an invading pathogen, and the benchmark SCC for a healthy gland is 
200,000 cells/ml of milk (or lower). However, during a case of mastitis, the SCC will 
increase dramatically in the infected quarter due to the recruitment of neutrophils to clear 
the infection (Wellnitz and Bruckmaier, 2012), and in some cases this rise in SCC can be 
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detected by the monthly SCC testing. However, the increase in SCC due to some 
mammary infections, especially coliforms like E. coli, can be missed as the infection can 
be cleared in a matter of days (Bannerman et al., 2008, Kandasamy et al., 2011). Even if 
the infected quarter still has an elevated SCC at the time of sample collection, the 
composite SCC could be close to a healthy SCC, which may result in that animal being 
inadvertently classified as an un-infected animal that has higher mastitis resistance than 
her herd-mates. Including other traits, such as mastitis severity, may increase the 
accuracy of selecting for animals that mount an effective yet more controlled 
inflammatory response towards mastitis.   
In conclusion, the similar in vitro response between the low and high PL 
fibroblast cultures suggests that PL may not be an accurate predictor of the innate 
immune response phenotype of an animal. However, the animals on the collaborating 
dairy farm have undergone genomic testing and selection for several generations, creating 
a herd of cattle with higher genetic merit than the average commercial dairy herd. 
Therefore, even animals with a low PL (for this herd) may still have a higher PL 
compared to the average commercial Holstein cow. Additionally, the lower numbers of 
animals in each group may have limited our ability to detect differences in the in vitro 
innate immune response. Due to the high worth of these cattle, we were limited in the 
number of animals available for fibroblast collection and in vivo challenges were not an 
option.   
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Table 1 Productive life (PL) values and birth dates for the selected animals. 
 
 
 
Animal ID Birth Date Productive Life (PL) 
Low Productive Life Animals 
2706 7/11/08 -0.7 
2510 8/26/07 -0.3 
2699 7/2/08 0.3 
2705 7/11/08 1.2 
2590 12/17/07 1.3 
High Productive Life Animals 
2683 6/10/08 5.1 
2610 1/25/08 5.1 
2793 10/23/08 5.2 
2563 11/16/07 5.3 
2629 3/18/08 5.6 
2472 7/7/07 6.3 
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Figure 1 IL-8 protein production from dermal fibroblasts following LPS and IL-1β 
challenges.  
 
Aliquots of fibroblasts isolated from animals with a high productive life (PL) value (n=6) 
and animals with a low PL (n=5) were revived and challenged in parallel for 24 h with 
LPS (100ng/ml; A) or IL-1β (1ng/ml; B). Media was collected and the amount of 
secreted IL-8 protein was quantified via ELISA. Values are mean ± SEM. There were no 
significant differences between low and high PL cultures in the amount of IL-8 produced.  
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Figure 2 IL-6 protein production from dermal fibroblasts following LPS and IL-1β 
challenges.  
 
Aliquots of fibroblasts isolated from animals with a high productive life (PL) value (n=6) 
and animals with a low PL (n=5) were revived and challenged in parallel for 24 h with 
LPS (100ng/ml; A) or IL-1β (1ng/ml; B). Media was collected and the amount of 
secreted IL-6 protein was quantified via ELISA. Values are mean ± SEM. There were no 
significant differences between low and high PL cultures in the amount of IL-6 produced. 
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Appendix B: A comparison of LPS-response of dermal fibroblasts 
isolated from young Angus and Holstein animals 
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B.1 Experimental Design and Rationale 
 
 Within our dermal fibroblast cellular model we observed a range in the IL-8 
protein responses following LPS challenge. Based on the wide range in the amount of IL-
8 produced, we have classified the extremes of this range as low and high responding 
phenotypes, and went on to confirm that these in vitro phenotypic classifications are 
maintained in vivo during an intra-mammary challenge (Kandasamy et al., 2011). 
Similarly, Green and Kerr (2014) observed low and high IL-8 response phenotypes from 
fibroblast cultures established from the same animal at 5 and 16 months of age. Cultures 
from the young animals had a much lower IL-8 response following an LPS challenge 
compared to cultures from the older animals. Expanding on the phenotypic differences, 
we observed that fibroblasts from 19 month old Angus animals exhibited a lower IL-8 
protein response following an LPS challenge compared to fibroblasts from age-matched 
Holstein animals (Benjamin et al., 2016). The aim of this study was to confirm the breed-
difference observed previously in a second set of fibroblast cultures established from 
younger animals.  
B.2 Materials and Methods 
B.2.1 Dermal Fibroblast Isolation and Challenge 
Skin biopsies were collected from Angus (n=7; age 13.2 ± 0.46 months) and 
Holstein (n=8; age 15.2 ± 0.26 months) animals and dermal fibroblasts were isolated as 
previously described (Kandasamy et al., 2011). Following a 6 h digestion with 
collagenase type I (Life Technologies, Grand Island, NY), fibroblasts were seeded into 
25-cm2 flask (Corning Inc., Corning, NY) in Dulbecco’s Modified Eagle Medium 
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(DMEM; Hyclone Laboratories, Logan, UT) with 10% fetal bovine serum (FBS; Hyclone 
Laboratories), 1X antibiotic cocktail (100 U/mL penicillin, 100µg/mL streptomycin, and 
0.25µg/mL amphotericin; Hyclone Laboratories), and 1X Insulin-Transferrin-Selenium 
(ITS; Mediatech Inc., Herndon, VA). Upon confluency, cells were detached with 0.25% 
trypsin (MP Biomedical, Santa Ana, CA) and seeded into a 75-cm2 flask (Corning Inc.) 
in DMEM with 5% FBS, 1X antibiotic cocktail, and 1X ITS. After approximately three 
days, cells were expanded into three 75-cm2 flasks, and once confluent, cells were 
detached from the flasks with trypsin, diluted in DMEM supplemented with 20% FBS 
and 10% dimethyl sulfoxide (Sigma- Aldrich, St. Louis, MO), and cryopreserved in 
liquid nitrogen for subsequent challenges.   
Aliquots of fibroblasts were revived from liquid nitrogen, seeded into a 75-cm2 
flask, and incubated at 37°C with 5% CO2 for three days to allow for adequate cell 
expansion. Cells were detached with trypsin, counted, and seeded into 6-well plates 
(Corning Inc.) at 1.25 x 105 cells/ml in a total volume of 2ml. Media was replaced 24 h 
later with 2 ml of either fresh media, media containing 100ng/ml of ultra-pure LPS 
isolated from Escherichia coli O111:B4 (Sigma-Aldrich), or media containing 1ng/ml of 
recombinant bovine IL-1β (AbD Serotech, Raleigh, NC). Following a 36 h challenge, 
media was collected from each well, centrifuged at 10,000 x g for 1 min to remove 
cellular debris and stored at -20°C for IL-8 protein analysis.  
B.2.2 IL-8 Quantification  
The concentration of IL-8 in conditioned media samples was determined by a 
custom sandwich ELISA as described previously (Kandasamy and Kerr, 2012). Mouse 
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anti-bovine (clone 170.13, gifted by Samuel Maheswaren, University of Minnesota, St. 
Paul, MN) and a biotinylated goat anti-human IL-8 (R&D Systems Inc., Minneapolis, 
MN) were used as capture and detection antibodies, respectively. Recombinant bovine 
IL-8 (Thermo Scientific, Rockford, IL) was used as the assay standard. The detection 
limit for this assay was 130pg/ml.  
B.2.3 Statistical Analysis 
Differences in IL-8 protein production between Angus and Holstein fibroblast 
cultures were determined using a Student’s t-test (Graph Pad Prism 6.0). 
 
B.3 Results 
Fibroblasts isolated from young Angus (13.2 m) and Holstein (15.2 m) animals 
were challenged for 36 h with either LPS (100ng/ml) or IL-1β (1ng/ml) and IL-8 protein 
was quantified. Angus cultures produced significantly lower levels of IL-8 following LPS 
exposure compared to Holstein cultures (74 ± 38 vs. 453 ± 78 pg/ml, respectively; Figure 
1). A similar response was observed following IL-1β treatment, with Angus cultures 
producing less IL-8 than Holstein cultures (Figure 1). 
 
B.4 Discussion 
In this study, dermal fibroblasts were isolated from young Angus (13.2 m) and 
Holstein (15.2 m) animals to confirm breed-differences in the fibroblast LPS response 
observed previously (Benjamin et al., 2016). Similar to the low IL-8 response phenotype 
previously observed in cultures from 19 month old Angus animals, cultures isolated from 
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13 m old Angus produced significantly less IL-8 protein post-LPS exposure compared to 
15 month-old Holsteins. A potential drawback of this experiment was the two-month, 
significant (P < 0.05) difference in age between the breed groups. Given that we have 
previously reported an age-dependent increase in fibroblast responsiveness (Green et al., 
2011), a portion of the observed breed difference could have been due to an age 
difference. However, we are confident that the breed-difference observed in 19 month old 
animals was confirmed in a set of fibroblast cultures isolated from younger Angus and 
Holstein animals. 
B.5 References 
 
Benjamin, A. L., B. B. Green, B. A. Crooker, S. D. McKay, and D. E. Kerr. 2016. 
Differential responsiveness of Holstein and Angus dermal fibroblasts to LPS 
challenge occurs without major differences in the methylome. BMC genomics 
17(1):258. 
 
Green, B. B. and D. E. Kerr. 2014. Epigenetic contribution to individual variation in 
response to lipopolysaccharide in bovine dermal fibroblasts. Veterinary 
immunology and immunopathology 157(1-2):49-58. 
 
Kandasamy, S., B. B. Green, A. L. Benjamin, and D. E. Kerr. 2011. Between-cow 
variation in dermal fibroblast response to lipopolysaccharide reflected in 
resolution of inflammation during Escherichia coli mastitis. Journal of dairy 
science 94(12):5963-5975. 
 
Kandasamy, S. and D. E. Kerr. 2012. Genomic analysis of between-cow variation in 
dermal fibroblast response to lipopolysaccharide. Journal of dairy science 
95(7):3852-3864. 
 
  
 197 
 
 
 
 
 
 
 
 
 
 
Figure 1 IL-8 protein production from Angus and Holstein dermal fibroblasts. 
Dermal fibroblasts were isolated from Angus (n=7; age 13.2 m) and Holstein (n=8; age 
15.2 m) animals and challenged for 36 h with either LPS (100ng/ml) or IL-1β (1ng/ml). 
Media was collected post-challenge from each well and the amount of IL-8 protein was 
determined via ELISA. Wells containing plain media (negative control) had no detectable 
IL-8. Values are mean ± SEM and ** indicates a P < 0.01.  
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Appendix C: Detailed methods for IV catheterization prior to an in vivo 
LPS challenge  
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C.1 Methodology Rationale 
 This appendix contains a detailed description of the methodology for inserting 
an intravenous (IV) catheter in the jugular vein of an animal to facilitate blood sampling 
and administration of lipopolysaccharide (LPS) during a challenge.    
 
C.2 Catheterization Method 
Twelve hours prior to an IV LPS challenge, each animal was fitted with a jugular catheter 
to allow for easier administration of the LPS solution and blood sampling. Twenty-four 
hours prior to the catheterization, a 50 cm section of polyethylene tubing (I.D. 1.19mm, 
O.D. 1.70mm; Intramedic, BD) was cut per animal and sanitized overnight in a Nolvasan 
S solution (Pfizer, NY, NY). The day of catheterization each animal was secured in a 
headlock and a small square patch of fur on top of the jugular vein was clipped and the 
area was cleansed with 70% ethanol. The polyethylene tubing was prepared by rinsing 
and flushing out the Nolvasan solution with sterile saline. A 12-gauge, 1.5-inch metal hub 
needle (Hamilton, Reno, NV) was then inserted into the jugular vein, and upon 
visualization of blood through the needle, 20-25 cm of the polyethylene tubing was 
inserted through the needle. The needle was carefully removed from the skin, leaving the 
tubing in the jugular vein. A 7.6 x 7.6 cm square piece of veterinary elastic adhesive tape 
(3M, St. Paul, MN) was prepared by cutting a small hole in the center (for the tubing), 
and a small amount of Kamar adhesive (Kamar Products, Inc., Zionsville, IN) was 
applied to the non-adhesive side of the elastic tape. The needle was pulled along the 
length of the tubing and removed, and then a small 2.5 x 2.5 cm square of white medical 
tape was folded over the tubing at the entry point to act as a reference point for the length 
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of tubing in the jugular vein. The tubing was then carefully fed through the small opening 
in the tape and the Kamar adhesive was stuck to the animal’s neck over the site where the 
tube entered the skin. An 18-guage luer stub adapter (Intramedic) was attached to the free 
end of the tubing and a sterile syringe was used to draw a small amount of blood to 
ensure the tubing was still properly placed. Once this was confirmed, a solution of 
heparinized saline was injected to prevent clotting in the tubing. A three-way stopcock 
with Swivel Male Luer Lock (Smiths Medical ASD, Inc., Dublin, OH) was then attached 
to the adapter to allow for infusion of the LPS solution as well as drawing of samples. 
Finally, the excess tubing was loosely coiled and two rolls of vet wrap (SyrVet, Waukee, 
IA) were wrapped around the animal’s neck to protect the catheter site and contain the 
excess tubing. A single strip of white adhesive medical tape was wrapped loosely around 
the animal’s neck to secure the vet wrap. The animal was rested for ~12 hours. The 
following morning, each catheter was inspected to ensure it was functional prior to the 
start of the LPS challenge. 
 
 
 
 
 
 
 
 
 
